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Abstract 
Dielectrophoresis (DEP) is an electrostatic technique which can be used to examine cellular 
electrophysiology. This method offers many advantages in characterising a cell population over 
conventional methods; however, it has yet to see mainstream pharmacological application.  This 
work demonstrates a DEP assay, 3DEP, as a viable method in the electrophysiological measurement 
of cells, its application for measuring drug effects, and more specifically, its use as a molecular 
targeting tool in circadian research.   
The reliability of the assay was investigated measuring DEP response of several cell types with high 
resolution spectra and the operational limits of automatic fitting algorithms were determined for 
single and multiple populations. It was found that reliable readouts from 3DEP could be achieved in 
as little as 6 s.  The ability of 3DEP to test drug cytotoxicity on Jurkat cells was tested with 
doxorubicin. DEP measured IC50 values  compared well with previoiusly measured colorimetric assay 
3-(4,5-Dimethylthiazol-2-yl)-2,5-Diphenyltetrazolium Bromide (MTT) experimental results, 
suggesting 3DEP could provide an alternative way to measure molecular events due to drug 
intervention.   
With 3DEP having been appropriately optimised, it was then applied to the study of RBC circadian 
rhythm through both human and vole in vitro and in vivo studies.  Disruption of these rhythms can 
lead to negative health outcomes related to areas such as metabolism, cardiovascular health, and 
mental health. Since RBCs are anucleated, the mechanism cannot rely on the typically accepted 
transcription-translation feedback loop found for other cells. 3DEP detected robust rhythmicity in 
the electrophysiological properties of RBCs in isolated and whole blood samples.  These rhythms 
were altered when introduced to pharmacological intervention. Taken together, these findings 
suggest a model for the non-transcriptional clock in RBCs.  
Many applications of the 3DEP system were investigated with respect to molecular targeting 
highlighting 3DEP’s utility and limitations as a biological tool in research.    
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Chapter 1: Introduction 
1.1 Molecular Targeting 
Molecular targeting is normally a lengthy process involving identification of drug targets, 
characterising drug effect on those targets, and validation of the drug in vivo. This testing stage 
usually involves a great number of experiments typically carried out on animals. With European 
legislation dictating that animal experimentation may only be conducted when no other alternative 
is available, the need for adequate in vitro testing is high (Freshney 2005).  New cell lines, 
organotypic cultures and long established cultures have made testing in vitro a good alternative to 
animal testing. However, these also present a number of challenges. Since the potency of a 
treatment can vary by cell types, many cell types must be tested before the drug effectiveness can 
be adequately characterised.    
Typically, this is done through colorimetric or fluorescent assays to monitor cell reactions. It has 
been found, however, that the use of markers could cause interference with the cell or the drug 
mechanism. Addition of markers is also costly, time consuming and requires highly skilled operators. 
Thus there has been an increase in the need for low cost, non-invasive, rapid, miniaturised systems 
for sample preparation, analysis and diagnosis. The reduction in size has benefits such as mass 
production, transportability, automation, parallelization, reduction in sample volume and precision. 
Advances in micro-engineered systems and fabrication have begun to meet some of these issues 
allowing for tightly controlled and monitored microfluidic systems (Ota et al. 2010, Hardelauf et al. 
2011, Jin et al. 2011). There are several tools for the analysis of materials in micro-fluidic systems 
such as capillary electrophoresis, field-flow fractionation, and optical methods, based on labs on 
chips. However, labelling procedures are often still necessary prior to analysis, which can alter 
critical cell characteristics. 
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1.2 Circadian Rhythms 
Coordination of many of the body’s behavioural, metabolic, and physiological processes are 
controlled around the 24 hour clock typically controlled through endogenous mechanisms, but can 
be resynchronised (entrainable) by external stimuli. The process of the body overcoming jetlag via 
rhythms resetting is one example of this. Circadian rhythms are observed in most mammalian cells, 
in vivo and in vitro. From rhythmic gene expression and cell division, to metabolic oscillations, 
biological clocks regulate myriad aspects of cell biology and physiology. Hence, their disruption is 
strongly associated with disease (Partch et al. 2014). This interest centres on the possibility of 
producing pharmacological interventions to counteract the problems associated with disrupted 
circadian rhythms. With the rise of instances of sleep disorders, psychiatric disease and shift work all 
associated with circadian disruption, this is of wide interest across society.  
Much work has gone into finding molecular targets for this intervention. Current models indicate the 
main drivers of the process are the products of rhythmic expressions of ‘clock genes’ over a 24 hour 
cycle, though the specific transcriptional component can differ (Partch et al. 2014). O’Neill & Reddy, 
2011 showed following temperature entrainment, circadian rhythms were present in human red 
blood cells (RBCs) (O'Neill and Reddy 2011). Mature RBCs shed their nucleus to maximize their 
accommodation of haemoglobin and thus are anucleated. Since RBCs contain no nucleus, they are 
incapable of transcription, and thus a cycling gene clock cannot exist in these cells. Very little is 
known about RBC clock mechanisms, or whether functional consequences exist for erythrocyte 
biology.  
Delineating this mechanism requires comprehensive characterisation of circadian rhythms in RBCs. 
One key question is whether post-translational systems that govern the period of circadian 
oscillations in nucleated cells similarly impact RBC timekeeping. Currently, no manipulations of the 
RBC clock period have been reported. Another key question is whether the RBC clockwork is simply a 
lingering evolutionary rhythm that solely affects metabolism, or whether instead it functionally 
regulates other aspects of RBC biology that directly influence gas transportation, for example.  
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Whole blood is also of interest as the number of RBCs in blood demonstrates rhythmicity under 
clock gene control as it was suppressed and phased advanced in CLOCK mutant mice. Whole blood 
performs many essential functions through its three types of cells such as oxygen transport (RBCs), 
immune response (leukocytes), and clotting (thrombocytes-platelets). Blood cells account for 45% of 
whole blood (plasma the remaining 55%) and all three types have demonstrated circadian rhythm 
(Pritchett and Reddy 2015). Of particular interest is the observed daily rhythmic severity of instances 
of stroke, heart attack and allergic response. The clock in whole blood could underlie these 
conditions’ severity and serve as a vestibule to treat these as well as effects of diet, shift work and 
drug delivery.  
Since pharmacological intervention depends on a molecular target, any medications designed to 
counter effects of circadian disruption, the mechanism behind these rhythms must first be 
discovered. Since RBCs have no nucleus, the membrane and cytoplasm will be essential in this 
discovery with the potential for electrophysiology to have a prominent role.  
1.3 Dielectrophoresis  
Dielectrophoresis (DEP) is the movement of a polarizable particle, such as a cell, as the result of 
induced polarization by a nonuniform electric field (Pohl 1951, Pohl 1958, Pohl 1978b). The 
direction and velocity of cell motion is dependent, in part, on the frequency of the applied 
voltage and the dielectric properties of the cell. Every membrane-bound cell or sub-cellular 
particle has dielectric properties such as surface charge or membrane capacitance, together with 
resistive properties of the membrane and cell cytoplasm. By observing the response of cells to a 
nonuniform electric field across a range of frequencies, these dielectric properties can be 
measured (Irimajiri et al. 1979, Gascoyne et al. 1992, Jones 1995). The resultant 
electrophysiological spectrum, when analysed, allows the determination of electrophysiological 
parameters including effective membrane conductance (Geff)-indicative of ionic transport across the 
membrane and on its surface, capacitance (Ceff)-indicative of membrane morphology and/or 
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composition and cytoplasmic conductivity (σcyt)-indicative of free ionic concentration within the 
cytoplasm.  
This technique exploits intrinsic cell electrical properties and does not require labelling with 
antibodies or stains, rendering DEP an ideal tool for rapid cell analysis and manipulation.  Early 
studies characterised malignant melanocytes (Mischel et al. 1983), B-lymphocytes, hybridomas and 
myeloma (Stoicheva 1986), erythrocytes (Tsoneva et al. 1986) and chloroplasts (Stoicheva et al. 
1987) and was also used to detect changes of cells as a result of adding chemicals (Burt et al. 1990). 
More recent applications of DEP characterisation include multi-drug resistance (MDR) of human 
breast cancer cell lines (Coley et al. 2007), distinction of neural stem/precursor cells (NSPCs) from 
different developmental progression and prediction of fate (Flanagan et al. 2008), neurogenic 
potential of NSPCs (Labeed et al. 2011), and separation of cells by stage within the C2C12 myoblast 
multipotent mouse model (Muratore et al. 2012). Along with characterisation, DEP has been used in 
a wide range of cellular applications with examples including stem cells (Pethig et al. 2010), cancer 
(Salmanzadeh et al. 2013, Zhao et al. 2014), and drug discovery (Pethig 2013). Despite its attractive 
advantages, its adoption as a method in general cell biology has been limited by the electrode 
technology and the difficulty of data analysis. 
To address this, a DEP well instrument, branded as 3DEP, has been developed. This consists of three-
dimensional electrode circular wells made of alternating layers of copper and glass fibre reinforced 
epoxy resin (FR4).  The wells have annular electrodes along the length of the tube, reducing cell 
movement due to DEP to a 1-dimensional system; cells move towards or away from the centre line 
at a rate proportional to their DEP response. The 3DEP chips contain 20 of these wells, 
simultaneously filled with cell suspension, each energised by a different frequency via 
independently-controlled connections. This provides simultaneous measure of the DEP response of a 
cell suspension across a 20 frequency spectrum.  The 3DEP system provides real-time analysis of 
these spectra, with minimal user input.  
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1.4 Thesis Aims and Objectives 
It has been shown that electrophysiological changes in cells are often times precursors to molecular 
events typically investigated in pharmacological studies. Though DEP has shown promise, its broader 
use in research has been limited. This thesis aims to realise 3DEP’s potential in this setting, and to 
determine its utility for molecular targeting in circadian studies.  
 A number of research questions were investigated with respect to the 3DEP system, with the 
following objectives: 
1.) Can 3DEP provide real-time cellular measurements and analysis on large quantities of 
spectra data essential for practical use in a research setting? 
To investigate this, the 3DEP system has been used to obtain dielectric spectra from cell 
suspensions under varying electric field exposure times (40s, 20s, and 6s) with or without 
resuspension in the 3DEP chips. High resolution spectra of 40 and 100 points were 
investigated to determine the reliability of the fitting algorithm on a number of cell types 
(Jurkat, Yeast, RBCs, k562, HeLa). 
2.)  Do 3DEP measurements correlate to typically acquired values obtained in molecular 
targeting and pharmacological studies? 
Subsequently, this thesis investigates the sensitivity of the 3DEP system to account for 
heterogeneous (multipopulation) samples. The multipopulation dielectric model was 
employed on known mixtures of healthy and affected Jurkat cells treated with doxorubicin 
to assess 3DEP’s sensitivity in measuring up to 4 subpopulations of cells. These dielectric 
parameters were then carried through to determine dose response of Jurkat cells to 
doxorubicin comparing the IC50 determined by DEP to that of standard measuring 
techniques.  
3.) Can DEP be used as a screening tool in molecular targeting?   
To examine this, the 3DEP system has also been employed to determine if there is circadian 
rhythmicity in the electrophysiological parameters of fractionated and entrained RBCs as 
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well as whole blood; with the aim of providing the molecular mechanism to serve as a 
pharmacological target. Several pharmacological interventions were investigated to 
delineate the mechanistic genesis of this rhythmicity. Additionally, the rhythmicity of whole 
blood was investigated through vole tail knick samples and human finger prick samples to 
investigate DEP as a physiological phase marker of rhythmic events occurring in whole 
blood.   
1.5 Thesis Outline and Structure 
This thesis consists of two background chapters the first of which (Chapter 2) focuses on the theory, 
development, and applications of DEP. The theoretical basis of DEP force and the single-shell model 
is explained introducing Clausius-Mossotti factor. The history of DEP in the context of electrode 
design, data acquisition and analysis as well as biomedical applications is reviewed. Additionally, the 
commercialisation of DEP is discussed introducing the 3DEP system and advantages this technology 
offers. The second background chapter (Chapter 3) introduces mammalian cell physiology 
highlighting the various cell types used in this thesis. Cellular processes and pathologies such as 
apoptosis, circadian timing, and cancer are introduced and discussed in the context of 
electrophysiology.  
In the first research chapter (Chapter 4), the dielectric properties of several cell types (Jurkat, Yeast, 
RBCs, k562, HeLa) are determined through various generations of data acquisition and analysis. 
Methods including the various DEP media, cell counting and measuring, as well as MATLAB code 
development are highlighted. Here the results of high resolution spectra are examined for their 
statistical reliability for each cell type. Cell viability post-DEP is investigated as a key advantage of 
DEP over other measuring techniques.  Results from this are then applied to determine the 
sensitivity of the 3DEP system at assessing multiple populations of Jurkat cells treated with 
doxorubicin and undergoing apoptosis. This multipopulation analysis is then used to measure the 
IC50 of doxorubicin and compared to standard MTT analysis. The potential for 3DEP system to be 
employed in drug discovery is assessed and the limitations of the system are identified.  
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The second research chapter (Chapter 5) examines the application of DEP in measuring circadian 
rhythmicity in the dielectric properties of RBCs. Methods to fractionate, entrain, and test RBCs are 
optimised with methods of circadian analysis introduced such as cosinor curve fitting. Results from 
four blood donors are discussed along with two drug interventions to further examine the molecular 
mechanism of the RBC clock. The potential of 3DEP analysis as a circadian phase marker is 
introduced in this chapter with the application of 3DEP analysis on whole blood. This is done through 
vole tail knick samples on an ultradian time cycle (cycles of approximately every 2 hours). These 
results are additionally discussed in the context of minimising animal sacrifice as tail knick samples 
can be measured from the same host animal through the course of the experiment. Initial analysis 
on human finger prick samples is investigated to determine methods moving forward with 3DEP in a 
clinical setting.  
The last chapter of the thesis (Chapter 6) highlights and separates key findings and future work in 
several categories. The first being data analysis; suggestions for improved automatic fitting are made 
as well as potential additional information available from high resolution spectra. The second, drug 
interventions and experiments are proposed to further decipher the clock mechanism in the RBC (as 
well as nucleated cells). Lastly, the possibility of dielectric parameters being used as a phase marker 
in animal and human experiments is discussed.  
This thesis concludes with appendices containing individual DEP spectrum for the various 
optimisation studies (Appendix A), statistical analysis results (Appendix B), code used to analyse data 
(Appendix C), individual donor DEP data for control, treated, human and vole whole blood samples 
(Appendix D), ethics application approval letter (Appendix E) followed by a publication and 
conference proceedings list where data from this thesis has been presented (Appendix F). 
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Chapter 2: Dielectrophoresis (DEP) 
Since it was first described by Pohl (Pohl 1951, Pohl 1958, Pohl 1978b), DEP on biological particles 
has received a renewed attention as an attractive technology for precise particle manipulation in a 
variety of micro-bioprocesses (µ-bioprocess) over the past 20 years.  DEP is similar to underlying 
principles of electrophoresis, but uses more complex electric field conditions to induce particle 
motion dependent on the particles’ electrophysiology (Figure 1).This phenomenon was explained as 
a net force generated on a particle by the interaction between the particles’ induced dipole and the 
applied electric field. When a (polarizable) particle is exposed to an electric field, it polarizes creating 
a dipole. If the electric field is nonuniform, the electrostatic forces at each pole of the particle are 
unbalanced creating a net force (Figure 1) (Pohl 1958, Pohl 1978b). Unlike electrophoresis where 
motion depends solely on the charge of the particle (and thus only charged particles will exhibit a 
net force), the velocity and direction of cellular motion in DEP are dependent on the 
electrophysiological properties; in the case of a cell, the various cellular compartments, and the 
frequency of the applied electric field.    
 
Figure 1: Schematic of electrophoresis versus DEP.  A.) Electrophoresis is a common technique 
used to induce movement of charged particles (such as DNA, RNA and proteins) in a spatially 
uniform electric field. Neutral particles, such as cells, will experience no net force in this uniform 
field.  B.) Dielectrophoresis enables movement of cells (and any polarizable particle) suspended in 
a nonuniform electric field. The direction and magnitude of the movement is dependent on the 
applied frequency, suspending medium and the unique electrophysiological parameters of a 
particle type. 
 
Early experiments used machined needles to create the nonuniform electric field (Pohl 1951, Pohl 
1958, Pohl and Crane 1971, Pohl 1978b). Since then the term DEP has been expanded to include all 
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force components including higher order multi-poles and travelling wave DEP (Jones 1995, Gascoyne 
and Vykoukal 2002).  Such components include electrorotation in which the DEP force is generated 
by the dipole lag in a rotating electric field (Arnold and Zimmermann 1982, Arnold and Zimmermann 
1988, Wang et al. 1994a), electro-orientation in which the induced dipole aligns with the electric 
field , pearl chaining caused by dipole-dipole interaction (Pohl 1951, Pohl 1958, Pohl 1978b, Dussaud 
2000, Wong 2004) and  travelling wave DEP (twDEP)  in which the DEP force is generated by the 
dipole lag in a traveling electric field (Batchelder 1983, Masuda et al. 1988). The force fields exerted 
on the suspended particle have been shown to have minimal adverse effects on the integrity of the 
biological structures (Wang et al. 1999, Menachery and Pethig 2005, Lu et al. 2012), making it an 
attractive, easy to control, label-free technique over typically low throughput systems requiring 
extensive cell preparation. DEP has been extensively used to manipulate and non-invasively 
characterise normal and cancerous cell types, red blood cells, bacteria, fungi, viruses and DNA to 
obtain their intrinsic electrophysiological properties (Pethig 2010a).  
2.1 DEP Theory 
To derive the DEP force acting on a cell, some assumptions must be made about the system. 
Since the dipole approximation is valid for most electrode configurations except when the 
particle size and length scale of the nonuniformity of the electric field are of similar size  (Jones 
2003), this approximation will be used throughout. Additionally, the cell will be assumed 
perfectly spherical and be modelled as a lossy dielectric particle. 
2.1.1 Governing Equations of a Dipole 
Consider the dipole in Figure 2 immersed in an electric field with a charge separation 𝑑 a 
distance 𝑟 from the origin. The net force on this dipole is given as: 
 ?⃗? = 𝑞?⃗?(𝑟 + 𝑑) − 𝑞?⃗?(𝑟) (2.1) 
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Figure 2: The net force on a dipole due to an electric field. 
This net force will equal zero when E(r) = E(r+d). 
 
Using Taylor series and taking the limit as |𝑑| → 0,  the dipole approximation can be written as: 
 ?⃗? = 𝑞𝑑 ⋅ ∇?⃗? = 𝑝 ⋅ ∇?⃗? (2.2) 
where 𝑝 is the dipole moment. If the electric field is uniform (∇?⃗? = 0), there is no net force on 
the dipole. There is, however, a torque (dipole moment) generated by the couple of equal and 
opposite forces, 𝑞?⃗?(𝑟)  and 𝑞?⃗?(𝑟 + 𝑑) described by: 
 
?⃗⃗? =  
1
2
𝑑 × 𝑞?⃗? + 
1
2
𝑑 × (−𝑞)?⃗?
= 𝑝 × ?⃗? 
(2.3) 
 
This dipole moment generates an electrostatic potential where 𝜀𝑀 is the suspending medium 
permittivity: 
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Φ =
𝑝𝑐𝑜𝑠(𝜃)
4𝜋𝜀𝑀𝑟2
 (2.4) 
Since the distance between charges, 𝑑, is small compared to the nonuniformity of the electric 
field, the force and torque can be rewritten and approximated as: 
 
?⃗? ≈ 𝑝 ⋅ ∇?⃗? 
?⃗⃗? ≈ 𝑝 × ?⃗? 
(2.5) 
(2.6) 
 
Now consider, instead of a permanent dipole, a dielectric spherical particle with radius 𝑅 and 
permittivity 𝜀𝑝 immersed in an electric field with a suspending medium permittivity of 𝜀𝑀. While 
the external electric field causes a displacement of charges within the dieletric material, the 
sphere will have an effect on the electric field inducing an electrostatic potential g iven by 
(Hughes, 2000): 
 
Φ𝑖𝑛𝑑𝑢𝑐𝑒𝑑 ≈
(𝜀𝑝 − 𝜀𝑀)𝑅
3?⃗? ⋅ 𝑟
(𝜀𝑝 + 2𝜀𝑀)𝑟3
 (2.7) 
   
By setting Equation 2.4 and 2.7 equal, the expression for the induced (effective) moment can be 
solved: 
 
𝑝𝑒𝑓𝑓 = 4𝜋𝜀𝑀𝐾𝑅
3?⃗?          (2.8) 
       
 
where 𝐾(𝜀, 𝜔) is the Clausius-Mossotti factor and given by: 
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𝐾(𝜀, 𝜔) =
𝜀𝑝 − 𝜀𝑀
𝜀𝑝 + 2𝜀𝑀
     (2.9) 
      
To determine the DEP force on a perfectly dielectric ( infinitely resistive) particle in a nonuniform 
electric field Equation 2.8 can be substituted into Equation 2.5.  
Using the relation, (?⃗? ⋅ ∇?⃗? =
1
2
∇|?⃗?|
2
) , the DEP force acting on a dielectric, spherical particle 
can be described by the following (Pohl 1951, Pohl and Crane 1971, Jones 1995, Morgan and 
Green 2003): 
 𝐹𝐷𝐸𝑃 = 2𝜋𝜀𝑀𝑅
3𝐾∇|?⃗?|
2
 (2.10) 
2.1.2 Clausius-Mossotti Factor 
For a perfect sphere, this Clausius-Mossotti factor ranges in value from -0.5 to 1 and in a perfectly 
dielectric material, in which no losses occur, 𝜀𝑝 and 𝜀𝑀 are scalar values. This is not the case, 
however, when considering a cell since, at its simplest, a cell model will contain an homogeneous 
core (intracellular space/cytoplasm) and a shell (the membrane) and will not be perfectly insulating. 
These two key assumptions change the model of the Clausius-Mossotti factor dramatically. Changes 
in this model are necessary to include since the direction and magnitude of DEP force experienced 
by a particle is dependent on the Clausius-Mossotti factor.    
First, consider a dielectric (lossless) single-shell model (Irimajiri et al. 1979, Gimsa et al. 1991, 
Jones 2003) (Figure 3) with core radius and permittivity R2 and ε1 and outer radius R1 with shell 
permittivity ε2 suspended in a medium of permittivity ε3.  This system can be equilibrated to a  
particle of radius R1 with permittivity εpeff. Here εpeff represents the effective permittivity of the 
combined core and shell.  
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Figure 3: A single shell particle with inner and outer radii R1 and R2 respectively and permittivities 
ε1 and ε2 can be modelled equivalently to a particle of radius R with inner effective permittivity 
εpeff and outer (medium) permittivity εM. Applying this to a cell of radius R and membrane 
thickness, d, simplifies the intracellular and membrane permittivity to an effective permittivity 
εpeff and medium permittivity εM.  
Applying this model to a cell (Figure 3) of radius R and membrane thickness d with permittivities of 
the cytoplasm, 𝜀𝑐 and membrane,  𝜀𝑚, the Clausius-Mossotti factor can be rewritten as: 
 
𝐾 =
𝜀𝑝
𝑒𝑓𝑓 − 𝜀𝑀
𝜀𝑝
𝑒𝑓𝑓 + 2𝜀𝑀
     (2.11) 
with the expression 𝜀𝑝
𝑒𝑓𝑓
 meaning the effective permittivity of the entire cell given as: 
 
𝜀𝑝
𝑒𝑓𝑓 = 𝜀𝑚
𝛾3 + 2(
𝜀𝑐 − 𝜀𝑚
𝜀𝑐 + 2𝜀𝑚
)
𝛾3 − (
𝜀𝑐 − 𝜀𝑚
𝜀𝑐 + 2𝜀𝑚
)
 (2.12) 
where 𝛾 = 𝑅/(𝑅 − 𝑑). This process can be repeated for multi-shell models yielding scalar values for 
the Clausius-Mossotti factor (Irimajiri et al. 1979). 
Since a cell is not perfectly dielectric (lossy), electric permittivity must now be considered as a 
function of frequency where 𝜀𝑝
∗  and 𝜀𝑀
∗  are the complex permittivities of the cell and the medium 
respectively. Now the Clausius-Mossotti is written as: 
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𝐾(𝜔) =
𝜀𝑝
∗ − 𝜀𝑀
∗
𝜀𝑝
∗ + 2𝜀𝑀
∗      (2.13) 
where complex permittivity is defined as:  
 𝜀∗ = 𝜀 −
𝜎
𝑗𝜔
 (2.14) 
where ε and σ are the real permittivity and conductivity of the subject, 𝑗 = √−1 , and ω is the radial 
frequency. The loss is caused by the frequency dependent conductivity term. Due to this 
dependence, at high frequencies the imaginary term of complex permittivity tends to zero and thus 
is dominated by the permittivity while at low frequencies the conductivity term becomes very large 
dominating over permittivity. This leads to permittivity and conductivity driven behaviour. The 
transition frequency between these behaviours is known as the dielectric dispersion (Pethig 1979). 
The effective complex permittivity of a single shell cell (or particle) now becomes: 
 
𝜀𝑝
∗𝑒𝑓𝑓 = 𝜀𝑚
∗
𝛾3 + 2(
𝜀𝑐
∗ − 𝜀𝑚
∗
𝜀𝑐
∗ + 2𝜀𝑚
∗ )
𝛾3 − (
𝜀𝑐
∗ − 𝜀𝑚
∗
𝜀𝑐
∗ + 2𝜀𝑚
∗ )
 (2.15) 
Another effect of loss is a phase lag. This lag can derive from the delay of the dipole moment when 
the field is first switched on or, in the case of an AC electric field in which the dipole moment lags 
behind the harmonically oscillating field. In either case the dipole moment must play “catch up” with 
the field.  The Maxwell-Wagner relaxation time, 𝜏𝑀𝑊 =
𝜀𝑝+2𝜀𝑀
𝜎𝑝+2𝜎𝑀
 , is used to describe the lag present 
in a lossy particle or in a harmonically oscillating field. By introducing the term 𝜏𝑜 =
𝜀𝑝−𝜀𝑀
𝜎𝑝−𝜎𝑀
,  the 
Clausius-Mossotti becomes: 
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𝐾(𝜀𝑝
∗ , 𝜀𝑀
∗ , 𝜔) = (
𝜎𝑝 − 𝜎𝑀
𝜎𝑝 + 2𝜎𝑀
) [
𝑗𝜔𝜏𝑜 + 1
𝑗𝜔𝜏𝑀𝑊 + 1
] (2.16) 
Using the complex permitivity definition given in equation (2.14) the real part of Clausius -
Mossotti factor is (Morgan et al. 2007): 
 
𝑅𝑒[𝐾(𝜀𝑝
∗ , 𝜀𝑀
∗ , 𝜔)] =
(𝜎𝑝 − 𝜎𝑀)
(1 + 𝜔2𝜏𝑀𝑊
2 )(𝜎𝑝 + 2𝜎𝑀)
+
𝜔2𝜏𝑀𝑊
2 (𝜀𝑝 − 𝜀𝑀)
(1 + 𝜔2𝜏𝑀𝑊
2 )(𝜀𝑝 + 2𝜀𝑀)
 (2.17) 
Thus the real components of effective permittivity and conductivity of the cell (particle) considering 
this single shell model is given by:   
 
𝜀𝑝 = 𝜀𝑚
𝛾3 + 2(
𝜀𝑐 − 𝜀𝑚
𝜀𝑐 + 2𝜀𝑚
)
𝛾3 − (
𝜀𝑐 − 𝜀𝑚
𝜀𝑐 + 2𝜀𝑚
)
 (2.18) 
 
𝜎𝑝 = 𝜎𝑚
𝛾3 + 2(
𝜎𝑐 − 𝜎𝑚
𝜎𝑐 + 2𝜎𝑚
)
𝛾3 − (
𝜎𝑐 − 𝜎𝑚
𝜎𝑐 + 2𝜎𝑚
)
 (2.19) 
Where again, 𝛾 = 𝑅/(𝑅 − 𝑑); 𝑅 is the particle radius; 𝑑  is the cell membrane thickness; 𝜀𝑐 , 𝜎𝑐 and 
𝜀𝑚, 𝜎𝑚 are the complex permitivites and conductivities of the cytoplasm and the membrane, 
respectively (Morgan and Green 2003, Morgan et al. 2007). 
 
It is important to note that 𝐾(𝜔) can take both positive and negative values based on the sign of 
𝜀𝑝
∗ − 𝜀𝑚
∗   . Depending on the relative polarizability of a cell to the suspending medium, this term will 
either positive (pDEP) or negative (nDEP). When the cell is more polarizable than the medium ( 𝜀𝑝
∗ >
 𝜀𝑚
∗  ), the dipole reorients itself with the field and the net force acts up the field gradient (pDEP). 
When the cell is less polarizable than the medium ( 𝜀𝑝
∗ <  𝜀𝑚
∗  ), the dipole reorients against the field 
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with net force acting down the field gradient (nDEP). The frequency at which 𝜀𝑝
∗ =  𝜀𝑚
∗  and thus 
𝐾(𝜔) = 0 is known as the cross-over frequency. This frequency, given the same suspending 
medium, will be unique to a cell type and can be exploited for dielectric characterisation, separation 
and manipulation.   
A simple parametric study can demonstrate this. If the real part of the Clausius-Mossotti is plotted as 
a function of frequency, the change in cross-over frequency due to the shift of various parameters 
can be observed. First, if we look at controlled/measurable experimental parameters: medium 
conductivity and particle radius (Figure 4).  
 
Figure 4: Parametric study of experimentally controlled variables and the changes they induce on 
the Clausius-Mossotti factor. (A) Medium conductivity (𝝈𝑴 ) at (S/m):  10E-4, 100E-4, 1000E-4, and  
10,000E-4. (B) Cell radius (R) at (μm): 2, 5, 10, and 15. Nominal parameter values were: 𝝈𝑴=100E-4  
S/m, R=10 μm  
If the same is done assuming nominal (measured) values for medium conductivity and cell radii, the 
dielectric properties can then be observed.  Changes in membrane capacitance (Figure 5A) are the 
most significant in lower frequency ranges. Since the electric field cannot easily penetrate the cell 
membrane at lower frequencies, the cell acts as an insulator. At higher frequencies, the electric field 
can penetrate the membrane, thus the cell acts as a conductor. Changes in cytoplasm conductivity 
have the greatest effect at the mid to high frequency ranges and do not typically affect the first 
cross-over frequency (Figure 5B). This is significant since early DEP experiments could not achieve 
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these high frequency ranges, and thus measurements of the parameter were based on the plateau 
of the curve.  At high frequencies ( >108 Hz ), membrane capacitance shorts out the highly resistant 
cell membrane (Figure 5A) and interior cell properties dominate the DEP force (Figure 5B&C). 
Relative permittivity (Figure 5C) only affects the model at high frequencies ( >108 Hz ) and is the 
dominating factor at ( >1010 Hz ). Since most experiments never reach these frequencies, this 
parameter is often assumed approximately 60εo for most cells.  
 
Figure 5: Parametric study of assumed cell parameters on Clausius-Mossotti factor: (A) Membrane 
capacitance, (F/m2):  0.01E-2, 0.1E-2, 1.0E-2, and 10E-2. (B) Cytoplasmic conductivity, 𝝈𝒄, (S/m):  
0.05, 0.5, 5.0 and 50. (C) Relative cytoplasmic permittivity εc (*ε0): 40, 60, 80. 
2.2 DEP Applications 
Since Pohl’s early needle experiments, DEP has transitioned to micron-scaled devices which reduce 
the voltages (and thus field strength) required (Washizu et al. 1994). Techniques such as 
photolithography, electron beam patterning, and laser ablation have enabled use of more 
biocompatible electrode materials (such as gold), single cell analysis, and handling small bioparticles 
such as bacteria and DNA (Price et al. 1988, Washizu et al. 1994, Suehiro and Pethig 1998). Work in 
this area has shown that this traditional DEP is an effective means to concentrate and differentiate 
cells rapidly and reversibly based on their size, shape, internal structure, and intrinsic properties 
such as conductivity and polarizability. DEP has proven an efficient, non-invasive method to collect 
breast cancer cells from a blood sample, to characterise single cells, to detect pathogens, and to 
manipulate viruses and macromolecules (Becker et al. 1994, Stephens et al. 1996, Gascoyne et al. 
 Page | 18 
 
1997b, Huang et al. 1997, Cheng et al. 1998b, Huang et al. 2002, Gambari et al. 2003, Kim et al. 
2007). Sample throughput has been extensively considered and has inspired many three-
dimensional/micro-fluidic  DEP designs (Masuda et al. 1988, Suehiro and Pethig 1998, Muller et al. 
1999, Hoettges et al. 2008, Burgarella et al. 2010a). Clinical application of DEP has pushed current 
electrode design and data acquisition towards more user-friendly, cost effective platforms (Yu et al. 
2005, Labeed 2010, Hamada et al. 2011, Pethig 2013, Sonnenberg et al. 2013). 
2.2.1 Advances in Design and Data Acquisition 
Since the late 1980s, DEP devices are typically designed around two-dimensional, thin-filmed 
electrodes patterned onto the surface of a substrate within the sample channel (Figure 6). These 
electrodes generate a nonuniform electric field that interacts with the particles near the surface of 
the electrode array (Price et al. 1988, Huang and Pethig 1991, Washizu et al. 1994, Yang et al. 1999).  
Design and Modelling: Huang and Pethig (1991) first described the mathematical process of 
modelling electrode design and predicting field gradients on polynomial electrodes  which would go 
on to enhance rotational characterisation (ROT) (Arnold and Zimmermann 1988, Huang and Pethig 
1991, Gimsa et al. 1994, Wang et al. 1994b, Huang et al. 1995). Price et al. (1988) and Burt et al. 
(1989) advanced DEP from the needle electrodes and time-lapsed imaging analysis to patterned, 
castellated electrodes and measurement of optical absorbance across frequencies from 1 Hz to 4 
MHz (Pethig et al. 1992, Wang et al. 1993). Huang et al (1995) demonstrated ROT spectra up to 100 
MHz enabling the use of the single-shell model to predict membrane and intracellular dielectric 
properties. Circular electrodes (or “dot” electrodes) based on typical photolithography techniques 
(Fatoyinbo et al. 2008) creating individually addressable dots were integrated with a direct digital 
synthesizer (DDS) enabling simultaneous particle manipulation at different frequencies across 
multiple electrodes along with digital imaging capturing real-time DEP spectra (Fatoyinbo et al. 
2011).   
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Figure 6: Typical 2D patterned electrode designs. A) Interdigitated and B) Castellated 
interdigitated energised by a sinusoidal waveform and  C) Polynomial and  D) Patterned Bars with 
electrodes energised in phase. 
2D Patterned Electrodes: Many variations of the 2D patterned electrodes have since been 
developed. Dielectrophoretic Field-flow Fractionation (DEPfff) relies on interdigitated electrodes and 
exploits the balance between the upward (negative) DEP force generated by the electrodes and the 
downward sedimentation force (sum of gravity and buoyancy) acting particles in a laminar flow 
(Huang et al. 1997, Markx et al. 1997). This suspends particles of different sizes and/or 
polarizabilities at different heights within the chamber allowing for continuous flow separation (De 
Gasperis et al. 1999, Wang et al. 2000, Vykoukal et al. 2008, Gascoyne et al. 2009).  
 
Another application of 2D patterned electrodes is Travelling-wave DEP (twDEP). Like ROT, twDEP is 
found to be related to the imaginary, rather than to the real, component of the induced dipole 
moment. The forces exerted with twDEP depend on the polarizability of the particle and medium, 
the electric field strength and the frequency of the travelling field. Huang et al (1993) has shown 
similar sized particles under the same applied field strength could be separated based on the 
differences of the imaginary parts of their polarizabilities. At its simplest, twDEP consists of an array 
of thin, rectangular electrode strips patterned on glass with each electrode energised through an 
 Page | 20 
 
individual connection pad (Figure 6). To increase the throughput and sensitivity of cell separation 
Morgan et al (1997) utilised multi-layered electrode design enabling the use of thousands (as 
opposed to the typical 70) electrodes (Huang et al. 1993, Wang et al. 1994a, Hughes et al. 1996, 
Green et al. 1997, Morgan et al. 1997). This travelling wave concept was also implemented on a 
spiral electrode design for cell separation and concentration (Wang et al. 1997, Gascoyne et al. 
2002).  
 
Particle Focusing: Observations of particle clustering patterns in castellated electrodes and extruded 
quadrupole electrodes indicated a non-DEP force acting upon the particles. It was shown electro-
hydro-dynamic flow, arising from the electric field and electrode double layer was also contributing 
to the cell movement (Green and Morgan 1998, Ramos et al. 1999, Voldman et al. 2002). Two-
dimensional particle concentration techniques such as “zipper” electrodes have since been 
developed. These exploited dielectrophoresis and AC-electro-hydrodynamic flow, which were used 
to focus particles of various sizes between macromolecules and large cells to the centre of the 
electrode surface (Hoettges et al. 2003). This size independent DEP focusing showed improved 
detection capabilities of such DEP systems (Hubner et al. 2007). This zipper electrode design was 
applied on quartz crystal combining the resonance detection capability of quartz crystal and the 
rapid particle focusing of DEP (Fatoyinbo et al. 2007).  
 
3D Electrode Design: Recently, DEP applications and design have focussed on throughput, rapid 
analysis, and increased sensitivity. Multi-staged, on-chip designs have been developed to enhance 
DEP’s applications as a collaborative tool in biological research (Pethig et al. 1998, Hughes 2002, Cen 
et al. 2004, Martinez-Duarte 2012), as well exploiting advances in micro-fluidics and fabrication 
(Rajaraman et al. 2006, Dalton and Kaler 2007, Burgarella et al. 2010b, Cetin and Li 2011).Three-
dimensional design has been implemented in many DEP devices to increase throughput. At the most 
basic, 3D DEP structures consist of patterned electrode structures sandwiched together to generate 
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the electric field across the height of the electrode spacing (Schnelle et al. 1993, Suehiro and Pethig 
1998, Muller et al. 1999). Bundles of electrodes as well as mesh electrodes for 3D cell trapping and 
separation have also been investigated (Park and Madou 2005, Abidin et al. 2007). More recently, 
3D electrode design interpretations  have shown applications for cell separation using 3D twDEP 
(Cheng et al. 2009) and interdigitated comb arrays (Xing and Yobas 2015), cell patterning via 
electrode layering (Chu et al. 2015), and simultaneous trapping and ROT characterisation through 
the use of a 3D octode (Han et al. 2013).  
 
Another method of 3D DEP developed is known as insulator-based DEP (iDEP) (Masuda et al. 1988). 
This technology relies on DC voltage applied across the sample channel and on the geometry of 
insulating obstacles within the sample channel to produce electric field nonuniformities instead of 
the electrode geometry found in traditional DEP. Since these insulating structures typically traverse 
the entire depth of the channel, a larger area within the sample channel is affected by the electric 
field gradient greatly increasing device throughput. In addition, the DC field creates electrokinetic 
flow and moves the solution and particles through the device, alleviating the need for a pump 
required for a pressure-driven mechanism. In iDEP systems, trapping occurs when the DEP force 
overcomes the electrokinetic force moving the particle (Lapizco-Encinas et al. 2004a).  This 
technology has shown concentration factors on the order of 6000x and removal efficiencies greater 
than 98% (Lapizco-Encinas et al. 2005).Variations of this idea (Figure 7) include contactless-DEP 
(cDEP) in which the standard metal electrode pins used in iDEP, which can cause hydrolysis and 
sample contamination, are replaced with fluid-electrodes in which the capacitive behaviour of the 
PDMS barriers to the fluidic channel is exploited to generate the same DEP effects found in 
traditional DEP, but also utilise traversing insulating structures found in iDEP (Shafiee et al. 2009). An 
additional similar technique recently introduced uses carbon-electrode “pillars” that mimic  iDEP’s 
insulating structures, however since these are metal, they greatly reduce the voltages required of 
the technique (Martinez-Duarte et al. 2011). 
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Figure 7: 3-Dimensional dielectrophoresis techniques using alternative electrode configurations. A) 
iDEP (Lapizco-Encinas et al. 2004b), B) cDEP (Shafiee et al. 2010b), and C) carbonDEP (Martinez-
Duarte et al. 2011) 
Developed at the University of Surrey, a 3D well-structured electrode array has implemented DEP 
technology. This originated from a simple layering structure of aluminium foil and insulating epoxy 
with holes drilled through the depth (Figure 8A) (Fatoyinbo et al. 2005). These wells have since been 
developed into a commercially available analysis tool, 3DEPTM, distributed by LabTech, known as 
3DEP (Figure 8B) (Hoettges et al. 2008). This technique relies on 20 individually addressable wells 
drilled through successive conducting and insulating layers. The conductive layers form the field 
gradient required for DEP force generation across the radius of each well, with each well energised 
at a different frequency by 20 independently-controlled DDS-based signal generators. Each well is 
monitored simultaneously via a CMOS camera fitted with a bi-telecentric optic producing a 20 point 
DEP spectrum of a sample within 10 seconds of field gradient exposure. More information of this 
system is provided in section 2.3. 
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Figure 8: A) Early well designs with alternating layers of aluminum and epoxy, B) current 3DEP 
chips commercially available 
Commercialisation of DEP: As a consequence of these developments in fabrication, throughput, and 
design, dielectrophoresis has seen many patented technologies and intellectual property (IP). In his 
review, Pethig (2010) estimated 46 US patents granted in the DEP field from 2005-2010. Along with 
3DEP, many other examples of DEP commercialisation have capitalised on this (Figure 9). These 
include systems such as the Biological Dynamic’s ACE system and TR(ACE)™ assay for quantifying 
necrotic dsDNA found in blood plasma as an indicator of anti-cancer drug effect.  This technology 
utilises circular electrode arrays that attract the DNA to the electrode surface whilst repelling the 
other blood constituents that are washed away. This concentration of DNA allows for quantification 
when combined with fluorescent tags or antibody labelling (Krishnan et al. 2008, Krishnan et al. 
2009, Sonnenberg et al. 2012). A rapid bacteria detection method using Dielectrophoretic 
Impedance Measurement (DEPIM) has been implemented in a “bacterial counter” manufactured by 
Panasonic Healthcare. This system captures bacteria through DEP and measures the residual 
impedance. Impedance of the electrode increases as more bacteria are trapped (Suehiro et al. 1999, 
Hamada and Suehiro 2011). ApoStream™ is a device based on DEPfff designed to capture circulating 
tumour cells (CTCs) from blood. This technology, distributed by ApoCell, enables the antibody-
independent isolation of cancer cells from various types cancer leaving cells intact and viable for 
downstream proteomic and genomic analyses (Gupta et al. 2012). Distributed by Silicon Biosystems, 
DEPArray™ System uses DEP cages to isolate, move, and extract cells of interest from a 
heterogeneous sample. This has shown to isolate and molecularly describe CTCs from various 
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cancers (Abonnenc et al. 2013, Fabbri et al. 2013, Polzer et al. 2014). The IG-1000 Plus Single Nano 
Particle Size Analyzer from Shimadzu, utilizes an interdigitated-like electrode pattern combining 
dielectrophoretic particle concentration and the induced grating (IG) method, which is a principle for 
measuring the size of nanoparticles using diffracted light (Wada et al. 2006). 
 
Figure 9: Commercially available devices utilizing DEP technology: A) Biological Dynamic’s ACE 
system and TR(ACE)™ assay, B)ApoCell’s ApoStream™  C) Silicon Biosystems’ DEPArray™  D) 
Panasonic’s Dielectrophoretic Impedance Measurement (DEPIM),  E) LabTech’s 3DEPTM , and F) 
Shimadzu’s IG-1000 Plus Single Nano Particle Size Analyzer 
2.2.2 Characterisation 
Early Characterisation: Due to the unique response of cells exposed to field gradients, 
characterisation remains a common application of DEP. Early DEP characterisations were based on 
observations of cell behaviour under an applied field. Malignant myocytes were characterised by 
their pearl-chaining ability and mean chain length (Mischel et al. 1983). Dielectric coefficients 
characterised myeloma, hybridomas, and B-lymphocytes based on their type, age and drug 
treatment as well as chloroplasts untreated and treated with cationized ferritin (Stoicheva 1986, 
Stoicheva et al. 1987). Electro-rotation was used to characterise mouse myeloma cells before and 
after silver ion treatment based on their rate of rotation (Arnold and Zimmermann 1988). Burt et al. 
(1990) measured optical absorbance to track DEP frequency response of Friend murine 
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erythroleukaemia clones (DS19, D10, R1) as a function of hexamethylene bisacetamide (HMBA) 
treatment, saponin (R1 only) and RBC treatment of neuraminidase. From this, it was determined 
that cell surface charge and membrane conductivity changes as a result of these treatments. 
Gascoyne et al (1992) used a collection index to characterise normal, leukaemic, and differentiation-
induced leukaemic mouse erythrocytes with interdigitated castellated arrays. As a result, they were 
able to separate the sample based on treatment at 30 kHz.  
DEP “Spectra”: By utilizing properties such as DEP mobility and cross over frequency, characterising 
electrophysiological properties of cells is now a more common application. Becker et al (1994,1995) 
determined cross over frequencies for HL-60 leukaemic cells, T-lymphocytes, and red blood cells 
using ROT spectra (Figure 10) (Becker et al. 1994, Becker et al. 1995). 
 
Figure 10: Typical ROT spectra (Becker et al. 1994) for HL-60(◊) T-lmpyh (○) and erythrocytes (Δ) by 
measuring rotational rates as a function of frequency, fit to single shell model. 
From these frequencies, membrane specific capacitance values were calculated. Since membrane 
capacitance is the dominating force in DEP under the given frequencies, this value ultimately 
determined dielectrophoretic differences in the various cells and were exploited in the separation of 
these cells using castellated electrodes.  Wang et al (1994) demonstrated with ROT the fall of cell 
membrane capacitance as a result of Friend murine erythroleukaemia HMBA treatment which was 
confirmed by morphology. Cross over frequencies for MDA231 breast cancer cells, lymphocytes, and 
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erythrocytes using ROT spectra were also investigated by this group showing significant differences 
between these cell lines’ electrophysiological properties (Becker et al. 1995) and were successfully 
separated from RBCs using these results. The extent of this early characterisation work completed by 
this group can be seen in Table 1. Specific area was defined as the ratio of the actual membrane area 
that covers a cell to the membrane area that would be required to cover a smooth sphere of the 
same average diameter (Gascoyne et al. 1997). 
Table 1: Dielectric Parameters for Several Cell Types From ROT Measurements (Gascoyne et al. 
1992, Becker et al. 1994, Wang et al. 1994b, Becker et al. 1995, Gascoyne et al. 1997b)  
Cell Type r(μm) Cspec (mF/m2) Specific area, φ fσ/σs (MHz m/S) 
RBC 2.8±0.1 9±0.8 1 10 
T-lymphocyte 3.5±0.2 11±1.1 1.2 6.6 
Hepatocyte 10±0.61 80±17 8.9 0.32 
DS19 5.9±0.45 17.4±2.0 1.93 2.5 
HL-60 5.8±0.42 15±1.9 1.67 2.9 
MDA-231 6.2±0.58 25.9±3.7 2.88 1.6 
MDA-435 7.7±0.72 13.5±1.9 1.5 2.4 
MDA-468 7.2±0.66 27.5±4.2 3.06 1.3 
 
Huang et al. (1992) were one of the first to use both ROT and DEP spectra, by combining rotational 
rate data and DEP velocity (determined to be proportional to the DEP force) (Huang et al. 1992). This 
work was validated characterising viable and nonviable yeast (Figure 11). Gascoyne et al 
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Figure 11: Viable and Non-Viable Yeast 
 
(1997) used a similar approach by measuring ROT spectra of normal and malarial infected 
erythrocytes. It was found impossible to obtain reliable ROT data for the infected cells, and thus 
investigated the dielectrophoretic crossover frequency as a function of the suspending medium 
conductivity. They found specific membrane capacitance and conductance to be 11.8 mF/m2 and 
271 S/m2, respectively, for the normal cells and specific membrane capacitance of 9±2 mF/m2 and a 
specific membrane conductance of 1130 S/m2 for infected cells (Gascoyne et al. 1997a).  
Biomedical Applications: Until recently, most DEP characterisation applications were towards 
separation of a target population (Markx and Davey 1999). More recent applications of DEP 
characterisation aim for other biologically relevant tenders (Pethig et al. 2010, Pethig 2013). DEP 
characterisation of multi-drug resistance (MDR) human breast cancer cell lines (Coley et al. 2007) 
revealed cytoplasmic conductivity to be an indicator of drug sensitivity.  DEP characteristic 
distinction of neural stem/precursor cells (NSPCs) from different developmental progression was 
found, as well as prediction of their differentiation fate via DEP properties (Flanagan et al. 2008). 
Neurogenic potential of NSPCs was found to inversely correlate to DEP measured membrane 
capacitance (Labeed et al. 2011). Cytoplasm resistivity was measured for  mammalian atrial 
myocardium  using DEP and compared well to impedance methods (patch clamp). This measure can 
be used in computational  models of cardiac arrhythmias (Fry et al. 2012). Muratore et al. (2012) 
showed  separation of cells by stage within the C2C12 myoblast multipotent mouse model, but also 
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confirmed differences in cell membrane capacitance. Perhaps most intriguing,  this difference was 
found to be a function of, Raman spectroscopy confirmed, membrane morphology and composition 
differences rather than cell size.  
Membrane capacitance changes, that reflect changes in morphology, were also found to 
discriminate between derivatives of human embryonic stem cells (hESC) as they differentiated.  
Membrane capacitance was found to increase as cells differentiated to a mesenchymal stem cell-like 
phenotype (Velugotla et al. 2012). Total cell capacitance of similar-sized NCI-60 tumour cell types 
was shown to correlate with exterior morphologies of the cells during growth.  Comparing the DEP 
and morphological characteristics of subpopulations in peripheral blood, the potential for DEP 
isolation/detection of circulating tumour cells was realised (Gascoyne et al. 2013). Cell membrane 
morphology was also investigated for oral squamous cell carcinoma (OSCC) using scanning electron 
microscopy (SEM) and DEP. Cells with higher tumour forming ability were found to have higher 
effective membrane capacitance and also showed a rough surface, extremely rich in cellular 
protrusions under SEM (Liang et al. 2014). These changes in OSCC cells eventually led to a clinical 
study in which 57 brush biopsied samples revealed a diagnostic sensitivity of 81.6% through 
measurement of the membrane midpoint frequency (Graham et al. 2015). In addition to 
morphology, it was recently shown that variations in cell DEP membrane properties could be 
explained by membrane content. Cell surface N-linked glycosylation was found to significantly 
correlate to previously determined cell-fate electrophysiological properties (Nourse et al. 2014). 
Dielectrophoresis has also been used to characterise apoptosis (programmed cell death) soon after 
drug induction by measuring changes in electrophysiological properties (Wang et al. 2002, Chin et al. 
2006, Pethig and Talary 2007, Mulhall et al. 2015). Loss of the apoptotic process is the key to cancer 
cells being immortalized and thus the study of the initiation of this process holds much importance. 
This is highlighted in Chapter 3 Sections 3.2.3 and 3.3.2.  Dielectrophoretic characterisation has been 
used in other drug screening applications and has been established as a label-free method to assist 
 Page | 29 
 
in drug discovery (Labeed et al. 2003, Hubner et al. 2005). DEP has been used in IC50 cytotoxicity 
assays, the standard test of drug toxicity, which determines the drug concentration required to kill 
half of a cell population (Hubner et al. 2003, Hübner et al. 2006). Other characterisation studies have 
looked into methods which enable rapid or near real time characterisation of cells (Broche et al. 
2011; Fatoyinbo et al. (2011). Quantifying the effectiveness of new compounds is essential in drug 
discovery. MTT is the current method of obtaining the IC50 of a drug (the standard test of drug 
toxicity) on a cell line. There are many advantages already highlighted of DEP over assays such as 
MTT, such as sample preparation time and expense however clinical use of these measurements 
remains limited.  
2.2.3 Cell Trapping and Separation Toward Detection and Diagnostics 
Since Pohl and Hawk first used DEP to separate live and dead yeast cells (Pohl and Hawk 1966) the 
application of DEP to separate target cells from a solution has been studied extensively in the last 
two decades. DEP is an attractive technique for cell sorting since it is label-free. Typical sorting 
methods such as Fluorescence-activated cell sorting (FACS) and magnetic-activated cell sorting 
(MACS) require the use of cell-specific labels. Both procedures can be costly, and are restricted to 
where cell-specific antibodies are available. As described previously, DEP has been shown to detect 
changes in cells (such as ion flux and morphology changes) prior to the cellular events required for 
cell labelling. Other sorting methods rely on size or cell density (such as fractionation of whole 
blood). DEP has also been shown to be size independent and to differentiate similar-sized cells based 
on their electrophysiological properties (Pethig 2013).  
Cell Sorting and Separation: Several  standard DEP applications to isolate target cells have been 
effectively demonstrated including the separation of leukaemia, breast cancer and other targeted 
cells from blood (Gascoyne et al. 1997b, Cheng et al. 1998b, Huang et al. 2002, Gupta et al. 2012, 
Shim et al. 2013), cancer cells from CD34+ haematopoietic stem cells (Stephens et al. 1996), 
neuroblastoma cells from HTB glioma cells  (Huang et al. 2002), cervical carcinoma cells from 
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peripheral blood cells (Cheng et al. 1998a), K562 human CML cells (Altomare et al. 2003), 
mammalian cells based on their cell-cycle phase (Huang et al. 1997, Kim et al. 2007), and the 
separation of cells of the same type based on their activation state (Griffith and Cooper 1998, Toner 
and Irimia 2005). Separation of both leukaemia cells and breast cancer cells from human blood using 
various DEP methods (Becker et al. 1994, Becker et al. 1995) was also demonstrated. Cell sorting 
conditions were optimised as well as extended to other forms of breast cancer to include: MDA-231, 
MDA-435, and MDA-468 (Gascoyne et al. 1997b). In later studies, this group achieved stem cell 
isolation from adipose tissue (Vykoukal et al. 2008) as well as CTCs from peripheral blood (Gascoyne 
et al. 2009). Muratore et al (2012) separated C2C12 myoblast multipotent progenitor cells based on 
their differentiation stage with an efficiency of 96%. 
It has been shown that iDEP is effective for selective trapping of a range of biological particles such 
as separating and concentrating prokaryotic cells and viruses (Cummings et al. 2005, Davalos et al. 
2008), and sample concentration followed by impedance detection (Sabounchi et al. 2008). This 
technology has shown concentration factors on the order of 6000x and removal efficiencies greater 
than 98% (Cummings et al. 2005). This was used to successfully remove and concentrate bacterial 
cells, spores, and viruses from water (Lapizco-Encinas et al. 2005) and has been proposed as a 
method for pathogen detection (Cummings et al. 2005). iDEP has also shown separation and 
concentration of small molecules such as proteins, DNA, sperm cells as well as sensitive size 
differentiation in separation (Lapizco-Encinas et al. 2008, Gallo-Villanueva et al. 2009, Srivastava et 
al. 2011, Rosales-Cruzaley et al. 2013). Electrode geometry has been investigated to improve the 
sensitivity of this technique as well as account for Joule heating due to the large applied electric 
fields (Gallo-Villanueva et al. 2014, LaLonde et al. 2014, Nakano et al. 2014).  
Contactless-dielectrophoresis (cDEP) was designed to exploit the advantages of iDEP while also 
addressing  sample contamination, Joule heating, and fouling associated with iDEP (Shafiee et al. 
2009). This DEP technique has been shown to separate live/dead human THP-1 cells (Shafiee et al. 
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2010a),  breast cancer cells by stage (Henslee et al. 2011) and has shown promise for isolation of  
tumour initiating cells from blood (Sano et al. 2011). More recently,  the dielectrophoretic responses 
within cDEP devices were shown to vary for progressive stages of mouse ovarian surface epithelial 
(MOSE) cells, as well as mouse fibroblast and macrophage cell lines (Salmanzadeh et al. 2012a), 
isolated  prostate tumour initiating cells from non-initiating cells (Salmanzadeh et al. 2012b) and 
demonstrated 96% removal efficiency of cancers cells from blood cells with cancer cell 
concentrations as low as 1:10e6. Contactless methods have demonstrated particle alignment and 
positioning, developing the opportunity for this method not only as a detection technique, but for  
tissue engineering as well (Sano et al. 2010).  
Pre-concentration: Aside from sorting, pre-concentration of target cells from a mixture is a 
developing application of DEP towards diagnostics. As previously mentioned, CTC isolation from 
blood via DEP has seen much attention and has recently been made commercially available (Gupta 
et al. 2012, Shim et al. 2013).  Menachery et al (2011) introduced DEP tweezers trapping transfected 
HEI-193 human schwannoma cells from nonviable cells. Similarly, Wood et al. (2013) introduced an 
electrokinetic nanoprobe for the trapping of nanoparticles in potentially high conductive media. 
Nano-scaled cell manipulation for isolation of sub-micron particles has seen recent advances. 
Carbon-electrode DEP has been developed and shown promise for DNA preconcentration and 
enrichment (Martinez-Duarte et al. 2013). Zipper electrodes, which provides size independent DEP 
focusing showed a wide range of nanoparticles of biological interest: influenza virus, dissolved 
albumin, and DNA molecules (Hubner et al. 2007). Constriction-based DEP has been scaled down for 
the rapid preconcentration of protein within physiological media (Chaurey et al. 2013). Another 
variation of iDEP, DC insulator gradient DEP (DC-iGDEP), was shown to concentrate Aβ amyloid fibrils 
for Alzheimer’s pathogenesis. Giraud et al were the first to show the capture and release of 
Ribosomal RNA towards rRNA biosensing (Giraud et al. 2011). A unique example of DEP 
concentration is found from (Khoshmanesh et al. 2011) where DEP trapped embryo bodies were 
dynamically monitored with no apparent negative effects of the DEP trapping. Monitoring of 
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embryonic bodies has potential as a tool in genetic and pharmacological studies. Previously 
mentioned TR(ACE) and ACE assays are based on DEP isolation and concentration of DNA and have 
shown application as a cancer biomarker in blood (Sonnenberg et al. 2012, Sonnenberg et al. 2013, 
Sonnenberg et al. 2014).  
2.2.4 Cell Patterning  
In addition to separation, enrichment and characterisation, dielectrophoresis is also being applied to 
cell patterning and aggregation for tissue engineering purposes. DEP has the potential to produce 
diverse cell patterns in a 3D culture environment. This has great advantage over typical 2D 
monolayer cell culture techniques in the ability to mimic in vivo co-cultures, cell-cell interactions and 
signalling, and microenvironments. DEP’s ease of operation, low degree of cell damage, and 
precision make it an attractive alternative to improve the tissue engineering field (Lin et al. 2006). 
Pohl’s book in 1978 first described dielectrophoresis applied to tissue engineering from a cell 
suspension (Pohl 1978b). Dielectrophoresis has since been utilized as an aggregation technique for 
bacteria(Price et al. 1988, Zhu et al. 2010), blood (Burt et al. 1990), stem cells (Markx et al. 2009, 
Agarwal et al. 2012, Bajaj et al. 2013), liver and pancreas tissues (Pethig et al. 2008, Ho et al. 2013, 
Yahya et al. 2014), human cancer cells (Abdallat et al. 2013, Liu et al. 2014, Liang et al. 2015) 
amongst other cell and particle types. DEP has also assisted tissue engineering applications through 
the use of single-cell manipulation (Gray et al. 2004, Rosenthal and Voldman 2005, Mittal et al. 
2007). DEP creation of 3D cell constructs has shown that cells can be aligned and then later cultured 
with no significant damage to cells (Suzuki et al. 2008), constructs regulate and simulate cell-cell 
interactions found in vivo (Albrecht et al. 2006, Gupta et al. 2010, Soffe et al. 2015), and has 
potential for multi-phased/layered tissues (Albrecht et al. 2007, Sebastian et al. 2007).   
Among its advantages, DEP is a rapid method to construct patterned biomaterials (Alp et al. 2002, 
Alp et al. 2003, Verduzco-Luque et al. 2003, Markx et al. 2004, Andrews et al. 2006). These groups 
used dielectrophoresis, energising electrodes at low voltage (typically 5-20Vp-p), and high frequency 
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(~1MHz) AC fields. Cells were suspended in low conductive medium, and once they were positioned 
by DEP, the cells were immobilized on the electrodes. This was done to prevent redistribution of the 
cells by Brownian motion, fluidic and other forces once the field was removed. Verduzco-Luque et al 
(2003) used ployethlenimine (PEI) while others used various hydro-gels to immobilise cells. Bryant 
and Anseth (2002) encapsulated chondrocytes in both degrading and non-degrading polyethylene 
glycol hydrogels; collagen synthesis was monitored after cross linking. The study showed the ability 
to use synthetic hydrogels such as PEG in tissue engineering. Alp et al (2002) used DEP to position 
three types of microbial species stabilising them in an acryl-amide based hydrogel and monitored 
the viability (Alp et al. 2002). Albrecht et al. (2005) examined the ability to fabricate living cell arrays 
encapsulated in PEG hydrogels by two methods, photo- and electro-patterning, and whether these 
two methods could be combined together to create 3D environments for cells. In another study, to 
ensure that the DEP chamber used was biologically versatile, many cell types such as rat 
hepatocytes, mouse fibroblasts and human hepatoma cell lines were patterned and their viability 
tested over a 2 week period (Albrecht et al. 2006).  
Other biomaterials instead of PEG hydrogels were investigated for 3D micro-patterning. Some 
biomaterials such as collagen and alginates are better than others in terms of supporting cell survival 
or cell-cell interaction (Bryant and Anseth 2002). Since these biomaterials have a higher conductivity 
and higher viscosity limiting efficient DEP patterning, cells, proteins and micro-beads were 
encapsulated in a local phase hydrogel of the materials (termed microgel). These microgels were 
then DEP patterned in PEG creating a 3D architecture for mouse embryonic liver cells, BMEL (Figure 
12 I) (Albrecht et al. 2007). Murine embryonic stem cells (mESC) were aggregated in PuramatrixTM to 
initiate embryoid body (EB) formation (Figure 12 II), an essential step in the induction of 
differentiated cells from ESCs (Agarwal et al. 2012). Creating micro-niches was also demonstrated 
using DEP to pattern cells to mimic the hematon (Markx et al. 2009). Suzuki et al (2008) used nDEP in 
culture media to pattern different types of C2C12 mammalian cells (Figure 12 III). Due to differences 
in the dielectric properties between different cell types, cells were patterned in different regions of 
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the electrode surface where they adhered before a second cell type was introduced (Suzuki et al. 
2008). 
 
Figure 12: I.) Albrecht et al 2007 micro-gels II.) Agarwal et al (2012) PuraMatrix encapsulation and 
III.) Suzuki et al (2008) aggregation in culture media 
In addition to cell aggregation and combining DEP patterning with gel-based techniques, integrating 
microfluidics with DEP to create cell micro environments for specific cell patterning such as cardiac 
myocytes (Yang and Zhang 2007) and hepatocytes (Ho et al. 2006) has been achieved. DEP has also 
been used to pattern cells around collagen beads enabling spheroid formation with a collagen core 
that can be disassociated (Miyata and Sugimoto 2010). Recently, Hsiung et al (2011) conducted anti-
cancer drug screening on DEP formed aggregates of MCF7 breast cancer cells whilst using 
microfluidic perfusion cultures (Hsiung et al. 2011). Three-dimensional electrode patterns have also 
been used to pattern cells within a microfluidic environment (Bocchi et al. 2012, Yamamoto et al. 
2012, Chu et al. 2015). 
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2.2.5 Summary 
DEP is an electrokinetic technique which relies on the electrophysiological properties of particles (or 
cells) and the suspending medium, and the geometry of the applied electric field to induce 
movement of these particles. The electrophysiology can be studied through means of ROT and DEP 
spectra, cross-over frequencies, DEP mobility and other movement related behaviour. The sensitivity 
of these methods has been shown to discriminate subtle differences between cells; differences that 
in some cases, occur prior to any other means of labelling being available. Since DEP does not rely on 
biomarkers or other fluorescent labels, it has become an increasingly popular method of sorting, 
characterising and patterning of cells. These applications of DEP have been used in a wide range of 
biomedical platforms.  Diagnostics and detection, drug discovery, stem cell isolation and enrichment, 
as well as tissue engineering are all areas in which DEP has been developed. Many new forms of DEP 
have been created to increasingly improve upon the technology’s throughput, sensitivity and 
usefulness. Recently, some DEP techniques have been implemented in commercially available 
platforms.  The surge in DEP research should see even more applications of the technology in the 
future. 
This thesis investigates DEP characterisation via the 3DEP analysis system as well as DEP cell 
aggregation and its applications through use of the DEP dot-array. The underlying theme of this 
thesis is applying DEP to an array of relevant, physiological applications to contribute to the forward 
momentum of DEP biomedical usage discussed in this review.   
 
2.3 The 3DEP System 
As previously discussed, DEP is a useful, label-free tool for cell characterisation. The 3DEP system 
described in this section is one such tool for DEP characterisation. The design began as alternating 
layers of conductive (aluminium) and insulating (epoxy) material with a hole drilled through the 
depth (Fatoyinbo et al. 2005). The original application of the design was towards cell separation, 
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however due to the radial symmetry of the wells it was shown with RBCs that the polarizability of 
the cells could be directly related to changes in light transmission through the well, and quantified 
through the analysis of digital images, and thus characterise the cells (Hubner et al. 2005). The light 
intensity changes in images were measured with a camera mounted on a microscope. One well was 
visualized and energized with a single channel signal generator. This could be repeated for a range a 
frequencies to create a DEP spectrum.  The system has since been developed into manufactured 
3DEP chips with 20 individually addressable wells, and a 3DEP reader which contains 20 
independently-controlled DDS-based signal generators, and simultaneously monitors each of the 20 
wells with a CMOS camera fitted with a bi-telecentric optic.   
2.3.1 The 3DEP Chip 
The current version of the chip was designed to be compatible with standard well plate platforms to 
enable data collection from existing lab equipment. This early 1536 spectra-plate prototype, along 
with the “spectra-chip” prototype, are described in Hoettges et al (2008). Chips are constructed of 
alternating layers of copper (70µm thick) and glass fibre reinforced epoxy (150 µm thick). The drilled 
wells are 1mm in diameter and the exposed electrode surfaces are gold-plated to ensure 
biocompatibility (Figure 13B). Each well is served by a separate set of power lines, allowing 
independent signals to be sent to each well, which are energized through pin connections at the 
back of the chip (Figure 13).  After fabrication, a glass cover slip is affixed to the bottom to form a 
gasket.  The gasket allows cell solution to pass between the wells, allowing the chip (20 wells) to be 
filled by pipetting approximately 80µl of solution into a single well.  Once the chip is filled, an 18 mm 
x 18 mm cover slip is placed over the well area, and the chip is inserted into the reader.  
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Figure 13: 3DEP chip structure. A.) 20 individually addressable wells.  B.) Consisting of alternating 
conductor and insulator material.  
 
2.3.2 Data Acquisition  
Once the sample is loaded, the chip is inserted into in the custom, zero-insertion force mount inside 
the 3DEP reader where the 20 wells are energised through 20 pin connections independently-
controlled through DDS-based signal generators, each individually controllable for frequency (up to 
45MHz) and voltage (up to 20Vpp) (Figure 14).  A collimated light source is used since it provides 
parallel rays that when light is reflected or refracted (by the particles within the well), produces 
darker areas on the image easily detected.  The 20 wells are monitored by a CMOS camera fitted 
with a bi-telecentric optic. The bi-telecentric lens is used for improving the image quality by 
minimising distortion and perspective issues related to telecentric lenses. Images of all the wells are 
captured every second during an experiment and saved/analysed in real-time. The instrument is 
controlled from a PC via a USB connection to a motherboard which then controls the signal output 
as well as data acquisition (Figure 14).  
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Figure 14: 3DEP reader with integrated software 
2.3.3 Data Analysis 
When the electrodes within wells of the chip are energised, the DEP force causes cells to move 
either towards or away from the edges (Figure 15), meaning that examining the way in which light 
passing through the well changes can determine the polarizability at that frequency.  Since the wells 
are axisymmetric, the light intensity can be reduced to a one-dimensional axial value.  
 
Figure 15: Schematic of electric field in the well and cell response at different frequencies. 
 
During the experiment, the wells are energised with 20 different frequencies (typically selected to 
cover approximately five points per decade from 1kHz to 30MHz) and the motion of particles is 
tracked across the wells with time-lapsed images beginning prior to the electric field being switched 
on and ending at the last given time point (Figure 16 A&B).  Light intensity is monitored across ten 
concentric bands, and the rate of change in light intensity is determined according to the change in 
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these bands, scaled for relative band area (Broche et al. 2011). Images of light distribution across the 
well are taken once per second; theoretical and experimental analysis indicates that the system 
results are most linear up to 10 seconds for most cell types (as longer times increase the magnitude 
of displacement and hence reduces signal-to-noise ratio) (Broche et al. 2011). Typically, bands 6-9 
experience the most change and are thus the bands used to quantify the DEP response (Figure 16C). 
In positive DEP the cells are attracted to the edges of the electrodes, resulting in an increase in 
optical absorbance near the electrode edge (see Figure 16B up to 366 kHz).  In negative DEP the cells 
are repelled from the edges of the electrodes, resulting in a decrease in optical absorbance near the 
electrode edge (see Figure 16B 546 kHz – 20 MHz). Beer-Lambert’s law of absorbance is used to 
analyse these images with respect to changes in cell concentration across the two dimensional 
image of the well and plotted against frequency (Figure 17A) (Broche et al. 2011).   
 
Figure 16: Image analysis of the wells. Time lapsed images from A) time 0 s and B) time 30 s C) 
Wells are monitored across ten concentric band with bands 6-9 experiencing the most change. 
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This parameter is proportional to the Clausius-Mossotti factor (Figure 17B) (Jones 1995). Dielectric 
parameters can be estimated by fitting a model to the experimental spectrum data (Irimajiri et al. 
1979) using the average of the measured cell radii and suspending medium values (Figure 17A&B).  
This can be extended to include multiple populations (Broche et al. 2005).  
 
Figure 17: A.)Example of a 3DEP analysis across bands 6-9 for 10 s and the single-shell model fit to 
the data points. B.) The single-shell model gives relative value of the polarizability of the cell 
suspension with respect to membrane and cytoplasm properties.  
 
One of the main benefits of 3DEP system is the ease of use. The user simply loads the chip, inserts it, 
and follows an automated process to collect the data. Wells are of similar size and pitch to those 
found on high-throughput well systems, so that for example, could use conventional liquid handling 
robots with little or no adaptation required. Cells are typically loaded at a concentration of 106 cells 
per ml, and with a total chip volume of 80µl, the total cell number required is low. The extended 
upper frequency limit is significant as it permits observation of the complete upper dispersion, 
allowing accurate determination of the cytoplasm properties.  Since cells are unaffected post-DEP 
exposure, the design of the chip (such as the temporary cover slip covering and being autoclavable) 
is also beneficial for monitoring the same cell population over time.  
The advantages of the system are investigated throughout this thesis. Studies investigating the 
possibility of multiple DEP analysis on a single suspended sample to reduce total volume were 
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implemented. Minimum time analysis required highlights the usefulness of the kit in real-time drug 
screening, as well as maximising technical repeats. This was carried over into high-resolution (100 
points compared to standard 20) spectra to verify the repeatability of the data acquisition and the 
high frequency response. Additionally, data collected on doxorubicin treated cancer cells was 
analysed for up to 4 subpopulations and verified with standard MTT assay. Cell viability post DEP 
exposure was investigated as an obvious advantage over MTT.  Automatic data analysis was 
investigated to reduce user analysis time. This was implemented on RBC experiments investigating 
circadian rhythms. During these experiments, 4 biological replicates were studied over 13, 4-hour 
time points in which at least 3 technical replicates were taken at each time point. Several drug 
studies were also conducted yielding over 1,000 spectra to be analysed.  Experiments with the 3DEP 
system were also designed for typically difficult DEP samples: whole-blood from human finger prick 
and rodent tail-prick.  
2.4 Conclusions 
DEP has been studied over the past five decades, with  a significant increase in the number of 
publications occurring in the last decade thanks to advances in fabrication, design and analysis 
(Pethig 2010b). It has been used to characterise, separate and manipulate cells of different origin, 
such as plant cells, bacteria, established mammalian cell lines and primary tissue, as well as viruses. 
The effects of changes in environment and the effect of drugs on cells have also been studied.  A 
push to realize DEP technology in biomedical research has concentrated efforts at optimising the 
technology in fields such as pharmacology, microbiology and oncology, as a cheaper, faster and label 
free method for particle analyses (Pethig 2013). 
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Chapter 3: Introduction to Cells and Electrophysiology  
This chapter introduces the basic concepts of cellular physiology for the cell types investigated in this 
thesis, setting them in context to electrophysiology. Brief review of molecular events associated with 
cancer, apoptosis and circadian rhythm are discussed and DEP measurement of these events is 
highlighted.  
3.1 Mammalian Cell Anatomy and Physiology 
3.1.1 General Cell Anatomy and Physiology 
Cells are the structural and functional units of an organism, which can either be unicellular (such as 
bacteria, archaea, protozoa, or unicellular algae and fungi) or multicellular organisms.  Cells are 
either eukaryotic or prokaryotic. Eukaryotic comes from the Greek meaning “true nut” and are cells 
that contain a nucleus where the chromosomal DNA is kept, unlike prokaryotic cells. Eukaryotic cells 
can be unicellular organisms or part of multicellular organisms, whereas, prokaryotic cells are usually 
unicellular organisms. Another distinguishing characteristic of eukaryotic cells is that they possess 
membrane bound organelles (Guyton and Hall 2006).  
Mammalian cells differ from other eukaryotic cells in their anatomy and physiology. The typical 
structure of a mammalian eukaryotic cell can be seen in Figure 18. No single cell has all of these 
structures as they differ depending on their role within the organism. However, all mammalian 
eukaryotic cells contain a plasma membrane, a cytoplasm and a nucleus. Mature red blood cells are 
still considered eukaryotic cells as they originally contained a nucleus (Guyton and Hall 2006).  
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Figure 18: Typical mammalian eukaryotic cell taken from (Guyton and Hall 2006) 
 
The Cell Membrane: The cell’s plasma membrane separates intracellular and extracellular space. The 
plasma membrane is responsible for the movement of substances into and out of the cell cytoplasm. 
This membrane consists of a lipid bilayer made up of phospholipids, cholesterol and glycolipids.  The 
lipid bilayer is permeable to water, oxygen and carbon dioxide, which diffuse in and out of the cells 
freely. However, the lipid bilayer is not permeable to ions, small hydrophilic molecules and 
macromolecules. These substances can be transported across membranes by a variety of membrane 
transporters. In a typical plasma membrane there are numerous K+ (potassium ions) or Cl- (chloride 
ions) channels. There are fewer channels available for Na+ (sodium ions) or Ca2+ (calcium ions). 
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Figure 19 demonstrates the movement of these ions and their relative concentration within the cell.  
 
Figure 19 A) Ion movement across plasma membrane, taken from Lockwood (1978) and B) 
compositions of intracellular and extracellular fluid, taken from (Guyton and Hall 2006). 
Membrane Transport: The lipid bilayer is only permeable to a few substances through diffusion. 
Protein molecules in the membrane vary depending on the substance it is transporting and the 
mechanism in which it transports these across the membrane (Figure 20). These proteins are highly 
selective in the molecules or ions they transport. Channel proteins have traversing watery space that 
allows free movement of water and some ions or molecules. Carrier proteins bind with molecules or 
ions; conformational changes in these proteins then move substances through the protein on either 
side of the cell membrane.  
 
Figure 20: Membrane transport mechanisms; Diffusion or Active Transport (Guyton and Hall 2006) 
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Movement across the membrane either happens by diffusion or active transport. Diffusion is the 
random molecular movement either through intermolecular spaces (simple diffusion) or with a 
carrier protein (facilitated diffusion) (Figure 20). An example of simple diffusion is the sodium 
channel (Figure 21A top). The inner surface is strongly negatively charged which can pull dehydrated 
sodium ions into the channel. From there the ions will diffuse under the normal laws of diffusion.  
The protein channel selective to potassium however, is not negatively charged, rather it is smaller 
only allowing the smaller hydrated potassium through under normal diffusion (Figure 21A bottom). 
Facilitated diffusion differs from simple diffusion in that the rate at which diffusion occurs is limited 
to the rate at which the carrier protein can bind, move, and release the molecule (Figure 21B). 
Glucose and amino acids are transported across the cell membrane under facilitated diffusion.   
 
Figure 21: Methods of diffusion:(A) Simple diffusion through proteins, (B) facilitated diffusion 
through carrier proteins, and (C) general conditions that affect diffusion such as concentration 
gradients, electric potential, or pressure gradients (Guyton and Hall 2006).  
 
The net rate of diffusion into a cell is proportional to the concentration gradient of a substance 
across the membrane (Figure 21C top). Another factor affecting diffusion is electrical potential 
difference on either side of the membrane (Figure 21C middle). When an electric potential is applied 
across a membrane the electrical charges of the ions cause them to move through the membrane 
even if there is no concentration gradient. This can be seen in Figure 21C (middle) in which 
negatively charged particles move towards the positive charge creating a concentration gradient of 
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negative ions on the right side of the membrane. This concentration gradient will then tend to move 
the ions back to the left. When this gradient is high enough, these two effects balance. The Nernst 
Equation defines the electrical difference (electromotive force- EMF) that will balance a given 
concentration of univalent ions (such as sodium): 
 
𝐸𝑀𝐹(𝑚𝑉) = ±61𝑙𝑜𝑔
𝐶1
𝐶2
 (3.1) 
Pressure gradients can also facilitate diffusion. Pressure is actually the sum of all the forces of the 
various surrounding molecules striking a unit of area of the membrane in an instant of time. If the 
pressure is higher on one side than the other in most cases, this means more molecules are on that 
side resulting in net movement from the high pressure towards the low pressure side (Figure 21 
bottom). Osmotic pressure is one example of this. Osmotic pressure is the pressure required of a 
given molecule to stop osmosis (water movement). This pressure is determined by the number of 
particles per unit volume since all particles will generally inflict the same pressure regardless of 
mass. This unit is known as an osmole.  A solution that has 1 omsole of solute dissolved in 1 kg of 
water has an osmolality of 1 osmole per kg. Normal cellular osmolality of inner and extracellular 
space is 300 milliosmoles per kg of water. Because it is difficult to measure mass of water in a 
solution, volume is used instead and the term osmolarity, or osmoles per litre of solution, is used 
instead (Guyton and Hall 2006).  
There are instances where a large concentration of a substance may be needed in the cell (such as 
potassium), or conversely, expelled from the cell, when there is not a large gradient on the other 
side. This movement of molecules requires energy to move substances against gradients or electric 
potential and is called active transport.  Active transport is classified as either primary or secondary 
active transport. Primary active transport is driven by energy derived from the breakdown of 
adenosine triphosphate (ATP). Secondary active transport’s energy is derived from energy stored as 
an ionic concentration gradient, originally created by primary active transport.  
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Figure 22: Schematic of (A) the primary active transport mechanism Na+-K+ pump and (B) the 
secondary active co-transport mechanism of glucose into the cell through a sodium gradient 
driven energy (Guyton and Hall 2006).  
Primary active transport transports sodium, potassium, calcium, hydrogen, chloride, and other ions 
across the cell membrane. The most well-known of these is the sodium-potassium pump (Figure 
22A). The most important function of this is to maintain cellular volume and to establish a negative 
electrical charge inside the cell. The process pumps sodium ions out of the cell whilst pumping 
potassium into the cell.  Another primary active transport is the calcium pump which keeps the 
intracellular calcium concentration approximately 10,000 times less than the extracellular fluid.   
The high concentration of sodium transported out of the cell through active transport yields a high 
concentration gradient creating a storehouse of energy. When activated, this diffusion energy can 
pull other substances into the cells through co-transport. This occurs with glucose and amino acids 
(Figure 22B). Hydrogen and calcium are removed from the cell through a sodium counter transport 
mechanism in addition to their removal through primary transport (Guyton and Hall 2006).  
 
Intracellular Space: The cell nucleus (Figure 23) is a spherical structure responsible for the genetic 
material of a cell. It contains the nucleolus: a cluster of protein, DNA and RNA which synthesizes 
ribosomes. These ribosomes are transported to the cytoplasm where they translate mRNA. Inside 
the nucleus, genes can be found arranged along chromosomes. The nucleus controls the cellular 
structure and directs cellular activities by regulating gene expression.  
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Figure 23: Typical cell nucleus (Guyton and Hall 2006) 
The cell’s cytoplasm consists of all the cellular contents between the plasma membrane and the 
nucleus organized into two components; the cytosol and the organelles. The fluid is the cytosol 
consisting of water, dissolved solutes and suspended particles. Surrounded by cytosol are the 
organelles which include the cytoskeleton, ribosomes, endoplasmic reticulum, Golgi complex, 
lysosomes, peroxisomes, and mitochondria.  
The cytoskeleton maintains cellular shape and consists of a network of protein filaments that extend 
throughout the cytosol. It provides a scaffold that aids to determine a cell’s shape and to organize 
the cellular contents. It helps with the movement of organelles within the cell, of chromosomes 
during cell division and of whole cells. 
 
Figure 24: Organelles in the cytosol. (A) endoplasmic reticulum, (B) the Golgi Apparatus in relation 
to the ER, and (C) mitochondria showing the folds in which the oxidative enzymes are attached 
(Guyton and Hall 2006). 
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Ribosomes are the sites of protein synthesis which have a high concentration of ribonucleic acid, 
ribosomal RNA. Those ribosomes associated with endoplasmic reticulum synthesize proteins for 
insertion in the plasma membrane or secretion from the cell and those that are free, synthesize 
proteins used in the cytosol (Marieb and Hoehn 2010). 
Exclusive to the cytoplasm of eukaryotic cells is the endoplasmic reticulum (ER), made up of a 
network of tubular or flattened membranes (Figure 24A). The granular ER synthesizes glycoproteins 
and phospholipids that are inserted into the plasma membrane or secreted during exocytosis. 
Agranular ER synthesizes fatty acids and steroids, inactivates or detoxifies drugs and other harmful 
substances, removes the phosphate group from glucose-6-phosphate, and stores and releases 
calcium ions that trigger contraction in muscle cells. Due to its high surface area and enzyme 
systems, it is the site of a majority of cellular metabolic function (Marieb and Hoehn 2010). 
The proteins synthesized by ribosomes attached to granular ER are transported to other parts of the 
cell, and the first step of this process is through the Golgi complex (Figure 24B). The Golgi complex is 
made up of several sacs called cisterns that have Golgi vesicles. The complex processes sorts, 
packages, and delivers proteins and lipids to the membrane.  
Lysosomes are vesicular organelles that form from breaking off from the Golgi complex and are 
dispersed throughout the cytoplasm. They are membrane-enclosed vesicles that contain enzymes. 
They act as the intracellular digestive system and digest substances that enter a cell, transport 
digestion products to cytosol, and carry out autophagy, autolysis and extracellular digestion. 
Peroxisomes are similar in structure to lysosomes but smaller, and contain oxidases, which are 
enzymes that can oxidize several organic substances. 
Most of the energy needed for all the cellular processes is generated in the mitochondria (Figure 
24C). Mitochondria are made of an outer mitochondrial membrane and an inner mitochondrial 
membrane with a small fluid-filled gap in between. The inner membrane consists of shelves formed 
from infolding where oxidative enzymes are attached. The inner cavity is filled with a matrix 
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containing dissolved enzymes. These enzymes operate with the oxidative enzymes to cause 
oxidation of the nutrients, forming CO2 and H2o and releasing energy. This is used to synthesize ATP, 
which is then transported out of the mitochondrion and diffuses throughout the cell (Marieb and 
Hoehn 2010).     
3.1.2 Fungal Cell Anatomy 
Fungal cells are eukaryotic cells generally forming multicellular organisms. Yeast cells, however, are 
unicellular organisms (Figure 25). They differ from mammalian cells in that they have an additional 
layer surrounding them called the cell wall. The cell wall is a rigid layer which serves to structurally 
support the cell and carry out filtering mechanisms. The cell wall is linked to the membrane by 
glycan and chitin chains. In this space various enzymes responsible for regulating yeast metabolism 
are contained. Other eukaryotes and prokaryotes also have cell walls but the material the cell wall is 
made of varies. Additionally, fungal cells have a vacuole, an organelle they have in common with 
plant cells. The vacuole can take many shapes. In the case of yeast, the vacuole is a dynamic 
structure that can quickly change its shape. The vacuole has many functions such as isolating 
harmful materials that pose a threat to the cell, containing waste and small molecules, and 
regulating cell pH, concentration of ions and osmotic pressure (Walker 1998). 
 
Figure 25: Schematic of a typical yeast unicellular organism consisting of a cell wall over the cell 
membrane, vacuole, nucleus and other typical intracellular organelles. 
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3.1.3 Red Blood Cell Physiology 
Erythrocytes or red blood cells (RBCs) are the most commonly found cell in the human body with a 
concentration of about 5 million cells per µL of blood. The primary functions of erythrocytes are to 
transport oxygen from the lungs to the body’s tissues via haemoglobin (Figure 27C), and transport 
some (about 24%) carbon dioxide waste back to the lungs for exhalation. A healthy male will 
transport 15 g of haemoglobin per 100 mL of blood. Each gram of haemoglobin can bind with 1.34 
mL of oxygen giving 20 mL of oxygen per 100 mL of blood. They also contain the enzyme carbonic 
anhydrase which catalyses the rapid reaction of CO2 and water into carbonic acid (H2CO3) allowing 
the water in blood to transport CO2 from tissues to the lungs (Figure 26) (Guyton and Hall 2006).  
This process begins when carbon dioxide diffuses into the blood plasma and then into the RBC in the 
presence of the catalyst carbonic anhydrase most CO2 reacts with H2o forming H2CO3 (carbonic acid). 
This dissociates to form hydrogen ions and hydrogen carbonate ions. This is also a reversible 
reaction and the carbonic acid, hydrogen ions and hydrogen carbonate ions are all in equilibrium 
with one another. Inside the RBC negatively charged HCO3- ions diffuse from the cytoplasm to the 
plasma. This is balanced by diffusion of chloride ions, Cl-, in the opposite direction, maintaining the 
balance of negative and positive ions on either side of the membrane. The dissociation of H2CO3 
increases the acidity of the blood which causes Hydrogen ions, H+, to react with oxyhaemoglobin to 
release bound oxygen (and thus reduce the acidity of blood). Haemoglobin is strongly attracted to 
carbon dioxide molecules and is removed as the waste product of a respiring cell. CO2 is transported 
to the lungs and exchanged for oxygen since oxygen’s concentration is higher outside of the RBC. 
This is a continuous process as the lung concentration and respiring cell concentrations will always 
be opposite. 
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Figure 26: Schematic of the transport and exchange of oxygen in RBCs 
The size, shape, and number of erythrocytes, and the number of haemoglobin molecules are of 
interest in many diseases such as anaemia, malaria, polycythaemia, as well as blood type related 
diseases (Guyton and Hall 2006, Liumbruno and Franchini 2013).  
RBCs are formed from pluripotent hematopoietic stem cells (HSCs) at a rate of about 2 million cells 
per second through a process known as erythropoiesis (Figure 27A). During this process, the cell will 
eject most of its organelles to accumulate iron and haemoglobin and finally, will eject its nucleus. 
This process takes 3 to 5 days upon which the haemoglobin filled reticulocyte enters the blood 
stream. Intracellular enzymes break down the remaining ribosomes resulting in a fully mature RBC. 
The majority of circulating cells are these fully mature RBCs with only 1-2% reticulocytes. This 
process is hormonally controlled (primarily through erythropoietin (EPO) produced in the kidney) 
and depends on adequate iron, amino-acid, and B12 supply (Guyton and Hall 2006, Tsiftsoglou et al. 
2009).  
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Figure 27: RBC physiology A) Erythropoiesis-HSCs transform to a committed proerythroblast which 
undergoes three phases including ribosome synthesis, haemoglobin accumulation, and ejection of 
the nucleus. The circulating reticulocytes then mature into RBCs. B) RBC’s geometry maximize the 
surface area to volume ratio for gas transport and are 97% haemoglobin. C) Haemoglobin is 
composed of the protein globin, which is made up of two alpha and two beta chains, each bound 
to an iron containing haeme group, which binds one-to-one with oxygen (i.e. each haemoglobin 
can transport four molecules of oxygen)  (Marieb and Hoehn 2010). 
 
Their lack of organelles and unique shape are optimally designed for the purpose of oxygen 
transport (Figure 27B). For example, their lack of mitochondria means they rely on anaerobic 
respiration allowing efficient delivery of the transported oxygen. RBCs are biconcave in shape and 
roughly 7.5-8µm in diameter, 2-2.5µm at their thickest and 1µm at the centre. This shape provides a 
greater surface area to volume ratio for gas exchange and storage. RBCs contain structural proteins 
such as spectrin providing flexibility through small capillaries.  These cells will circulate for about 120 
days at which point they undergo eryptosis and are removed from the blood by macrophages and 
degraded in the marrow, liver or spleen whilst the iron is recycled.  
RBC membrane: The RBC membrane aids in regulating the cell shape as it circulates through the 
capillary network (vessels 1-3 µm in diameter) as well as adhesion and the cell’s immune response.  
The membrane consists of the glycocalyx, a carbohydrate rich external layer, the lipid bilayer 
containing proteins, and the membrane skeleton which is a network of proteins on the cytoplasmic 
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side of the membrane (Yazdanbakhsh et al. 2000). The membrane skeleton is primarily composed of 
the molecule spectrin and is responsible for the flexibility and deformability of the RBC. Spectrin has 
alpha and beta subunits entwined to form heterodimers which associate head to head to form 
tetramers. This network is linked with actin filaments in association with protein 4.1 (Figure 28). The 
membrane skeleton is linked to the lipid bilayers via ankryin binding to the transmembrane protein 
Band 3 or through the binding of protein 4.1 to glyciphorin (Yazdanbakhsh et al. 2000, Pasini et al. 
2010b). The ratio of polymerised and depolymerised actin controls membrane flexibility whereby 
flexibility increases when actin polymerisation is inhibited. This ratio is controlled by the minor 
proteins tropomodulin, tropomyosin, αβ-adducin and protein 4.9 (dematin). 
 
Figure 28: Schematic simplification of the RBC membrane and cytoskeleton from (Pasini et al. 
2010b). 
Aside from the structural function, transport and maintenance of RBC volume are vital roles of 
membrane proteins. Band 3 is the primary transporter which acts as an anion exchanger rapidly 
exchanging bicarbonate and chloride. Other anions are exchanged at slower rates since it is the rapid 
reaction of CO2 and water catalysed by RBC carbonic anhydrases that produces the bicarbonate 
whilst the by-product H+ facilitates oxygen release to the tissues through binding with haemoglobin. 
RBC proteomics has identified many transporters on the RBC membrane (Figure 29).  
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Figure 29: Summary of the main RBC transporters described in (Pasini et al. 2010b). 
 
The RBC membrane is impermeable to cations and relies on a number of specific transport systems 
to maintain intracellular cation concentration. Two adenosine (ATPase)-dependent cation pumps 
(Na+-K+ pump and calmodulin activated Mg2+-Ca2+ pump) as well as copper and zinc transporters 
have been identified in RBC proteomics. Maintenance of intracellular calcium in the RBC is vital as 
increased levels of calcium leads to cell dehydration and protein degradation and cell death 
(Bratosin et al. 2001, Pasini et al. 2010b). Three facilitated glucose transporters (GLUT1, GLUT3 and 
GLUT4), providing the RBC its primary energy source, have been identified in the proteome whilst 
the RBC is predominately impermeable to nucleotides such as ATP. Additionally a number of passive 
symporters have been identified that rely on the Na+-K+ gradient. These include two chloride co-
transporters and a Na+-H+ exchanger. Chloride transport also relies on a K+-Cl- symporter as well as 
voltage gated chloride intracellular channels (CLIC1 and CLIC3). Particularly interesting for this work 
(and explained in Chapter 5), CLIC1 and CLIC3 have been found to be present within the cytoplasm 
and membrane of the RBC. These along with the Gardos channel are activated by intracellular 
calcium and expel potassium ions. Proteomics has also identified water channels aquaporins 1 and 3, 
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which may be regulated by the CLIC family, amino acid transport proteins, nucleosides transporters, 
as well as fatty acid transporters (Yazdanbakhsh et al. 2000, Pasini et al. 2010a, Pasini et al. 2010b).  
 
3.2 Cellular Pathologies and Processes 
3.2.1 The Molecular Clock 
Coordination of many of the body’s behavioural, metabolic and physiological processes are 
controlled around the 24 hour clock typically controlled through endogenous molecular 
mechanisms. This synchronisation allows mammals to achieve “temporal homeostasis” with its 
environment by regulating gene expressions for specific physiological events throughout the solar 
day (Figure 30). From rhythmic gene expression and cell division, to metabolic oscillations, biological 
clock regulates numerous aspects of cell biology and physiology. These rhythms can be 
resynchronized (entrained) by external stimuli, for example the process of the body overcoming 
jetlag and can adjust to changes in the day-night cycle through external cues such as feeding 
schedules.  
This area is of clinical interest because disruption of these rhythms (such as with shift workers) has 
many health implications including cardiovascular disease, depression, organ damage, obesity and 
diabetes. Irregular sleep patterns may also be an indicator of other underlying problems such as 
bipolar disorder and kidney function. Additionally, understanding these rhythms can help determine 
optimal timing of physical and mental activities as well as drug delivery (Gallego and Virshup 2007, 
O’Neill et al. 2013, Partch et al. 2014). This has shown particular implication in cancer therapies 
(Innominato et al. 2014). 
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Figure 30: Circadian timing of body function (Spivey 2010) 
 
Current models of the circadian clock indicate the main drivers are products of rhythmic expressions 
of “clock-genes” over a 24 hour cycle, the specific transcriptional component can differ (Figure 31). 
The molecular clock is a transcription–translation negative-feedback loop driven by activators 
(circadian locomotors output cycles kaput (CLOCK) and brain and muscle ARNT-like 1 (BMAL1)) and 
repressors (period proteins (PER) and cryptochromes (CRY)) with a delay between transcription and 
the negative feedback. Over the course of the day, the PER and CRY proteins heterodimerize in the 
cytoplasm, where they are phosphorylated by casein kinase I (CKI) and glycogen synthase kinase-3 
(GSK3). They then translocate to the nucleus in a phosphorylation-regulated manner where they 
interact with the CLOCK–BMAL1 complex to repress their own activator. The PER and CRY proteins 
are degraded through ubiquitin (Ub)-dependent pathways which releases the repression of the 
transcription and allows the next cycle to start. Another feedback loop involves the activator 
retinoid-related orphan receptors RORa and inhibitor REV-ERB which controls BMAL1 expression and 
introduces a delay in CRY1 mRNA expression which reinforces the oscillations (Gallego and Virshup 
2007, O'Neill and Reddy 2011, Partch et al. 2014).  
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Figure 31: Schematic of temporal control of clock physiology from (Partch et al. 2014). 
 
This molecular clock is present in nearly every cell of the body and is organised in a hierarchal 
structure controlled by the “master clock” found in the suprachiasmatic nucleus (SCN) of the 
hypothalamus. The master clock is the only clock to receive light input (from the retina) and thus 
synchronise with the solar day. The peripheral clocks receive this input through the endocrine 
system and systemic cues such as temperature. The SCN maintains a high degree of intracellular 
coupling of neurons to prevent phase changes in the master clock due to perturbations (and thus 
keeps a 24 hour cycle), whereas the peripheral clocks do not contain the same degree of intracellular 
signalling enabling them to respond to local metabolic status in the tissues they exist (Partch et al. 
2014).  
Ultradian Rhythm: Rhythms that persist on a 90-120 minute cycle are known as ultradian rhythms. 
These are normally superimposed on the 24 h circadian cycle and have been linked to various 
aspects of mammalian physiology. Ultradian oscillations have been observed in locomotion, sleep, 
feeding, body temperature, serum hormones, and brain monoamines in species ranging from fruit 
flies to humans (Tannenbaum and Martin 1976, Daan and Slopsema 1978, Dowse et al. 1987, 
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Rivkees 2003, Seki and Tanimura 2014). Generation of these rhythms appears to be independent of 
the circadian system as they persist even upon genetic disruption or ablation of the SCN (Ibuka et al. 
1977, Rusak 1977, Vitaterna et al. 1994, Bunger et al. 2000). Once thought to be food driven, it has 
also been shown these rhythms persist in voles even in the absence of food (Gerkema and 
Vanderleest 1991). Studies on the vole further indicate that one of the reasons may be an adapted 
social synchrony to reduce predator risk (Gerkema and Verhulst 1990).  
Blum et al. (2015) have identified a second internal clock within the brain, dopaminergic ultradian 
oscillator (DUO) which regulates daily patterns of arousal. Experiments in mice revealed that the 
DUO uses dopamine to generate bursts of activity roughly every four hours. Moreover, it continues 
to work when the circadian clock has been destroyed and drugs that flood the brain with dopamine, 
such as methamphetamine, disrupt the 4-hour cycle by lengthening the period between bursts of 
activity, whereas drugs that block dopamine receptors have the opposite effect. As well as revealing 
a mechanism by which the brain coordinates processes on an ultradian cycle, DUO could also 
provide insight into the biological mechanism of psychiatric disorders such as schizophrenia and 
bipolar disorder. These disorders are often associated with patterns of activity and rest and have 
been attributed to circadian rhythms, though very little molecular evidence exists (Blum et al. 2015). 
Despite their abundance across species and their evolutionary nature, very little is known about the 
molecular basis of ultradian rhythms. 
3.2.2 Differentiation 
Differentiation is a characteristic of cell growth and division which refers to the changes in a cell’s 
physical and functional characteristics as they proliferate during embryonic development.  It has 
been found that this process does not rely on changes to DNA but rather the selected repression of 
genes as differentiation into various cell types occurs. In humans, differentiation occurs to maintain 
tissue viability and repair.  To do this, cells within tissues divide to replenish themselves. The rate at 
which this occurs is tissue and cell types specific. For example, in the brain neurons rarely divide 
whereas glial cells divide throughout life. Epithelial cells replenish themselves every few days. 
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Tissues maintain a bank of stem cells to counter act any loss as cells lose their ability to divide. Stem 
cells have capacity to form many types of cells and it is transcription factors that are essential in 
regulating which genes will be expressed in a cell. A stem cell that has potential to become any cell 
type is a pluripotent stem cell. Cells that can differentiate into limited (but multiple) cell types are 
known as multipotent or progenitor cells. For example a hematopoietic stem cell can differentiate 
into several types of blood cells but could not differentiate into any non-blood type cell.    
3.2.3 Apoptosis 
In multi-cellular organisms cell death is regulated so that there is a balance between cell division and 
cell death. When cells are no longer needed or threaten an organism they undergo a suicidal 
programmed cell death called apoptosis. Cell death can occur during embryonic development in 
morphogenesis, during aging to maintain cell populations in tissue and also as a defence mechanism 
when virally infected cells are detected.  
Cell death was first recognized as a normal part of development by Vogt in 1842 (Vogt 1842). Since 
then this process has been studied and rebranded as programmed cell death (Glücksmann 1951, 
Lockshin and Williams 1965, Vaux and Korsmeyer 1999). In 1972 Kerr, Wyllie et al. gave this type of 
controlled cell deletion the name apoptosis, derived from the Greek word used to describe the 
“dropping off” of petals from flowers. The apoptotic process involves a proteolytic cascade; firstly 
apoptotic bodies are formed, then they are phagotized and degraded by other cells (Kerr et al. 
1972). The formation of apoptotic bodies consists of condensation of the chromatin in the nucleus 
into dense masses, shrinking of the cytoplasm, nuclear fragmentation and separation of membrane 
blebs to produce membrane bounded bodies of different sizes, called apoptotic bodies, which may 
or may not contain nuclear fragments (Kerr et al. 1972, Rang and Dale 2007). 
In contrast to apoptotic cell death, necrotic death causes cells to swell and burst, releasing their 
contents and causing an inflammatory response. Apoptotic death avoids leakage of its contents and 
allows the remnants of the cell to be recycled by cells such as macrophages. Once it was established 
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that apoptosis was a different process to necrosis, research began to focus on how apoptosis is 
initiated and inhibited in cells. 
Apoptosis is initiated by cysteine aspartyl proteases (apoptotic caspases). These are synthesized and 
stored in the cytosol and are inactive until they are activated by oligomerization and then cleavage. 
Once activated, they can cleave and activate other caspases setting off the proteolytic cascade.  
Caspases can be activated through extrinsic or intrinsic pathways (Figure 32)   
 
Figure 32: The extrinsic and intrinsic pathways that lead to apoptosis. The extrinsic pathway 
begins with binding of the ligands to their respective surface receptors whilst the intrinsic pathway 
begins through a stimulus (orange box) and affects the mitochondria.  
  
One of the earliest apoptotic events is the externalisation from the inner to outer leaflet of the 
plasma membrane of the phospholipid phosphatidylserine (PS). This signals macrophages to remove 
the cell. Another early change is the reduction of intracellular potassium which is a predecessor of 
membrane degradation and associated with loss of water from the cell. These are crucial events in 
terms of DEP measurement and discussed further in Section 3.3.2.  
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Apoptosis occurs from foetal development to death as human tissues are remodelled. In adults, 
billions of cells die each hour and are replaced by new cells such as in the bone marrow. 
Abnormalities in this process have been linked to Alzheimer’s disease, cancer, and autoimmune 
disorders (Favaloro et al. 2012).  
3.2.4 Cancer 
Cancer is a collection of diseases characterised by uncontrolled or abnormal cell proliferation. A 
tumour is the formation of excess tissue in a body part, cause by cells dividing without control. 
Tumours can be cancerous and fatal, malignant, or benign. A property of most malignant tumours is 
the capability to undergo metastasis, or spreading to other regions of the body of spreading to other 
parts of the body.  Cells of these malignant tumours multiply quickly and continuously competing 
with normal tissue for nutrients. Eventually this causes healthy cells to die, blocks passage ways to 
vital organs and can cause patients pain due to pressure on nerves (Guyton and Hall 2006).  
An agent that induces mutations in the DNA causing cancer is known as a carcinogen and these are 
associated with 60-90% of human cancers. Another cause can be oncogenes, or inappropriately 
activated genes that can transform a normal cell into a cancerous cell. Most oncogenes are derived 
from malfunctioning proto-oncogenes, which are normal genes that regulate growth and 
development. Over 100 different oncogenes have been discovered. Some cancers have a viral origin. 
Oncogenic viruses stimulate abnormal proliferation of cells, causing cancer. Cells also contain anti-
oncogenes that suppress activation of oncogenes. If these are lost or inactivated oncogenes can be 
activated and lead to cancer. Cancer may also be linked to a cell having abnormal numbers of 
chromosomes, leading to uncontrolled proliferation. There is also some evidence showing that 
normal stem cells that develop into cancerous stem cells can form malignant tumours (Guyton and 
Hall 2006). 
Current methods of detecting and classifying cancer typically involve diagnostic incisional biopsy and 
subsequent histopathology. This is both an invasive and time costing procedure and normally done 
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as a result of symptomatic response of the patient. Much research has gone into early, minimally 
invasive detection methods. 
3.2.5 RBC pathology 
 The morphology, content, and number of RBCs can have major implications on a person’s health. 
The general condition of low RBC count is known as anaemia, however there many (400+) types of 
anaemia caused by a decrease in RBC number or abnormalities in the proteins decreasing the 
oxygen transport capacity. Anaemia’s are caused by decreased or altered RBC production and can 
involve soluble RBC proteins (including sickle cell anaemia, iron/vitamin deficiency anaemia) and 
membrane/cytoskeletal RBC proteins like Band 3 (including spherocytosis and elliptocytosis) as well 
as autoimmune and diseases of the bone marrow and stem cells. Parasitic diseases such as malaria 
can infect RBCs or induce haemolysis-driven anaemia (Yazdanbakhsh et al. 2000, Pasini et al. 2010a, 
Pasini et al. 2010b). Conversely, high RBC count known as polycythemia can occur as a result of bone 
marrow alterations, dehydration and high altitude. This condition increases the viscosity of blood 
making it difficult for the heart to pump and raising blood pressure. RBCs are also of clinical interest 
due to their 120 day life span which can reflect protein alterations and long term status of the body 
(for example in diabetes the haemoglobin A1C assay indicates long-term glucose control). 
3.3 Electrophysiological Measurement of Cells 
3.3.1 Cell Electrophysiology  
Cells have a resting potential of approximately –100mV with respect to extracellular space. A cell can 
be modelled as two parts; the membrane and the cytoplasm, floating in some medium. The 
cytoplasmic fluid is regarded to be almost like salt water, as is the extracellular fluid. The lipid 
membrane separates these two fluids and thus the system can be modelled as two conductors 
separated by an insulator (and thus a capacitor).  
The membrane of a cell acts as a resistor and a capacitor in parallel, due to the ion-conducting 
channels and the phospholipid bilayer, respectively. The cytoplasm is highly conductive because it 
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contains plenty of ions that carry charge over large cross-sectional areas. It also has high 
permittivity, as it is able to polarize in response to an electric field. Overall, the cell has both resistive 
and capacitive properties (Figure 33) and so it can be regarded as a lossy dielectric (Hughes 2000). 
This is explained further in Chapter 2.   
 
Figure 33: Electric model of a cell in which each compartment is modelled with both resistive and 
capacitive properties, Well response data is fit to a single-shell dielectric model which fits 
parameters such as effective membrane conductance (blue), effective membrane capacitance 
(red) and cytoplasmic conductivity (green) all with respect to the suspending medium (white).    
 
Many cellular functions depend on transmembrane movement ions. The concept of the cell as a 
high, but variable, resistance barrier, with additional dielectric (capacitive) properties was developed 
by measurement of the frequency-dependent impedance properties of many plant and animal 
tissues.  The idea that cellular impedance properties were determined by the flux of ions across the 
surface membranes was highlighted in (Hodgkin et al. 1952). These electrophysiological principles 
have spanned decades and addressed a number of applications including transmission of signals in 
the nervous system and excitation-contraction/secretion coupling to membrane potential changes 
cancer phenotypes, and ion channel activity in apoptosis (Moore 1969, Park and Ja-Eun 2002, Yang 
and Brackenbury 2013).   
Electrophysiological measurements generally use intracellular electrodes to measure changes in the 
transmembrane potential or impedance, or voltage clamp to measure ion flux. Patch clamp 
techniques were developed to improve upon these methods allowing more accurate measurements 
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of less accessible cells (Hamill et al. 1981).  Simply, this method uses a micro pipette with a diameter 
1-2 µm that is abutted against a cell membrane. Suction is applied creating a high resistance (GΩ) 
seal where the edges of the pipette tip meet the cell membrane to form a patch through which 
electric current flow can be recorded (Figure 34).  
 
Figure 34: (A) Record of current flow through a single voltage gated sodium channel and (B) 
schematic of the patch clamp method on (left) a living cell and (right) a torn away patch of a 
membrane (Guyton and Hall 2006).  
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3.3.2 DEP Measurements of Cellular Functions 
As stated previously, dielectrophoresis (DEP) has been widely used as a characterisation tool 
whereby the DEP spectrum is used to elicit electrical properties of cells to infer information about 
their biological state. Early studies characterised malignant melanocytes (Mischel et al. 1983), B-
lymphocytes, hybridomas and myeloma (Stoicheva 1986), erythrocytes (Tsoneva et al. 1986) and 
chloroplasts (Stoicheva et al. 1987) and DEP was also used to detect changes of cells as a result of 
adding chemicals (Burt et al. 1990). DEP has shown membrane capacitance varies with cellular 
function. For example, cells in different states of differentiation (Wang et al. 1994b, Huang et al. 
1996, Cristofanilli et al. 2002) or in different stages of the cell cycle (Huang et al. 1999). More recent 
applications of DEP characterisation include multi-drug resistance (MDR) of human breast cancer cell 
lines (Coley et al. 2007), distinction of neural stem/precursor cells (NSPCs) from different 
developmental progression and prediction of fate (Flanagan et al. 2008), neurogenic potential of 
NSPCs (Labeed et al. 2011),  and separation of cells by stage within the C2C12 myoblast multipotent 
mouse model (Muratore et al. 2012).  
DEP on Cancer: Dielectric properties of cancer cells have been thoroughly studied in a variety of 
cancer phenotypes, both for purposes of separation and diagnosis. A summary of these results 
provided in Table 2 indicates effective membrane capacitance increases in cancerous cells when 
compared to cells of a more normal phenotype. This could possibly be due to changes in the 
membrane morphology (Gascoyne et al. 2013, Liang et al. 2014) as cancer cells appear to have 
rougher surfaces with ruffles, folds and microvilli. This is highlighted in the work of (Gascoyne et al. 
2013) in which NCI-60 cells (a panel of 60 diverse human cancer cell lines used by the Developmental 
Therapeutics Program of the U.S. National Cancer Institute) were compared by radius and DEP 
response to determine differences amongst cancer cells of similar size but varying membrane 
morphology.  
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Table 2: Summary of DEP measurements of Membrane Capacitance on Cancer and Healthy 
Comparison Cells 
 
  
DEP Measurement of Apoptosis: Dielectrophoresis has also been used to characterise apoptosis 
soon after drug induction by measuring changes in electrophysiological properties. Wang et al. 
(2002) investigated the effects of induced apoptosis with genistein on the membrane properties of 
human promyelocytic HL-60 cells. IN another study using HL-60 cells, a panel of eight different 
toxicants having different single or mixed modes of action were monitored by depFFF peak elution 
time during the first 150 min of exposure. In every case but one (low doses of nucleic acid-targeting 
Citation+A1:D22B19A1:D28A1:D24A1A1:D28Cell Type
Effective Membrane 
Capactitance of Healthy 
Cells (mF m-2)
Effective Membrane 
Capacitance of Cancer Cells 
(mF m-2)
Gascoyne et al. 1994 DS-19 (erythroleukemia) 8.8 (differentiated) 12.6
DS-19 (erythroleukemia) 15.3 (differentiated) 17.4
T-lymphocytes    11
RBCs 9
HL-60 15
T-lymphocytes    11
RBCs 9
MDA-231 26
Huang et al. 1996 6m2 42.3 (DEP) 37.2 (ROT) 30.3 (DEP) 27.4 (ROT)
RBCs 9
MDA-231 25.9
MDA-435 13.5
MDA-468 27.5
CD34+ 10.2
MDA-435 23
UP (HPV-immortalised dermal) 11.3
H157 OSCC (oral squamous cell carcinoma) 17.7
HOK (normal oral keratinocytes) 6.9
DOK (dysplastic) 10.9
H357 15.1
H157 14.3
Benign MOSE-E 16.05, 15.26 (treated)
Late stage MOSE-L 23.95, 16.46 (treated)
CaLH3  (Rapid Adherent Cells, MAC, LAC) 10.41 (treated RAC) 23.4 (RAC),~17 (MAC),~12 (LAC)
H357 (RAC, Middle AC, Late AC) 18.10, 15.05, 10.08
OSCC1 (RAC, MAC, LAC) RAC, MAC, LAC treated < 9 ~9, ~7, ~5
Liang et al.2014
Salmanzadeh et al. 2013
Wang et al. 1994
Becker et al. 1994
Becker et al. 1995
Gascoyne et al. 1997
Huang et al. 1999
Broche et al. 2007
Mulhall et al. 2011
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agents) depFFF was more sensitive to toxin detection when compared with the cell viability assay for 
all toxicants and with the mitochondrial potentiometric dye assay or DNA alkaline comet assay 
according to the mode of action of the specific agents (Pui-ock et al. 2008). DEP was also used to 
assess Staurosporine (STS) on human K562 cells and showed earlier recognition of apoptotic events 
than typical assays (Chin et al. 2006). Pethig and Talary monitored the morphological changes of 
Jurkat T-cells as they progressed through chemically induced apoptosis and showed decreases in 
membrane capacitance reflecting a smoothing of the membrane through loss of microvilli (Pethig 
and Talary 2007). Recently it was shown comparing the typical Annexin-V assay that cytoplasmic 
conductivity correlates with phospholipid phosphatidylserine (PS) expression (which signals to the 
macrophages) and a membrane conductance spike that correlates with permeabilisation (Mulhall et 
al. 2015).   Many cancer drugs act to restart the apoptotic processes in cancer cells and therefore 
rapid determination of this process is essential in anticancer drug discovery. Apoptosis is usually 
detected by later cellular events such as protein inversion on the membrane or the collapse of 
mitochondrial membrane potential. Dielectrophoresis can detect much sooner events in the 
apoptotic process such as the efflux of potassium and water. 
DEP on RBCs: Dielectrophoresis has been extensively used (and explained in detail in Chapter 2) to 
characterise RBCs (Gimsa et al. 1994, Wang et al. 1994b) as well as investigate changes in malarial 
infection of RBCs (Gascoyne et al. 1997a, Gascoyne et al. 2002, Gascoyne et al. 2004) and especially 
towards separation of infected or cancerous cells from whole blood (Martinez-Duarte et al. 2010, 
Mulhall et al. 2011, Sano et al. 2011, Gascoyne et al. 2013, Huang et al. 2013, Sonnenberg et al. 
2013, Jubery et al. 2014, Sonnenberg et al. 2014, Zhao et al. 2014). These separation studies, 
however, were primarily focused on removing cells of interest from blood, and in the case of malaria 
and anaemia detecting changes in cell morphology through DEP. 
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Chapter 4: 3DEP Analysis on Cells  
This chapter focusses on increasing the 3DEP system’s utility for the analysis of physiological 
samples. These samples can exist in heterogeneous mixtures, at low volume or low cell 
concentration. The system has already been optimised to provide an entire 20 point DEP spectrum 
with a single 70-100 µl sample of a “bulk” population, which this generally assumes the cell 
suspension can be modelled as a single population. The system has demonstrated potential in oral 
cancer diagnosis from brush biopsies (Graham et al. 2015) and measuring the apoptotic pathway on 
cancer cells (Mulhall et al. 2015). Here, a number of experiments were undertaken to investigate 
operational limitations of the system with respect to sample volume and sensitivity as well as 
examine its sensitivity and reliability at measuring several sub-populations within a sample to 
measure drug effectiveness. 
4.1 Background  
Quantifying the effectiveness of new compounds is essential in drug discovery but is often a lengthy 
process. Once researchers understand a disease and the target molecules, extensive tests must be 
conducted to prove how an agent affects those molecules, and hence the cells. In order to speed this 
process up, high throughput screening (HTS) is used at this stage, which uses robots for liquid 
handling, enabling millions of experiments to be carried out automatically. The potency of the drug 
varies with different concentrations for cell types and must be measured comprehensively for 
thorough knowledge of a drug’s activity.   
In pharmacological research, the half maximal inhibitory concentration, IC50, is a common toxicity 
measure which indicates the concentration of a drug that is needed to inhibit a given biological 
process in half of the cells in a population. For chemotherapeutic agents that are cytotoxic, the IC50 
represents the concentration of the chemotherapeutic agent that is needed to inhibit population cell 
growth by half. The cytotoxicity of a compound is the extent to which that compound can damage 
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the cell and this damage is dose dependent. Cytotoxic compounds can cause cell death in different 
ways including necrosis and apoptosis. The cytotoxicity can be determined by incubating cells with a 
range of concentrations of a drug for a period of time and quantifying the growth inhibition on the 
cells by comparing the viability of treated and healthy control. A dose response graph similar to that 
shown in Figure 35 is typically used in which the effect of cell growth is plotted as a function of drug 
concentration (Hill 1910).  
 
Figure 35: Typical dose response curve for drug studies. 
The Hill equation (Hill 1910) has been widely used to describe the dose response relationship, in the 
‘sigmoid Emax model’, given by:  
 


CEC
CE
E


50
max  4.1 
        
where E is the predicted effect of the drug, Emax is the maximum effect, C is the drug concentration, 
EC50 is the drug concentration for which 50% of the maximum effect is obtained and α is the Hill 
coefficient of sigmoidicity (Goutelle et al. 2008). For an inhibitory effect, values of α are negative. 
The in vitro effect of drug concentration should be well characterised to aid the development of a 
drug toward optimal therapeutic effect. There are various types of tests that are typically used to 
determine the cytotoxicity of a drug on a cell line including: simple light microscopy, fluorescent 
microscopy, the 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazoliumbromide (MTT) assay 
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(Mosmann 1983), and flow cytometry  (Ormerod 2000). All of these methods involve staining of the 
cells usually with expensive and cytotoxic dyes, lengthy preparation procedures, and rely on cellular 
events that occur as a result of drug exposure downstream of initial drug effect.  
DEP has been shown to provide a good alternative to these methods because it does not need the 
use of chemicals to label cells, which could affect the cell viability, allowing the cells to be returned 
to culture or separated for further experiments. Since DEP does not rely on dyes, and costly 
microscopy techniques, it is relatively low cost and has the potential to measure in real time the 
dielectric properties of the sub-populations contained in one sample. It is of interest to determine 
how well the 3DEP system works at measuring reliably across various cell types, determining the 
sub-populations, and then ultimately predicting the IC50 of the drug doxorubicin.  
Doxorubicin (also known as Adriamycin, 14-Hydroxyldaunomycin, Doxil or Rubex) is a 
chemotherapeutic drug which belongs to the chemical group of anthracyclines (Figure 36). 
Doxorubicin was chosen to induce cell death on Jurkat cell lines because it is a broadly used 
chemotherapeutic agent. The cytotoxicity of doxorubicin has been extensively studied (Hsu et al. 
2001, Georgakis et al. 2005, Zhang et al. 2006, Sadeghi-Aliabadi et al. 2010) providing a useful 
comparison with results obtained using the 3DEP system. 
 
 
Figure 36: Chemical structure of doxorubicin hydrochloride (Sigma-Aldrich) 
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To test the application of DEP in cytotoxicity studies, the system was first optimised using the Jurkat 
cell line for small sample volume, reduction in experimental timing and assessment of the reliability 
of measuring a healthy control sample in a number of cell types including yeast, RBCs, human 
erythromyeloblastoid leukaemia k562, and human epithelial adenocarcinoma HeLa cell lines. This 
tested a new automatic fitting algorithm implemented into the 3DEP software for a single 
population model.  Experiments were then carried out in collaboration with Dr. Ruth Torcal-Serrano 
on Jurkat cells to investigate the system’s ability of measuring multiple populations and IC50. These 
DEP experiments were then compared to Dr. Serrano’s MTT assays and trypan blue measurements.  
4.2  Methods 
4.2.1 Media and Measurements 
DEP Medium: The isotonic medium consisted of 8.5% (w/v) sucrose, 0.5% (w/v) dextrose, 250 µM 
MgCl2 and 100 µM CaCl2. Phosphate-buffered saline (PBS) (Sigma-Aldrich, UK) was added to the 
solution in order to achieve the desired conductivity. This medium has been formulated to maintain 
cell viability and preserve cell electrophysiological characteristics in vitro. The sucrose provides 
adequate suspension osmolarity which maintains viability and prevents cell swelling. The dextrose 
provides cells with glucose to metabolise whilst in the suspension. Divalent cations were included in 
the medium midway through these studies to prevent potential membrane function degradation 
(Burt et al. 1990, Fry et al. 2012). For yeast cells, this medium consisted of 280 mM D-Mannitol 
(Sigma-Aldrich, UK) in deionised water. 
Cell Size and Counting: A 10 µL aliquot of each cell sample was transferred onto a disposable C-
Chip™ haemocytometer (Labtech, Uckfield,UK). Images of the cells were taken under 10 and 20 
times magnification and measured in Image J 2.0 (National Institute of Health, Maryland, US). 
The chip was transferred to the microscope stage and the stage was moved to focus the grid in the 
chamber as seen Figure 37. Only the cells that lay on the top and left hand lines on each square were 
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counted. Four 1 mm2 areas were counted and averaged. The grid surface is 0.1 mm below the cover 
slip and so the volume for one of those areas is 0.1 mm3. In the case of high concentrations or small 
cell types, five 0.4 mm2 areas were counted and averaged (red boxes). Once this was done, the 
haemocytometer was moved to focus on the second chamber and a new cell count was carried out.  
 
Figure 37: Haemacytometer grid. Blue dots represent dead cells, white dots live cells, red lines 
show the area counted when high concentrations were used. 
 
 The scale was set by measuring the number of pixels across the smallest grid square (0.05 mm). At 
least 100, well focused, cell diameters were measured by drawing a line across the widest part of the 
cell, as seen in Figure 38.  
 
Figure 38: Example of image J analysis on radius measurements. Pixel distance is converted to unit 
measure via a known distance on the haemocytometer. 
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From this the average cell radius was calculated. The distribution of cell size was analysed using 
statistical analysis software Prism 6 (Graphpad) for confirmation of measurement normality.  
Osmolarity and Conductivity: Osmolarity of the mediums were measured with an Osmomat 030 
(Ganotec) osmometer (Wolf Laboratories Limited, York, UK). The osmometer was calibrated with 
distilled water and a 300 mOsm/kg calibration solution before measuring samples. A range of 280-
300 mOsm/kg was considered acceptable for use. Measurements were taken for every fresh buffer, 
and repeated for any buffer which had been stored for longer than two weeks.  
Conductivity of the DEP medium was verified with a Jenway 470 conductivity meter (Bibby Scientific, 
UK). All measurements were taken at room temperature (18-22 °C as verified through a temperature 
log kept near the work space) and validated prior to experiment.  
Data Fitting: In the first generation of data modelling (Broche et al. 2011), the single shell model was 
fit in MATLAB by manually manipulating parameters with the DEP_well_plotter.m graphical user 
interface (Figure 39).  
 
Figure 39: The MATLAB GUI designed to plot DEP spectra data and fit the single-shell model 
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These parameters were used in the single-shell model to estimate the DEP response of a given cell 
line. This code can be found in Appendix C under twoshell.m. Goodness of fit parameters; root-
mean-square error (RMS error) and Pearson’s Correlation Coefficient (R) were used to estimate the 
model fit to the data and to compare the various configurations. These were both calculated in 
MATLAB in DEP_well_specplotter.m using the following equations: 
 
𝑅𝑀𝑆𝐸 = √
∑ (𝑥𝑖 − 𝑓𝑖)
𝑛
𝑖=1
2
𝑛
 4.2 
 
𝑅 =
𝑛 ∑ (𝑥𝑖𝑓𝑖) − ∑ (𝑥𝑖) ∑ (𝑓𝑖)
𝑛
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4.3 
 
The R value is the measure of the linear correlation between two variables. This can be either 
negative or positive and range from -1 to 1. The further away from 0 this value is, the more 
correlation there is between the two variables. This value squared, denoted R2 is known as the 
coefficient of determination and measures the closeness of a data point to the fitted regression line.  
The RMSE is the sample standard deviation of the differences between the measured and model 
predicted values. It measures the spread of data with respect to mean and is most favourable the 
closer to 0 it becomes.  In general, a model fits the data well if the differences between the observed 
values and the model's predicted values are small and these residuals must be normally distributed 
and unbiased.  
Multi-population Modelling: When there is more than one sub-population present in a cell sample 
the DEP spectrum is the result of the addition of the DEP spectra of each sub-population in 
proportion to their presence in the sample (Broche et al. 2005). This was done in MATLAB 
(multipopulation.m) first modelling known mixed populations of healthy and drug treated to 
determine the goodness of fit of the model to the known mixed populations (Figure 40). Then, the 
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model was used to assess the cytotoxic effect of DOX on Jurkats cells with unknown sub-
populations.  
 
Figure 40: An example of relative DEP force of 4 sub-populations and the subsequent spectrum 
produced by their addition. 
  
Statistics: Whilst curve fitting was conducted in MATLAB and upon development 3DEP software 
based on MATLAB converted Visual Basic code, data was then collated in Prism6 (Graphpad) to 
determine normalcy of data and residuals and analyse statistical significance of the experimental 
setups using 1- and 2-way ANOVA where appropriate (and within this comparison tests where 
appropriate) as well as multiple comparison tests. Prism recommends using the D'Agostino-Pearson 
omnibus test as it explains the Shapiro-Wilk test also works very well if every value is unique, but 
does not work well when there are ties (i.e. the same value measured in multiples). Since radii 
measurements typically produced multiple similar values, this was taken into account.  
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4.2.2 Cell Culture 
Culture of Yeast Cells: Yeast cells were grown in Yeast extract-peptone-glucose (YPD) broth (Sigma-
Aldrich, UK) which consists of 5% (w/v) YPD broth in deionised water. This mixture was autoclaved, 
cooled and then a small amount of yeast was added and stored in an incubator at 37°C overnight. 
In order to avoid other microorganisms growing alongside the yeast, streaking was used. Streaking is 
a technique used in microbiology to isolate different species. 
YPD Agar, comprising 5% YPD broth and 1% Agar, was made in deionised water, and autoclaved. 
Before the mixture had cooled down and solidified, it was poured in a petri-dish and stored in a 
standard refrigerator for 2 hours. A sterile, platinum inoculation hoop was dipped into the yeast in 
YPD broth and was used to streak the agar plate in a zig-zag pattern. This was repeated until the agar 
had been covered as seen in Figure 41. 
 
Figure 41 Top view of petri dish with streaking of yeast on YPD Agar. Each colour represents 
another generation of the yeast growth (light to dark) 
 
This petri-dish, containing the streaked yeast, was incubated for 24 hours so that yeast colonies 
reproduced. After the 24 h it was kept at 5°C for up to 2 weeks. To grow yeast, the hoop was 
sterilized, yeast was picked up from a colony from the last inoculation and the loop was dipped into 
autoclaved YPD broth. This was incubated overnight at 37°C.  
To prepare yeast for experiments, cells were centrifuged at 1500 rpm for 3 minutes to form a pellet. 
The supernatant was removed and the cells were resuspended in DEP medium. The cells were twice 
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pelleted by centrifugation. The cells were finally resuspended in the required amount of DEP 
medium, to make up the desired concentration of 107 cells per ml in readiness for the 
dielectrophoresis experiment.  
Culture of k526 cells: Human chronic myelogenous leukaemia (K562) cells were cultivated in 
modified RPMI-1640 medium supplemented with 10% heat inactivated foetal bovine serum (FBS; 
Invitrogen, UK), 2mM L-Glutamine and 1% penicillin-streptomycin (Sigma-Aldrich, UK). The cells 
were grown in T75 flasks in a standard cell culture incubator at 5% CO2 95% humidified air at 37°C 
and subcultured every 48 h.  
K562 cells were centrifuged at room temperature at 1200 rpm for 6 minutes. The supernatant was 
removed and the pellets were resuspended in DEP medium. The cells were twice pelleted by 
centrifugation in order to remove any medium excess. The cells were finally resuspended in the 
required amount of DEP medium. The final cell population was counted using a haemocytometer 
and adjusted for DEP measurements to 1.15 x 106 (±15%) cells per ml.  
Culture of Jurkat cells: Jurkat cells were cultivated in modified RPMI-1640 medium supplemented 
with 10% heat inactivated foetal bovine serum (FBS; Invitrogen, UK), 2 mM L-Glutamine and 1% 
penicillin-streptomycin (Sigma-Aldrich, UK) and sub-cultured every 48 h. To prepare cells for the DEP 
assay, samples were washed twice in DEP medium and resuspended at a final cell concentration of 
the order 106 cells per ml as described for k562 cells.  
Red Blood Cells: Red blood cells (RBC) were fractionated from whole blood as described in section 
5.2.1. These cells were used immediately following blood draw and not stored. Fractionated RBCs 
were diluted in DEP medium at a typical concentration of 3 x 106 cells (± 10%) per ml.  
Post DEP Viability Assay: Post DEP viability was assessed with the adherent HeLa cell line. Prior to 
experiment, 3DEP chips, cover slips, pipette tips and tubes were autoclaved, and brought directly 
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under the biosafety hood. A scale was placed inside the hood and used to measure a 96-welll plate 
with 100 µL of complete RPMI media in each well and the weight was zeroed. Each DEP 
measurement was made on a separate 3DEP chip with new pipette tip and cover slip used for each 
measure. Exactly 75 µL of cell suspension was pipetted into the chip each run.  As much sample 
volume that could be reasonably extracted post experiment was pipetted out of the chip and into 
one of the wells with the mass weighed after each addition. Total post DEP cell retention was 
estimated assuming the volume retention could be estimated with the density of water and thus 
mass retention measured.  
Cells were left to culture for 24 h before testing viability. To enable observation under fluorescent 
microscope, cells were stained with fluorescent dye of LIVE/DEAD® Viability/Cytotoxicity Kit for 
mammalian cells (Sigma-Aldrich, UK).  Cells were washed of the serum enriched media with PBS and 
then incubated for 15 minutes with 200 µL PBS containing 2μL/ml Calcein AM and 6μL/ml Propidium 
Iodide (PI). Calcein-AM is enzymatically converted to green fluorescent calcein in living cells. PI is a 
nuclein staining dye which cannot pass through a viable cell membrane. It reaches the nucleus by 
passing through disordered areas of dead cell membrane, and upon nucleic acid-binding produces a 
red fluorescence.  
4.2.3 Cell Mixtures 
 
To calibrate how well the 3DEP system detects different sub-populations in a homogenous sample, a 
sample of healthy cells and a sample of treated cells were prepared for DEP experiments. Treated 
cells were incubated with a high dose (10 µM) of doxorubicin hydrochloride (Sigma-Aldrich, UK) for 
16 h. This incubation was optimised to provide a control sample of 100% affected cells. Then ratios 
of the healthy cell sample and the treated sample were prepared in ratios of 1:3, 2:2 and 3:1. A 
viability test was carried out on 20 μL of each of the mixtures as well as on the original samples using 
trypan blue 0.4% solution. Modelling was conducted in MATLAB with statistics run in GraphPad. The 
cell radii for each sample were also measured (n=100) and analysed using Prism6 (GraphPad).  
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Cytotoxicity Investigation: Doxorubicin hydrochloride (Sigma-Aldrich, UK) was dissolved in sterile 
filtered distilled water, to achieve a 1.72 mM stock solution, aliquoted, and kept in 4 °C refrigeration. 
Jurkat cells were seeded at a density of 1x10E5 cells/ml, 24 h after the previous passage, to ensure 
exponential growth. They were kept in T75 flasks in 20 ml of RPMI media with 0.1, 0.3, 0.5 or 1 µM 
Doxorubicin. Cells were incubated with the different doses of doxorubicin for 8, 16 or 32 hours 
before the drug treatment was terminated and cells were prepared for DEP experiments as 
described in section 4.1.2. 
MTT Assay: The 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazoliumbromide (MTT) assay 
experiments were conducted by Dr. Ruth Torcal-Serrano following a protocol described by Mosmann 
(1983).  Briefly, MTT was used to titrate cell viability following drug treatment. Doxorubicin stock 
solution (1.72 mM in DI water) was diluted in complete RPMI1640 in increasing concentrations (0.1, 
0.3, 0.5 and 1 µM). The cells were seeded at a density of 3.6x104 cells/ml, 24 h after the previous 
passage to ensure exponential growth, and kept in T25 flasks in 5 ml of media with the 
corresponding concentrations of doxorubicin.  Following the incubation for 8, 16, 32 and 48 hours, 
the cells were centrifuged, the supernatant removed and they were resuspended in 60 µl of MTT 
and 10 µl was plated per well in 6 wells (6 repeats) and incubated for 4 hours. Following incubation, 
Tetrazolium crystals were dissolved in 100 µl of DMSO. 
The absorbance intensity was measured by a microplate reader (VERSAmax) at 570 nm with a 
reference wavelength of 690 nm. Plates were read within 30 minutes of adding the DMSO. All 
experiments were performed in quadruplicate and the relative cell viability (%) was expressed as a 
percentage relative to the untreated control cells.  
Determining IC50: The data points collected from these MTT data and the DEP experiments were 
fitted to the survival curve in collaboration with Prof Christopher Fry using the Hill model and the 
IC50 was determined. Briefly, the data was fit to a rectangular hyperbola with iterative least squares 
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regression and error given is error of fit to data points. The software used was Kaleidagraph from 
Synergy Software (Reading, PA USA). 
4.3 Results and Discussion 
4.3.1 High Resolution Spectra in MATLAB 
In order to maximize the use of the 3DEP system on a small volume of sample, experiments were 
conducted to increase the available data from an individual experimental replicate. Statistically this 
is useful to either increase experimental repeats, or to increase the resolution of the DEP spectrum 
for regression analysis (by increasing the number of X, Y data).   
40 point resuspension: The first of these experiments designed a 40 point frequency sweep across a 
given range to increase the number of data points defining a DEP spectrum from 20 to 40. Increasing 
the number of data points allows better data fitting, smoothing and ultimately enables the system to 
detect minute changes in cell physiology more sensitively by more accurately modelling the 
dispersions. Due to their ease of preparation and availability, Jurkat cells were chosen for this study. 
Cells were prepared for experiment as describe in section 4.12. A revised DEP_well_centre GUI was 
written to stagger 40 frequencies across a user defined frequency range (Freq Run box on Figure 42). 
This GUI enabled the user to either manually run a typical 20 point spectrum or 40 point frequency 
sweep by evenly distributing the 40 frequencies across a log scale of the user defined frequency 
range. Since the 3DEP chip is only capable of running 20 frequencies at a time, the code used every 
other frequency of the 40 frequency range to define a 20 frequency set and assigned “set A” and 
“set B” to each.  The 3DEP chip could then be loaded, and upon pushing “Start Experiment” either 
Frequency Run A or B energized the 20 wells of the 3DEP chip for 40 seconds.  
 Page | 82 
 
 
Figure 42: The DEP_well_centre graphical user interface (GUI) originally programmed in MATLAB 
to control the 3DEP system. For purposes of this study the Freq Run box was added along with 
user options for start and end frequency. 
 
In between Run A and Run B, the sample in the chip was carefully resuspended (“mixed”) via 
pipetting whilst still in the reader. This was tested 10 times (for a total of 20 repeats) yielding 20 
point DEP spectra of Run A (n=10) (Figure 43A) and Run B (n=10) (Figure 43B) or 40 point spectra 
A&B combined (n=10) (Figure 43C). All spectra can be found in Appendix A. Optimal parameters for 
Jurkat cells were determined by best fitting the model parameters of all of the experiments 
averaged together (n=20). These parameters were then only adjusted within the standard deviation 
of each for an optimal fit and the goodness of fit of this model to the data was determined.  
 
Table 3: Averaged parameters of best fit for Jurkat cells 
 
radius (µm) σcyt (S/m) εcyt Geff (S/m2) Ceff (mF/m2) σmedia (S/m)
mean (n=27) 5.38 0.45 50.00 750.00 9.08 0.01
stdev 0.15 0.01 n/a 169.84 1.22 n/a
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Figure 43: The 40 frequency points were separated into 2 runs. Run A average (A) demonstrated 
slightly better fit (R=0.98269 when model fit to all data) compared to Run B average (B) 
(R=0.92735 when model fit to all data) whilst the 40 point spectrum combining A and B (C) 
demonstrated an R of 0.97558.  
It was found that the resuspended cells (B) did not perform as well as the initial run (A) with 
goodness of fit parameters slightly in favour of the Run A averages  (R=0.97 RMSE=0.16 compared to 
R=0.94 RMSE=0.21)(Table 4). The data in Run B can be seen to more scattered than that of Run A 
(Figure 43), however the combined average had an R value of 0.97588 and RMSE of 0.13582. The 
model values for individual repeats were checked for normalcy and the goodness of fit parameters in 
Table 4 were analysed for effect. Figure 44 summarizes this for both Pearson’s and RMSE. Run A and 
Run B (shown as MEAN±SD) for Pearson’s (Figure 44A) and RMSE (Figure 44B) were found to be 
statistically significant (p=0.0038 and p=0.005 respectively) using an unpaired t-test.  Tukey’s 
multiple comparison test also revealed the combined 40 point spectrum was significantly different 
to the original sample of Run A (p≤0.002) but not to the Run B (p≥0.05). 
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Table 4: Individual model fits for the 10 repeats of each frequency run 
Repeat 
Run A 
Pearson's 
Run A 
RMSE 
Run B 
Pearson's 
Run A 
RMSE 
40PT 
COMBINED 
Pearson's 
40PT COMBINED 
RMSE 
1 0.97249 0.14595 0.96664 0.16545 0.94528 0.20717 
2 0.96877 0.16471 0.94493 0.19583 0.94902 0.19114 
3 0.96982 0.17875 0.93856 0.2253 0.95237 0.19661 
4 0.97011 0.1597 0.94324 0.21122 0.95075 0.19649 
5 0.95405 0.19125 0.94269 0.22462 0.94583 0.21286 
6 0.97065 0.15699 0.96073 0.18587 0.9543 0.19678 
7 0.97999 0.13186 0.8854 0.29469 0.93594 0.22814 
8 0.9669 0.16231 0.955579 0.19552 0.96119 0.17831 
9 0.97459 0.13782 0.95733 0.20198 0.96307 0.17282 
10 0.96818 0.15827 0.95253 0.21057 0.95289 0.20097 
Mean 0.969555 0.158761 0.944763 0.211105 0.951064 0.198129 
 
 
Figure 44: Goodness of fit parameters of the DEP data produced across the two frequency runs of 
the same sample. Run A and Run B (shown as MEAN±SD) for Pearson’s and RMSE were found to 
be statistically significant (p=0.0038 and p=0.005 respectively) using unpaired t-test.  Tukey’s 
multiple comparison test also revealed the combined 40 point spectra was significantly different 
to the original sample of Run A (p≤0.002) but not to the Run B (p≥0.05). 
 
Together these results suggest that resuspending the sample within the chip and running a second 
frequency sweep on that same sample would produce significantly effected results in the goodness 
of fit.  This change could be due to a loss of cells during the resuspension, cells adhering after the 
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first 40 second exposure to the well wall, or clumping together in the centre. This is not to say the 
fits themselves are considered unreliable, as they still maintain respectable R and RMSE values; 
however this reveals users may need to alter the single-shell parameters for best fit to 
accommodate a better end result. In other words, it would not be recommended to automatically fit 
the same modelled parameters to the two data sets, but rather model each separately.  
No Resuspension: It was then investigated whether multiple spectra could be obtained from a 
sample without resuspension (i.e. leaving the chip unaltered in the reader). This could prove useful 
when sampling very low volumes or in instances of light sensitive cells (such as light-sensitive ion 
channels). The limiting factor in this case is the length of time needed to obtain reliable data. The 
current set-up required analysis over at least 40 seconds. This long exposure time reaches the 
“saturation point” of cell movement (Broche et al. 2011) and thus if Run B were to be triggered 
immediately following this, no cell movement would be detected.  Timings of 30 (n=10), 20(n=5), 
and 6 (n=12) s for Jurkat cells were analysed to determine the minimal time necessary to achieve 
reliable (reproducible and high R values) data both for Run A and Run B.  Individual repeats of this 
can be found in Appendix A. It was found that 30 s runs were not conducive to reliable spectra. In 
Figure 45 this can be seen when comparing the best and worst fit Run B frequency sweep to their 
Run A counterpart.  
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Figure 45: Staggered frequency sweep produced by 30 second exposure of frequency run A (A&C) 
followed by 30 second of frequency run B (B&D) with no resuspension. (B) is the best fit found for 
a run B repeat and (D) is the worst fit of run B. Run A in both cases was accurate and remained 
unchanged.  
 
An interesting pattern emerged with the 20 s data, in that the Run B plots (Appendix A) were 
consistently proportionally lower than the Run A frequencies (Figure 46A). To compensate for this, a 
scaling factor was introduced to DEP_well_average_spectra.m (Figure 46C). This factor was 
determined by the already used scaling factor of the model of each Run B file to the corresponding 
Run A by dividing the model scales. Run B data was then multiplied by this scale and replotted 
(Figure 46B). Subsequently this scaling factor was used to plot, fit and analyse the Run A and Run B 
data. This could be done  since all statistics used to compare are relative to the model and this 
should not change when multiplying both the model (already scaled to data by existing code) and 
data by a constant. 
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Figure 46: DEP_well_average results of Run A (A-top data points) and Run B (A-bottom data 
points) not scaled in image (A) and automatically scaled (B) using the GUI with auto scale added 
(C). 
 
Next, a series of 6 s experiments were conducted. While the Run A files of these did not perform as 
well with regards to goodness of fit as compared to 20 s (Figure 47), the Run B files were consistently 
superior to any of the preceding experiments with higher Pearson’s average and lower RMSE (Table 
5 and Figure 47). 
Table 5: Summary of Pearson's Correlation Coefficients and RMSE values for frequency Runs A and 
B for 6, 20, and 30 s DEP force exposure 
 
 Page | 88 
 
 
Figure 47: Summary of results for no resuspension 40 point spectra. The bars are MEAN±SD of 
Pearson’s Correlation Coefficient (left axis) and RMSE (right axis) for Frequency Run A (black) and 
B (grey). Using Sidak’s multiple comparison test, Pearson’s Correlation Coefficient was found to 
have no statistical change between Run A and Run B for 6 s (p=0.1) or 20 s (p=0.053) but was 
found to be significantly affected for the 30 s exposure (p<0.0001). RMSE was found to be 
significantly changed between Run A and Run B for all experimental times (p=0.014, p=0.0065, 
p<0.0001)   
 
The crux of this work is not how well each frequency sweep fits the single-shell model, but rather 
how consistent Run B is relative to Run A for each experimental time (i.e. is it possible to run the 
experiment for a short enough time to allow for a second run without resuspending the cells?). 
Using grouped quantification of Pearson’s and RMSE  showed Pearson’s Correlation Coefficient was 
found to have no statistical change between Runs A and Run B for 6 s (p=0.1) or 20 s (p=0.053) but 
was found to be significantly affected for the 30 s exposure (p<0.0001). RMSE was found to be 
significantly changed between Runs A and Run B for all experimental times (p=0.014, p=0.0065, 
p<0.0001) however less so for the shorter experimental times by 2-way ANOVA for Run affect. From 
this, it can be determined that the 30 s experimental time, despite having a better Run A, would not 
be suitable for this purpose.  
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Group quantification using Sidak’s multiple comparison test to guise timing affect overall was then 
investigated. No difference was found in any experimental time for Run A for both Pearson’s and 
RMSE (p>0.9 for all Pearson’s timing comparisons and p>0.3 for all RMSE timing comparisons) whilst 
there were timing effects in Run B when comparing 30 s to the other shorter experimental times 
(p≤0.0006 for Pearson’s and p≤0.01 for RMSE). Interestingly, no difference was observed when 
comparing 6 s to 20 s for either Pearson’s (p=0.92 (A) p=0.69 (B)) or RMSE (p=0.99 (A) p=0.87 (B)) for 
Run A or Run B. This would indicate that in fact the 6 s timing is the best condition despite having a 
slightly worse goodness of fits for Run A. Ultimately this was tested on the 40 point spectra 
produced by fitting all of Run A and Run B data points for each timing (Figure 48). Goodness of fit 
parameters were found to be best overall for 6 s experimental time for the 40 point spectra.  
 
Figure 48: Single-shell fits of 30 s with R=0.94579 and RMSE=0.19934 (A) 20 s with R= 0.96292 and 
RMSE= 0.18093 (B) and 6 s with R= 0.98529 and RMSE 0.10093 (C).  
 
Consequently, this work demonstrated two significant findings. First, that the 3DEP system is 
capable of producing two experimental repeats from one 80 µl sample without resuspension. And 
second, experimental protocols for running the 3DEP system can in fact be altered for allowing 
shorter experimental time down to 6 s per experiment without any effect on model fitting. This is in 
line with previous mathematical modelling in which it was found that the proportional relationship 
assumption for most cells between DEP force and changes in light intensity began to collapse at after 
5 seconds (Broche et al. 2011). This is a substantial finding in DEP analysis as it drastically reduces 
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the time necessary to have cells suspended in DEP media, exposed to electric fields, and increases 
throughput of these measurements giving it a distinct advantage over patch clamping techniques.  
4.3.2 Automatic Fitting in MATLAB and High Resolution Spectra 
 
Whilst a short analysis time permits many experiments to be performed sequentially, with this 
comes the necessity of analysing large data sets. For this purpose the manual DEP_well_plotter.m 
was archaic and cumbersome. A fitting library was implemented in a new BatchProcess.m  GUI in 
MATLAB, and later coded into Visual Basic as part of the 3DEP software (VB coded by Dr. Kai 
Hoettges). This fitting algorithm relies on user input of what parameters are fixed, upper and lower 
limits for fitted parameters, and uses the previous fitted values as initial conditions for the next fit. 
The C library version of MPFIT created by Markwardt (2009) implemented robust non-linear least 
squares curve fitting on the data.  User defined parameter holds (constants) and physiological limits 
of parameters were set within the BatchProcess.m GUI.  
 
Figure 49: BatchProcess.m MATLAB GUI 
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This fitting algorithm on the single-shell model was tested across 4 cell types and 100 frequencies. 
This was done by staggering start and end frequencies across five (a fresh cell suspension pipetted 
into the chip each time) twenty frequency sweeps for a single 100 point “run”. An example of this is 
shown in Figure 50 for one trial day.  
 
Figure 50: Frequency sweeps to achieve 100 point spectrum "run", repeated 4 times for each trial. 
Yeast cells were sampled over two separate days (from two separate batches). Five 100 point runs 
for each day were conducted each trial day and modelled automatically in 3DEP (Figure 51 Figure 
52). These were modelled separately and then collated together for a total of n=10 spectra to 
achieve parameter MEAN±SEM and n=10 data points at each of the 100 frequencies to analyse data 
point distribution and significance. The cell parameters (cytoplasmic conductivity, membrane 
conductance, and membrane capacitance) determined are given in Table 6 and compare well with 
previously published results (Broche et al. 2011). 
Table 6: Yeast Parameters Determined by n=10, 100 point Spectra 
 
Cell parameters: 
Cytoplasm Conductivity S/m:  0.0992 ±0.01
Cytoplasm Permitivity:  50.0000 fixed
Specific Membrane Conductance S/m2:  2551.3106 ±76
Specific Membrane Capacitance F/m2:  0.0065 ±0.00037
Cell Radius µm:  4.0000 fixed
Medium Coductivity S/m:  0.0100 fixed
Medium Permitivity:  78.0000 fixed
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Figure 51: Yeast trial 1 of 5, (A-E), 100 point frequency runs. 
 
Figure 52: Yeast trial 2 of 5 (A-E), 100 point frequency runs. 
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Figure 53: Column graphs at each of the 100 point frequencies with columns representing MEAN 
±SEM (n=10) of normalised light intensity. D’Agostino and Pearson omnibus normality test 
conducted across all 100 frequencies and 1-way ANOVA with multiple comparisons across all 
repeats were conducted (* indicating frequency(ies) where significance between trials was 
determined).  
 
D’Agostino and Pearson omnibus normality test conducted across all 100 frequencies revealed all 
but 3 frequencies demonstrated normal distribution across the 10 repeats.  One-way ANOVA with 
multiple comparisons across all frequencies of the two trials revealed 4 frequencies (point 51, 53, 
76,78) in which the two means were statistically significant from each other.  None of the data 
points from the two trials were shown to be statistically different than model mean (p>0.05 for all 
points) (Figure 53).  
To demonstrate the robustness of the model across the data, regression plots were generated for 
both Trial 1 and Trial 2 against the averaged model. These both showed good linear correlation to 
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the model and demonstrated similar linear fits to the regression curve. 
 
Figure 54: Regression plots for Trial 1 and Trial 2 of yeast fit against the model. 
Next, RBCs harvested from two separate donors were prepared and run similarly to yeast (Figure 55 
and Figure 56). Since donor blood had never been modelled prior to this, each donor average was 
modelled separately to determine whether or not the models yielded different parameters across 
donors for the 5 runs of each. 2-way ANOVA with multiple comparison demonstrated no statistical 
significance of the three fitted parameters (p>0.05) for all donors. Thus, one set of parameters 
determined from an average of all 10 repeats was deemed suitable and shown in Table 7. These 
parameters vary from typically published values (Gascoyne et al. 1997a, Gascoyne et al. 2013) 
however, the variations can mostly be accounted for in the measurement of radius as membrane 
conductance and capacitance are related to surface area (here 4.2 µm compared to these studies’ 
values of 2.8-3.1 µm). The radii measurements were also noted to be higher than standard literature 
values (3.5-4.0 µm). Osmolarity of the suspending medium was observed between 290-300 mOsm to 
eliminate hyperosmolarity as a cause.  
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Table 7: RBC Parameters Determined by n=10, 100 point Spectra 
 
 
Figure 55: RBC Donor 1 (Trial 1) of 5 (A-E), 100 point frequency runs. 
Cell parameters: 
Cytoplasm Conductivity S/m:  0.082 ±0.00042
Cytoplasm Permitivity:  60 fixed
Specific Membrane Conductance S/m2:  2818.05 ±71
Specific Membrane Capacitance F/m2:  0.006507 ±0.0014
Cell Radius µm:  4.2 fixed
Medium Coductivity:  0.01 fixed
Medium Permitivity:  78 fixed
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Figure 56: RBC Donor 2 (Trial 2) of 5 (A-E), 100 point frequency runs. 
 
D’Agostino and Pearson omnibus normality test conducted across all 100 frequencies revealed all 
but 2 frequencies demonstrated normal distribution across the 10 repeats (and once any obvious 
outliers due to faulty pin connection or bubbles in the well  were removed all points were normally 
distributed).  One-way ANOVA with multiple comparisons across all frequencies of the two donors 
revealed 5 frequencies (points 35, 60, 61, 75, 77) in which the two means were statistically 
significant from each other.  None of the data points from the two trials were shown to be 
statistically different than model mean (p>0.05 for all points) (Figure 57).  
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Figure 57: Column graphs at each of the 100 point frequencies with columns representing 
MEAN±SEM (n=10). D’Agostino and Pearson omnibus normality test conducted across all 100 
frequencies and 1-way ANOVA with multiple comparisons across all repeats were conducted (* 
indicating frequency(ies) where significance between trials was determined).  
 
To demonstrate the robustness of the model across the data, regression plots were generated for 
both Donor 1 and Donor 2 against the averaged model. These both showed good linear correlation 
to the model and demonstrated similar linear fits to the regression curve. 
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Figure 58: Regression plots for Donor 1 and Donor 2 of RBC fit against the model. 
 
Once the reliability of this fitting algorithm and 3DEP performance was confirmed with relatively 
simple cell models, two cancer lines were investigated. One suspension (k562) and one adherent 
(HeLa) cell lines were chosen. For these, three trials were conducted using different flasks of cells on 
different passage numbers with 4 runs conducted for each (n=12 total) (Figure 59 Figure 64). The 
parameters for each cell type determined by averaging all of the 12 fits for each cell line are shown 
in Table 8. 
Table 8: Model Parameters Determined by best fit of n=12 for k562 and HeLa cell lines 
 
Cell parameters: 
Cytoplasm Conductivity S/m:  0.2167 ±0.029 0.109557 ±0.00057
Cytoplasm Permitivity:  60 fixed 60 fixed
Specific Membrane Conductance S/m2:  204.947 ±52.48 395.5258 ±18.08
Specific Membrane Capacitance F/m2:  0.006257 ±0.00029 0.015163 ±0.0016
Cell Radius µm:  9.3 fixed 8.05 fixed
Medium Coductivity:  0.01 fixed 0.01 fixed
Medium Permitivity:  78 fixed 78 fixed
K562 HeLa
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Figure 59: K562 trial 1 of 4 (A-D), 100 point frequency runs. 
 
Figure 60: K562 trial 2 of 4 (A-D), 100 point frequency runs. 
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Figure 61: K562 trial 3 of 4 (A-D), 100 point frequency runs. 
 
 
Figure 62: HeLa trial 1 of 4 (A-D), 100 point frequency runs. 
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Figure 63: HeLa trial 2 of 4 (A-D), 100 point frequency runs. 
 
 
Figure 64: HeLa trial 3 of 4 (A-D), 100 point frequency runs. 
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D’Agostino and Pearson omnibus normality test conducted across all 100 frequencies revealed all 
frequencies demonstrated normal distribution across the 12 repeats (once outliers determined by 
faulty pin connections or bubbles in the wells were removed).  One-way ANOVA with multiple 
comparisons across all frequencies the revealed that there was not a single frequency in which all 
three trials were different from one another for either cell type. Moreover, the averaged model for 
each cell type showed no statistical difference across the data points for over 80% of the points 
(Figure 65).  
 
Figure 65: Column graphs at each of the 100 point frequencies with columns representing 
MEAN±SEM (n=12) for (A) k562 and (B) HeLa. D’Agostino and Pearson omnibus normality test 
conducted across all 100 frequencies and 1-way ANOVA with multiple comparisons across all 
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repeats were conducted (* indicating frequency(ies) where significance between trials was 
determined).  
 
 
Regression plots revealed HeLa cells were less reliably measured by their model than that of k562 
(Figure 66). This could be due the nature of HeLa preparation and damage to cells done during 
trypsinisation (Mahabadi et al. 2015).  
 
Figure 66: Regression plots for (A) k562 and (B) HeLa cells against their respective models. The 
correlation of k562 cells proved to be more reliable than that of HeLa.  
 
Overall, the automatic fitting algorithm proved successful in consistently modelling varying cell 
types, with known radius. A few interesting observations can also be made from the subsequent 
high resolution spectra. Firstly, the dual population of the two cancer cell lines are quite obvious 
from Figure 65 with two plateaus observed suggesting a second population with lower membrane 
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properties (This will further be discussed in the subsequent multi population study). Secondly, RBC 
cells are shown to experience no negative DEP force at the given medium conductivity and thus 
should ultimately be tested at higher conductivities (this is carried through in Chapter 5). Thirdly, 
each cell type experiences a slight “dip” in their top plateau and this appears to be at varying 
frequencies between the cells. This dip occurs at 1336 kHz for yeast, 2329 kHz for RBCs and 3250 kHz 
for k562 and HeLa cells.  This suggests that it is not a hardware issue, but perhaps a higher frequency 
response of the cells (such as realignment) that warrants further investigation.  
4.3.3 Post DEP Retention and Viability 
 
Lastly, one important advantage of DEP over other measurement techniques is that cell viability 
remains intact. Due to the nature of the live/dead assay requiring removal of cells from serum 
enriched media, only adherent HeLa cells were tested for this during one of the 100 point trials 
(yielding n=15 for each of the three viability assays). Cells were carefully removed from the 
(autoclaved) 3DEP chips via pipette after each frequency sweep (conducted under the biosafety 
hood) and placed in their own well of a 96 well plate. Assuming the density of water (1 kg per m3) 
the average volume retention of the 75 µL sample was found to be 58 ± 4µL (or 77.3%). These cells 
were monitored for viability over several days and at least one passage. 24 hr post DEP experiment 
the 15 wells measured at 91 ± 4% viable. The 72 hr follow-up was slightly lower at 88 ± 5% however 
the viability post passage remained consistent at 90 ± 4%. An example of these can be found in 
Figure 67. 
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Figure 67: Viability test conducted post DEP on HeLa cells. Viable cells are stained in green and 
non-viable cells in red. (A) 24 hr post DEP (B) 72 hr post DEP (C) 24 post first passage (96 hr post 
DEP) 
 
4.3.4  Multipopulation Modelling  
These results highlight another important advantage of DEP technology over assays such as MTT. 
The sensitivity of the system to elucidate electrical properties of up to four subpopulations from a 
heterogeneous sample of human Jurkat cells treated with doxorubicin is demonstrated. Not only 
does this provide label-free assessment but since the assay only takes 10 seconds to collect data, it 
shows the crucial potential to provide real-time drug toxicity screening. The accuracy of the four 
sub-population detection (code multipopulation.m found in Appendix C) is assessed and illustrates 
how DEP technology can give information on cells that are not only proliferating (such as MTT) but 
that are affected by the treatment in a rapid and relevant approach.  
First, the untreated Jurkat sample was best fit to a two population curve indicating a 10% sub-
population with lower cytoplasmic conductivity and lower membrane capacitance (Figure 68A and 
C). It also showed a slightly smaller radius measurement but was within the standard deviation of 
radii measurements (n=100) conducted on the whole sample under microscopy. This could indicate 
a sub-population damaged in the cell sample handling and releasing ions as a result. The cell samples 
incubated with 10 µM DOX also showed a DEP spectrum made up of two sub-populations (Figure 
68B and C). Both sub-populations of the treated sample showed a decrease in cytoplasmic 
conductivity, radius, and membrane conductance with slight changes in membrane capacitance. This 
correlates with the cell dying, losing the membrane integrity and leaking ions. After careful 
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observation of the cells under the haemocytometer, a large presence (about 50%) of cell debris was 
noticed. The debris was around 1.5 µm in diameter with the best fit of the data to the model 
indicating a radius measurement of 1 µm of 46% of the total treated population. The four 
subpopulation parameters are tabulated in Table 9.  
 
Figure 68: The untreated cells (A) fit a two population model and the treated cells  (B) also fit a 
two population model. The parameters of these two populations (C) indicated as MEAN ± STDEV 
were then used to fit the mixtures. The treated and untreated samples were shown to have 
statistically varying parameters with cytoplasmic conductivity  (p<0.0001) and radius (p<0.0001) 
the most effected through 2-way ANOVA and multiple comparison.  
Table 9: Multi-population best fit parameters for the 4 sub populations.  
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These healthy control parameters coincide well those found in literature as well as previously 
measured DEP parameters with previous generations of the chip and analysis (Table 10). Perhaps, 
the variation in these measurements could be explained by the presence of this second sub 
population.  
Table 10: Jurkat healthy control parameters compared to those found in literature 
 
Once these two control groups were established, these cell parameters of the four sub-populations 
were used to fit the known mixtures of the untreated and treated cells (Figure 69 A-C). Ratios of 
untreated healthy control to treated control of 1:3, 2:2 and 3:1 were fitted to the four population 
model (Table 11) with R > 0.99 for three of the four mixtures (R>0.97 for the 1:3 mixture). The 1:3 
mixtures were later determined to have a well not connected and thus the large standard deviations 
 3DEP 
 
Well electrode 
(Hübner 2010) 
Literature 
Membrane capacitance 
(mF/m2) 
9.96 11.4 13.24 (Pethig and Talary 2007) 
13.5-14 (Kiesel, Reuss et al. 
2006) 
7.1 (Sukhorukov, Kürschner et 
al. 2001) 
7.6-10 (Garner, Chen et al. 
2007) 
8.3 (Reuss, Horbaschek et al. 
2004) 
Membrane 
conductance 
(S/m2) 
25 62.5 35 -82 (Kiesel, Reuss et al. 
2006) 
137 (Sukhorukov, Kürschner et 
al. 2001) 
75 (Reuss, Horbaschek et al. 
2004) 
Radius 
(µm) 
6.5±0.9 5 5.25 (Pethig and Talary 2007) 
7.4 (Kiesel, Reuss et al. 2006) 
7.6 (Sukhorukov, Kürschner et 
al. 2001) 
5.18 (Garner, Chen et al. 2007) 
7.4 (Reuss, Horbaschek et al. 
2004) 
5.5 (Zhuang, Baldwin et al. 
2010) 
Cytoplasm relative 
permittivity 
60 - 90 (Pethig and Talary 2007) 
80 (Reuss, Horbaschek et al. 
2004) 
60 (Zhuang, Baldwin et al. 
2010) 
Cytoplasm conductivity 
(S/m) 
0.46 0.7 0.7 (Pethig and Talary 2007) 
0.84-1.1 (Kiesel, Reuss et al. 
2006) 
0.25 (Garner, Chen et al. 2007) 
0.15 (Reuss, Horbaschek et al. 
2004) 
0.3 (Zhuang, Baldwin et al. 
2010) 
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of the data points (Figure 69 2C) and smaller R value can be accounted for. These were optimised by 
0.5% steps to achieve the best fit given the known cell parameters for each population. The known 
versus measured percentages are shown in Table 11. 
 
Figure 69: Once the untreated and treated parameters were determined (Figure68) the mixture 
samples were modelled with these parameters adding each population based on the percentage 
of the population given in Table 1: 3:1 untreated to treated (A) 2:2 treated to untreated (B) and 
1:3 treated to untreated (C).  
 
Table 11: Based on the best fit of the healthy control (HC) untreated cells, known ratios of healthy 
and treated (3:1, 2:2, 1:3) were modelled with all four sub-populations and optimised for 
subpopulation percentage. 
Spiked/model Pop 1 Pop 2 HC Best Fit Pop 3 Pop 4 DOX Best Fit R value 
100% HC 90% 10% -- -- -- -- 0.9980 
75% HC 67.50% 7.50% 75.00% 13.50% 11.50% 25.00% 0.9908 
50% HC 49.50% 5.50% 55.00% 24.30% 20.70% 45.00% 0.9933 
25% HC 27.00% 3.00% 30.00% 37.80% 32.20% 70.00% 0.9742 
100% DOX affected -- -- -- 54% 46% -- 0.9943 
 
The 50% HC to treated sample had an optimal fit of 55% HC however, due to the similar parameters 
of sub population 2 (HC) and sub population 3 (DOX) this can be accounted for with this matched 
mixture. The 25% HC sample however, demonstrated a 10% variation from the known mixture 
percentage with optimal HC population measuring 35%. This suggests the error of the 3DEP 
detection could be as high as 10% when estimating these subpopulations.  It can be noted that when 
the known subpopulations of these two mixtures are modelled the fits still produce R>0.9. 
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4.3.5 Measuring IC50 by 3DEP 
Jurkat cells were then incubated with 0.1, 0.3, 0.5 or 1 µM Doxorubicin and DEP measurements 
(n=7) were taken at 8, 16 and 32 hours. The multipopulation model was optimised for each averaged 
spectrum with the known parameters for healthy and DOX affected cells found in 4.3.4. The 1 µM 
treatment result is shown in Figure 70. The properties used in these models can be found in Table 9 
and of all the results for all concentrations can found in Table 13.  
 
Figure 70: DEP spectra of healthy Jurkat cells (A) and those incubated for 8h (B), 16h (C) and 32 h 
(D) with 1 µM DOX (data points are MEAN ± SEM with n=7). 
 
Sub-population 3 shows a drop in cytoplasmic conductivity, which is associated with cells that are 
stressed or dying and releasing their ions into the surrounding medium. There is also a drop in the 
membrane capacitance from 9.96 to 6.64 mF/m2, which indicates a reduction in cell size or cell 
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surface complexity such as ruffles, folds, or micro villi. As previously discussed in Chapter 3, DEP has 
demonstrated this shift in membrane capacitance during apoptosis. Pethig and Talary (2007) 
describe a drop in membrane capacitance in Jurkat cells as a result of etoposide-induced apoptosis, 
due mainly to a drop in cell size. They compare their results to those of Wang et al. (2002) which 
observed a reduction in membrane capacitance, from 17.5 to 9.1 mF/m2, in genistein-induced 
apoptotic HL-60 cells after 4 h. This can be accounted for with the membrane topography 
parameter, φ, which is the ratio of the actual membrane area of the cell to the membrane area of a 
perfectly smooth cell; a value of 1 for φ would represent a perfectly smooth cell. For purposes of this 
study however, this is not necessary since it is the population percentage, not parameter used to 
determine IC50. Sub-population 4 shows a further drop in cytoplasmic properties and in the 
membrane conductance, as well as in radius, and could represent a sub-population of cell fragments, 
apoptotic bodies or necrotic cells as a result of apoptosis.  
To determine the DEP measured IC50 the sum percentage of the healthy cells (subpopulation 1 and 
2) were inputted into the Hill model. These were compared with previously measured IC50 values 
using MTT and Trypan Blue and shown in Table 12. These results show favourable correlation 
between MTT and DEP whereas Trypan Blue did not prove very accurate until 32 hr incubation. The 
values for the IC50 of doxorubicin on Jurkat cells found in the literature vary between 0.106 µM (Hsu 
et al. 2001) and 0.24 µM (Georgakis et al. 2005) for 48 h incubation which is reasonable comparable 
to the data obtained by this study. 
Table 12: Comparison of IC50 determination on Jurkat cells with DEP, MTT and trypan blue, at 
different time points. Numbers are the fitted IC50 ± 95% CI. 
 
IC50 (µM) of doxorubicin on Jurkat 
cells at different incubation times 
  8 h 16 h 32 h 
M
et
h
o
d
 DEP 0.14±0.11 0.70±0.11 0.25±0.04 
MTT 0.37±0.07 1.21±0.20 0.33±0.04 
Trypan 
blue 
Did not 
converge 
5.07±0.75 0.36±0.035 
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Table 13: Summary of optimal fitting of the multipopulation model to DEP data collected over 32 h 
of DOX treatment.  
 
The dielectrophoretic spectrum of a large population of cells shows their average properties and, 
although it cannot distinguish the properties of individual cells within that sample, it can distinguish 
between several sub-populations with different dielectric properties. Although DEP does require a 
large number of cells (cell concentration of 106 cells/ml and approximately 1 ml for 5 to 10 runs) it 
offers the advantage of providing information about the different sub-populations arising from drug 
incubation, not just proliferating cells. In apoptosis, the cells die in an organized manner and are still 
able to metabolize the tetrazolium salt, so MTT could over-estimate the viable population for 
Dox 
Conc Pop %
Radius 
(um)
Thickness 
(nm)
Cspec 
(S/m2)
Gspec 
(mF/m2)
Permittivity
Conductivity 
(S/m)
Pearson 
correlation 
coefficient
RMS 
Error
1 90 6.5 8 9.96 25 60 0.46
2 10 6 8 7.75 12.5 60 0.07
1 81 5.8 8 9.96 25 60 0.46
2 9 6 8 7.75 12.5 60 0.07
3 10 5.8 8 6.64 12.5 70 0.25
1 85.5 6.5 8 9.96 25 60 0.46
2 9.5 6 8 7.75 12.5 60 0.07
3 5 5.8 8 6.64 12.5 70 0.25
1 74.7 6.5 8 9.96 25 60 0.46
2 8.3 6 8 7.75 12.5 60 0.07
3 17 5.8 8 6.64 12.5 70 0.25
1 76.5 6.5 8 9.96 25 60 0.46
2 8.5 6 8 7.75 12.5 60 0.07
3 15 5.8 8 6.64 12.5 70 0.25
1 81 6 8 9.96 25 60 0.46
2 9 6 8 7.75 12.5 60 0.07
3 10 5.8 8 6.64 12.5 70 0.25
1 76.5 6 8 9.96 25 60 0.46
2 8.5 6 8 7.75 12.5 60 0.07
3 15 5.8 8 6.64 12.5 70 0.25
1 58.5 6 8 9.96 25 60 0.46
2 6.5 6 8 7.75 12.5 60 0.07
3 30 5.8 8 6.64 12.5 70 0.25
4 5 2 8 6.64 1.25 50 0.09
1 18 5.8 8 9.96 25 60 0.46
2 2 6 8 7.75 12.5 60 0.07
3 70 5.8 8 6.64 12.5 70 0.25
4 10 2 8 6.64 1.25 50 0.09
1 81 7 8 9.96 25 60 0.46
2 9 7 8 7.75 12.5 60 0.07
3 10 6.5 8 6.64 12.5 70 0.25
1 36 6.5 8 9.96 25 60 0.46
2 4 6 8 7.75 12.5 60 0.07
3 10 5.8 8 6.64 12.5 70 0.25
4 50 2.4 8 6.64 1.25 50 0.09
1 31.5 6.5 8 9.96 25 60 0.46
2 3.5 6 8 7.75 12.5 60 0.07
3 7 5.8 8 6.64 12.5 70 0.25
4 58 2.5 8 6.64 1.25 50 0.09
3 35 5.8 8 6.64 12.5 70 0.25
4 65 2.5 8 6.64 1.25 50 0.09
1 0.9705 0.0980
32h
0.1 0.9926 0.0155
0.3 0.9868 0.0934
0.5 0.9834 0.0869
0.5 0.9913 0.0389
1 0.9948 0.0220
1 0.9858 0.0247
16h
0.1 0.9945 0.0055
0.3 0.9972 0.0161
8h
0.1 0.9937 0.0040
0.3 0.9896
0.5 0.9874 0.0009
0h 0 0.9980 0.0178
0.0661
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shorter incubation times. In addition to providing this distinct advantage over MTT which can only 
distinguish between affected and non-affected cells, the cell preparation protocol for these DEP 
experiments with suspension cells takes approximately 30 min whereas the MTT preparation 
protocol involves centrifuging and washing steps with PBS and the incubation of the cells with the 
tetrazolium salt which can total up to 5 hours. Another advantage of this method is that after the 
experiments are performed, the cells remain viable as shown in Section 4.3.4 and can be used to 
perform further experiments, such as separation of sub-populations, or returned to cell culture.  
4.4 Conclusions 
This chapter has focused on 3DEP’s utility in measuring physiologically relevant samples. It has 
shown it is possible to obtain several repeatable readings from small sample volumes using the 
Jurkat cell line. It has assessed cell properties across a 100 point spectrum for four cell types (yeast, 
RBCs, HeLa and k562) for optimal automated modelling of a single population with the single-shell 
model. Several programs have been designed to automate data collection and analysis with the 
single-shell model giving not only real-time DEP spectra data, but real-time electrophysiological 
analysis. From this, it was determined that reliable data could be obtained in as little as 6 seconds. 
Additionally it was shown with HeLa cells (a human cervical cancer line) that approximately 80% of 
the cell suspension pipetted into a 3DEP chip could be recovered after experiment and cultured as 
normal, including passage, with nearly 90% cell viability. Another application of the 3DEP system was 
tested on multi-population models and applied to measuring the IC50 of doxorubicin, an anti-cancer 
drug on Jurkat (an immortalized line of human T lymphocyte) cell line. Future work would include 
automating the multi-population to achieve the same real-time analysis as the single population 
model shown in this chapter. Together this establishes 3DEP as a viable measurement tool across 
cell types and as an attractive alternative to assays such as MTT and has potential for more complex 
samples such as primary cell samples from biopsy.  
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Chapter 5: Blood Electrophysiology and the Circadian Clock 
5.1 Introduction 
Coordination of many of the body’s behavioural, metabolic, and physiological processes is 
synchronised around the 24 hour clock, typically controlled through endogenous mechanisms. 
However, as in the case of overcoming jetlag and shift work via rhythms resetting, these can be re-
synchronised (entrainable) by external stimuli (Partch et al. 2014). 
Current models indicate the main drivers of the process are the products of rhythmic expressions of 
‘clock genes’, though the specific transcriptional component can differ (Partch et al. 2014). O’Neill & 
Reddy (2011) showed circadian rhythms present in human red blood cells (RBCs) following 
temperature entrainment. RBCs have no nucleus and thus transcription is not required. If not the 
nucleus, what other mechanisms are controlling the rhythms found in RBCs, and how can we identify 
them? 
Fitting a model of the electrical properties of a cell allows many parameters, such as membrane and 
cytoplasm properties, to be determined. The aim of this chapter was to establish models and 
protocols within the 3DEP system to investigate the electrical parameters of RBCs using donor blood 
samples. These were investigated as to whether they demonstrate circadian timing in RBC 
electrophysiology and DEP’s sensitivity in measuring the RBC clock. Additionally, the vole, which is a 
validated model of circadian desynchrony (van der Veen et al. 2006, van der Veen et al. 2011) was 
utilised as an animal correlate to measure DEP response in an entrained animal model of whole 
blood. Here the ultradian rhythm of DEP response was measured matching behavioural output of 
the vole, delineating the DEP response as a mechanistic output of the RBC timing independent of the 
type (circadian versus ultradian).   Thus the potential for DEP as phase marker of clock timing was 
considered.  
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5.1.1 Clock Rhythms and RBCs 
As stated previously, mature RBCs shed their nucleus to maximize their accommodation of 
haemoglobin. Since RBCs are anucleated, they are incapable of transcription, and thus a cycling gene 
clock cannot exist in these cells.  Rhythmic properties of RBCs have, however, been observed.  For 
example, circadian regulation of processes such as metabolism, redox balance and proteasomal 
degradation persist in isolated human and mouse RBCs (O'Neill and Reddy 2011, Cho et al. 2014), 
suggesting that gene expression is not essential for some form of molecular clock to continue to 
function.  Oscillation in the over-oxidation of abundant 2-Cys peroxiredoxin (PRX) proteins has 
served as the primary reporter for circadian timekeeping in RBCs. Peroxiredoxins are antioxidant 
enzymes responsible for controlling levels of harmful reactive oxygen species (ROS) by reducing ROS 
through the oxidation of the catalytic cysteine 2-Cys PRX to sulfenic acid form (PRX-SO), over-
oxidation to sulfinic acid form (PRX-SO2), and hyperoxidation to sulfonic acid form (PRX-SO3). Over-
oxidation inactivates the PRX until it is reduced and reactivated.  Robust rhythms in PRX-SO2/3 were 
observed in isolated RBCs (O'Neill and Reddy 2011). This metabolic cycle persists for at least five 
days ex vivo, and satisfies the criteria defining a circadian rhythm: A temperature compensated 
oscillation with a period of approximately 24 h (the period did not change when RBCs were cultured 
at 32°C or 37°C), that can be entrained by biologically relevant external cues such as 12 hour 
temperature cycles (32°C:37°C), that mimic daily changes in body temperature (Figure 71) (O'Neill 
and Reddy 2011, Pritchett and Reddy 2015). 
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Figure 71: Temperature compensation of circadian PRX rhythms in RBC observed by (O'Neill and 
Reddy 2011) 
In addition, circadian oscillations of Peroxiredoxin-2 (PRX2) expression, haemoglobin oxidation, ATP 
and the levels of reducing agent NADH and NADPH were observed. These observations in RBCs are 
similar to previous work using the prokaryotic cyanobacterium, Synechococcus elongatus. Nakajima 
et al (2005) found that whilst rhythmic clock gene expression enhances the robustness of cellular 
timekeeping and temporal regulation of cell physiology, the molecular circadian clock can be 
reconstituted in vitro from just three recombinant proteins (KaiA, B & C) and can operate entirely 
post-translationally (Nakajima et al. 2005).  Since PRX-SO2/3 rhythms are present in eukaryotic and 
prokaryotic cells, and are highly conserved across species, they likely predate the evolution of 
genetic circadian feedback systems (Edgar et al. 2012, Pritchett and Reddy 2015). No mechanism 
however has yet been proposed for the clock in RBCs that would allow its reconstitution in vitro. It is 
unlikely, however, that overoxidised PRX is itself an essential clock component, since only ~1% of the 
major isoform (PRX2) becomes overoxidised each day (Cho et al. 2014, Hoyle and O'Neill 2015). 
Moreover whilst genetic and pharmacological perturbation of PRX activity is sufficient to affect 
biological timekeeping (Edgar et al. 2012), in nucleated cells cellular rhythms persist in the absence 
of PRX over-oxidation (Causton et al. 2015). Thus PRX over-oxidation cycles are likely a downstream 
output from some more fundamental timekeeping mechanism. Recently, a number of other 
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observations have questioned whether cycling clock gene expression is absolutely required for 
circadian rhythmicity in mammalian and other eukaryotic cells (O'Neill et al. 2011, Paulose et al. 
2012, Miyagishima et al. 2014, Roy et al. 2014, Larrondo et al. 2015).  
Delineating this mechanism will require comprehensive characterisation of circadian rhythms in 
RBCs. One key question is whether post-translational systems that govern the period of circadian 
oscillations in nucleated cells similarly impact RBC timekeeping. Currently, no manipulations of the 
clock have been reported that affect circadian period in RBCs. Another key question is whether the 
RBC clockwork is simply a lingering evolutionary rhythm that solely affects metabolism, or whether 
instead it functionally regulates other aspects of RBC biology that directly influence gas 
transportation, for example.  
An example of the hierarchal body clock structure can be found in RBCs since not only molecular 
processes within the RBC show 24 hour oscillations but also, RBC number within the blood. The 
rhythmicity of the number of RBCs was found to be under clock gene control as it was suppressed 
and phased advanced in CLOCK mutant mice. Whole blood is also of interest as it performs many 
essential functions through its three types of cells such as oxygen transport (RBCs), immune 
response (leukocytes), and clotting (thrombocytes-platelets). Blood cells account for 45% of whole 
blood (plasma the remaining 55%) and all three types have demonstrated circadian rhythm 
(Pritchett and Reddy 2015). Of particular interest is the observed daily rhythmic severity of instances 
of stroke, heart attack and allergic response (Partch et al. 2014). The clock in whole blood could 
underlie these conditions’ severity and serve as a vestibule to treat these as well as effects of diet, 
shift work and drug delivery.  
5.1.2 RBCs and Electrophysiology 
The fact that RBCs lack DNA and therefore gene expression, drastically limits the rhythmic 
parameters that can be studied, and the methods available to study them. The frequency of action 
potential generation in the neurones of the SCN is a well-established cellular readout of the effects 
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of manipulating clock gene expression (Colwell, 2011) . It is reasoned that electrophysiological 
properties may be altered in the gene-less oscillations of the RBCs as well, and yield important 
insight into their mechanism within either the cytoplasm or the membrane.   
This work is the first to investigate circadian timing in RBC electrophysiology and DEP’s sensitivity in 
measuring the RBC clock.  
5.1.3 Pharmacological Intervention 
Altered clock speed is a key requirement for excluding the possibility that RBC rhythms are driven by 
environmental variables, and any disruption of the RBC clock through pharmacologic intervention 
would be a step towards realising the underlying mechanism. According to the literature, no 
manipulations that alter the period of circadian rhythms in isolated RBCs have yet been reported.   
Staurosporine: Circadian period was shown to be sensitive to selective kinase inhibition across a 
wide range of eukaryotes (Isojima et al. 2009, O'Neill et al. 2011, Causton et al. 2015), with the 
effect of these kinase inhibitors being interpreted as  post-translational regulation of clock protein 
activity/stability. Since no clock proteins or DNA exits in RBCs specific inhibition of kinases that 
phosphorylate (clock protein) transcription factors in nucleated cells (such as CK1δ) might be 
expected to have minimal effects upon RBC rhythms. It was hypothesized though, that some aspect 
of timekeeping in RBCs must be dependent upon phosphorylation. To test this Staurosporine (STS) 
(Sigma-Aldrich, UK) was used (Figure 72). Staurosporine was chosen as it is a non-specific, ATP-
competitive inhibitor of cellular protein kinases (protein kinase C) that is highly cytotoxic in 
nucleated cells but not cytotoxic in RBCs (Bratosin et al. 2001). It was predicted that decreased 
activity of ATP-dependent, rate-limiting enzymes would lengthen the period of the circadian 
oscillation in isolated RBCs. 
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Figure 72: Molecular structure of Staurosporine (STS). Molecular formula: C28H26N4O3, Molecular 
Weight: 466.53 g/mol (Sigma-Aldrich) 
Valinomycin: Changes in ion transport and membrane excitability make an important contribution 
to pacemaker neurons in both flies and mouse models (Nitabach et al. 2002, Colwell 2011). It is 
shown that PRX over-oxidation rhythms are absent in RBC lysates, thus transmembrane ion flux may 
contribute in formation of these rhythms. It was therefore tested whether the potassium ionophore, 
Valinomycin (VAL) (Figure 73), has an effect on the electrophysiological rhythms reported by DEP. 
Valinomycin is an ionophore with a high affinity to K+, rendering cell membranes permeable to it. In 
addition to demonstrating K+ membrane flux, VAL has been used to uncouple oxidative 
phosphorylation, induce apoptosis, and inhibit neuronal differentiation and vasoconstriction (Sigma-
Aldrich). As shown previously, K+ transport is an abundant and crucial mechanism in the RBC 
membrane.  
 
Figure 73: Valinomycin (VAL) molecular structure. It is a cyclopeptide with three repeats of D-
valine, L-lactate, L-valine and D-hydroxyisovalerate. Chemical formula: C54H90N6O18 Molecular 
weight: 1111.32 g/mol (Sigma-Aldrich) 
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5.2 Methods 
5.2.1 RBC Fractionation and Culture 
This study was performed following the tenets of the Declaration of Helsinki, and had been given a 
favourable ethical opinion by the University of Surrey Ethics Committee (Appendix E). Male donors, 
free of self-reported health problems including sleep disorders, each provided 10-ml blood samples 
in heparin/EDTA tubes. All preparation was carried out at room temperature and within a sterile 
culture environment. Isolation of RBCs followed a similar protocol used in O’Neill and Reddy (2011). 
Whole blood was mixed by inversion with PBS at a 1:3 ratio (volume dependent on how many 
samples were necessary). This mixture was layered on top of Histopaque -1077(1.077 g/ml 
polysucrose solution) (Sigma-Aldrich, UK) via careful pipetting. This was centrifuged for 30 minutes 
at 480 rpm. The whole blood could then be observed to be fractionated into its components (Figure 
74). The RBC pellet at the bottom of the tube was then washed twice with PBS, centrifuged at 1270 
rpm for 15 minutes. Upon visual observation of a clear supernatant, the pellet was resuspended into 
KHB (Figure 74). A cell count was conducted to determine the dilution necessary for approximately 
6x106 cells per ml (yielding approximately 3x106 cells in each 0.5 ml PCR tube). The sample was 
diluted in KHB and aliquotted as necessary (400-500 µL in each tube depending on drug treatment) 
in PCR tubes for experiment.  
 
Figure 74: Donor RBC fractionation. (A) Whole blood was mixed with PBS and layered on top of 
histopaque. (B) Centrifugation resulted in RBCs pelleted at the bottom with plasma layer on top 
(C) RBCs were diluted in KHB and (D) aliquotted into PCR tubes. 
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5.2.2 Entrainment 
A criteria of a circadian rhythm is that it must be entrainable by biologically relevant external timing 
cues (such as light/dark, temperature, food, or social cues). As in O’Neill and Reddy 2011, 
temperature entrainment was used to investigate circadian DEP behaviour in RBCs. Once RBCs were 
isolated they were placed into a PCR machine, and with the hot lid turned off, exposed to two 
consecutive 12h:12h temperature cycles (37°C:32°C), to mimic body temperature rhythms. After 48-
hour entrainment RBCs were left free running at 37°C for the remainder of the experiment (Figure 
75). Any drug treatment was introduced prior to entrainment. DEP experiments were conducted (as 
described in section 4.2) at four hourly intervals during or post entrainment by carefully opening the 
PCR and removing one PCR tube for each time point. In these experiments, the final transition to 
37°C is taken as onset of light (or Zeitgeber time 0, ZT0). 
 
Figure 75: RBC treatment and entrainment procedure. RBCs are fractionated from whole blood, 
treated, entrained, and then sampled with DEP. 
5.2.3 Whole Blood Sampling 
Healthy male and female donors were recruited for this experiment. Whole blood was obtained via 
finger prick with a lancet (accu-chek,UK) with droplets of blood captured by coated capillary tubes 
(Sigma-Aldrich, UK). Optimisation of whole blood sampling was conducted on vole specimen and 
explained further in section 5.2.4.  Approximately 1 cm of blood was captured in the tube (equating 
to 10 µL of blood). A 1 ml syringe and needle were used to flush the blood out of the tube and into a 
5 ml total volume of DEP medium at 10 mS/m. This procedure resulted in an adequate cell 
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concentration (on the order of 106 cells per ml) and consistent conductivity (13 ± 6 mS/m). Where 
multiple samples were taken from a donor, a different fingertip was used at each time point.  
5.2.4 Vole RBC Sampling 
This study was conducted in collaboration with Dr. Daan Van der Veen (University of Surrey) and 
given favourable ethical opinion by the University of Surrey Ethics Committee and carried out under 
UK Home Office License in accordance with the Declaration of Helsinki.  The vole is a validated model 
of circadian desynchrony (van der Veen et al. 2006, van der Veen et al. 2011) and was used as an 
animal correlate to measure DEP response in an entrained animal model of whole blood.  
Optimisation: Since vole ultradian sampling must be conducted circa every 20 minutes, it was not 
feasible to adhere to the same protocol for isolation of RBCs as these required upwards of 30 
minutes centrifugation. Thus, conditions were optimised for vole whole blood sampling by DEP 
through the use of one sacrificed vole (yielding enough blood for n=5 of each experimental 
condition) in which blood was drawn from the heart. 10 µL increments of whole blood were added 
to 43 mS/m and 10 mS/m medium for DEP sampling. Conductivity and cell concentration were 
measured as well as goodness of fit of the DEP spectrum for each sample.  
Ultradian DEP Measurement via Tail Knick: For a week prior to DEP analysis voles were entrained to 
12 hour light/dark cycles and monitored via passive infrared light for behavioural activity. At the 
onset of light (ZT 0h) tail knicks were performed within the animal care unit using a razor blade. 
Approximately 10 µL of blood was drawn into a coated capillary tube and brought to the 3DEP kit for 
analysis. A 1 ml syringe and needle were used to flush the blood out of the tube and into a 5 ml total 
volume of DEP medium at 10 mS/m. This was done every 30 minutes over four hours (approximately 
two ultradian cycles). At each time point at least five technical replicates were conducted.  In some 
cases a time point may have been skipped or experiment ended (Vole 2 for example) due to vole 
stress inhibiting adequate blood flow to the tail.   
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5.2.5 Pharmacological Intervention 
Staurosporine: Following an adaptation of the method from (Bratosin et al. 2001), RBC suspensions 
from all four donors were treated with 10 µM of STS. STS was diluted at 5mg/ml in DMSO per the 
recommendation by Sigma-Aldrich and then further diluted in DI water such that a 10µL volume of 
STS yielded a 10 µM dose. Cell viability and morphology were initially screened at this concentration 
over a period of 4 days to ensure reliable DEP measurements at 10 µM of STS treatment. 
Additionally, DEP and morphological dose responses of 0.1, 0.3, 0.5, 1, 3, and 5 µM were conducted 
over four 4 days in case the 10 µM STS treatment proved to be too harmful for DEP testing. It was 
found, however that 10 µM STS treatment was (as predicted and shown by previous studies) a 
tolerable dose to RBCs and did not differ from the control with respect to cell morphology or 
reliability in DEP response (Figure 76). 
 
Figure 76: Microscopic inspection of RBC morphology after 96 hours of incubation for control (A) 
and STS treated (B) cells. As expected, a small number of cells (in red boxes) show signs of stress 
(spindle) in both the control and treated samples. DEP data at ZT0 (48 hour incubation) for control 
(C) and STS (D) treated both demonstrated DEP data which achieved model fits of R2>0.99. 
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 Control (KHB buffer), DMSO-carrier control, and STS treatment groups were all conducted 
simultaneously for each donor. Treatment of all four donors was administered prior to 48-hour 
entrainment which began immediately following treatment (Figure 75). DEP analysis, as described 
previously, was conducted beginning at ZT0 every four hours for the following 48 hours. 
Valinomycin:  Valinomycin Ready Made Solution at 1 mg/ml DMSO (Sigma-Aldrich, UK) was diluted 
in DI water for a final treatment volume of 10 µL at concentrations of 0.5, 1, 10, 100 and 103 nM.   
After DEP and morphological dose response was carried out on 0.5, 1, 10, 100 and 103 nM (sample 
shown in Figure 77), a concentration of 30 nM of valinomycin was established to cause no harmful 
effects on RBCs with respect to viability and morphology. 
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Figure 77: VAL dose study investigating dose response on cell morphology and DEP response. This 
is a sample data set from 96 h post treatment of control (A&B), DMSO control (C&D) 10 nM (E&F) 
and 100 nM (G&H). 100 nM began to show a breakdown in RBC integrity and DEP spectra. In 
addition to the decreased R2 (the measure of goodness of fit used for comparison) it can be seen 
the first dispersion midpoint (orange cross) begins to shift to lower frequency and intensity at 100 
nM 
Doses above 100 nM showed poor cell viability and unreliable DEP spectra whilst below 100nM 
showed consistent cell morphology and DEP data with R2 values greater than 0.9. Upon microscopic 
observation control and treated RBCs up to 10nM looked normal, whilst cells treated with 100 nM or 
more showed signs of eryptosis (RBC cell death) (Figure 78). 
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Figure 78: Control RBC morphology (A) after 96 hours versus 100 nM VAL (B) at the same time 
point. VAL treated cells (and otherwise unhealthy) develop spindle-like shape indicating 
hyperosmotic stress and is a precursor to cell death. Cell number has also decreased indicating cell 
death has already occurred in some of the treated RBCs. 
RBCs from each donor were treated with 30nM and entrained for two days as previously described. 
DEP analysis was then conducted starting at ZT0 every 4 hours for two days. 
5.2.6 Data Analysis 
DEP spectra were obtained via the 3DEP system described in Chapter 4. Individual spectra were fit in 
MATLAB whilst averaged time point values were collated in excel. The raw data were fitted to the 
single-shell model in order to extract the electrophysiological parameters, accepting spectra 
producing fits with R  values of 0.9 or greater.  
Circadian Phase: Initial investigation of phase was conducted by curve fitting in MATLAB (Appendix 
C) to the standard circadian cosinor model (Figure 79). An original SAS file provided by Dr. Daan van 
der Veen (van der Veen et al. 2006) was adapted for DEP measurements in MATLAB.  
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Figure 79: Standard model of circadian cosinor curve where M is mesor, A is amplitude, τ is period, 
and AP is acrophase in Equation 5.1. 
 𝐹(𝑡) = 𝑀 + 𝐴𝑐𝑜𝑠(2𝜋 (
𝑡
𝜏
− 𝐴𝑃) /𝜏) 5.1 
Time course data were then detrended to remove baseline changes and then fit with a damped 
cosine in order to determine circadian parameters period, amplitude and phase as described in 
(Hirota et al. 2008).  This was performed in Prism 6 (Graphpad). 
Statistical Analysis: All statistical analysis was conducted in Prism 6 (Graphpad). Data fit to the 
single-shell model or damped cosinor were checked for normalcy (D'Agostino-Pearson omnibus test) 
and goodness of fit with 95% CIs obtained. Optimisation measures of conductivity and cell 
concentration were analysed for donor effect by 1-way ANOVA. Individual donor time course data 
was analysed for time-effect by 2-way ANOVA whilst period of the averaged data for both 
parameters fit to the damped cosinor curve was evaluated with the unpaired t-test to determine the 
difference in period between the two parameters. Grouped quantification of the periods of the 
treated groups was performed with Sidak’s multiple comparisons test and 2-way ANOVA was used 
to determine drug interaction effect.  
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5.3 Results and Discussion 
5.3.1  Rhythmicity in RBC Electrophysiology 
As previously stated, DEP measurements were taken every four hours post entrainment. Spectra 
data were fit to the single-shell model with RBC effective membrane conductance (Geff), cytoplasmic 
conductivity (σcyt), and effective membrane capacitance (Ceff) observed for all four donors (Appendix 
D). The mean of each donor at each time point with standard error can be seen in Figure 80.  
 
Figure 80: (A) Effective membrane conductance exhibits a robust circadian rhythm, mean±SEM for 
each donor, p<0.0001 for time effect by 2-way ANOVA. (B) Cytoplasmic conductivity also exhibits a 
circadian rhythm, mean±SEM for each donor, p<0.0123 for time effect by 2-way ANOVA. (C) The 
effective membrane capacitance shows no significant circadian variation over time, mean±SEM 
are shown for each donor, p=0.2092 for time effect by 2-way ANOVA. 
These individual traces show statistically significant variation with respect to time with visible peaks 
and troughs with circa 24-hour rhythms in Geff (p<0.0001), indicating circadian regulation of ionic 
transport across the RBC membrane. Interestingly, an antiphasic fluctuation of σcyt was observed and 
though still significant (p=0.012) the rhythm in σcyt was less robust and of lower amplitude. This 
perhaps could suggest that ionic movement is occurring out of the RBC during these peaks in Geff.  In 
contrast, no significant variation (p > 0.1) was observed in Ceff, confirming observations by 
microscopy that cell radius (4.3 ± 0.4 µm) and morphology do not change over the course of RBC 
incubations (Figure 80 and Figure 81).  
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Figure 81: RBC images used for radius measurement and morphology inspection at ZT 4hr and ZT 
16hr as an example. 
Graphically, this can be demonstrated at the level of individual DEP spectrum at a given time point. 
For example, in Figure 82 it can be seen that the spectrum in (a) (ZT 4hr) has a low frequency 
response around -0.8 and peaks around 1.5 on the normalised y axis, whereas in (b) (ZT 16hr) the 
low frequency response is -0.5 and peaks slightly higher approaching 2. This is reflected in the GSPEC 
parameter highlighted in blue (ZT4hr=3750 S/m2 and ZT16hr=8750 S/m2). This trend carries 
throughout the time course of each donor shown previously in Figure 80 where the peak values for 
effective membrane conductance are found around ZT 16hr and ZT 40hr.  From Figure 82 it is 
expected (and confirmed) then to observe trough values of cytoplasmic conductivity at these 
corresponding times (ZT 16 hr and 40 hr). Figure 82 clearly demonstrates this as the plateau width of 
(b) (ZT 16hr) is smaller than that of (a) (ZT 4hr) reflecting the smaller cytoplasmic conductivity value 
(0.13 < 0.18 S/m). Also important is that visual inspection detected no changes to radius or over RBC 
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morphology and this can be confirmed in the CSPEC parameter in pink which is non-significantly 
(p=0.2092) different across time for all donors.  
 
Figure 82: Example of single shell parameters fit to individual time course data at A) ZT4 hr and B) 
ZT16 hr. The blue, red and green highlight the section of the spectra most affected by each 
parameter.  
Population mean values Geff and σcyt were then calculated for the four donors. These were initially fit 
to the standard cosinor curve given in Equation 5.1 (cosinor.m  Appendix C) and shown in Figure 83.  
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Figure 83: All four donors were averaged across time points for Geff (left) and σcyt (right) and fit to a 
cosinor curve. DEP data is presented as mean±SEM with goodness of fit reported as R2 values. 
Above the graphs is the model used for curve fitting with a, b, and c representing MESOR, 
AMPLITUDE, and ACROPHASE respectively.    
These gave circadian periods of 22h (τGeff, R2=0.91) and 21.75h (τσcyt, R2=0.95). The antiphasic 
oscillations of Geff compared with σcyt strongly suggest rhythmic regulation of transmembrane ion 
flux.  
To investigate this further, data was then compared to overoxidised peroxiredoxin (PRX-SO2/3) data 
collected and provided by John O’Neill (MRC Laboratory of Molecular Biology) shown in Figure 84. 
Electrophysiological data was refit in Graphpad to a damped cosinor curve giving circadian periods of 
22.3±0.7 h (R2=0.91) and 21.5±0.4 h (R2=0.96) with no significant difference between the periods of 
the two parameters. (p=0.3705 by unpaired t-test). 
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Figure 84: Effective Membrane Conductance and Peroxiredoxin Over-Oxidation Levels Peak during 
the Anticipated Cold Phase. (A) In human RBCs, peroxiredoxin over-oxidation rhythms peak during 
the anticipated cold phase following temperature cycles and are abolished by incubating cells with 
0.1% SDS. Representative blots are shown. (B) Western blot quantification showing no PRX-SO2/3 
rhythm in lysed human RBCs (n=3), p<0.0001 for interaction effect by 2-way ANOVA. (C) Effective 
membrane conductance also peaks during the anticipated cold phase, in antiphase with 
cytoplasmic conductivity (n=4) (D) No significant difference between the periods of the two 
rhythmic DEP parameters detected (p=0.3705). 
 
The observed peak membrane conductance coincided closely with the previously observed peaks in 
overoxidised peroxiredoxin (PRX-SO2/3) also observed to occur during the (anticipated) cold phase 
for human RBCs during or following entrainment by temperature cycles (Figure 84  A&B). 
Importantly it was observed that cycles of PRX over-oxidation were not observed in lysed 
erythrocytes sampled in parallel, suggesting that the clock in erythrocytes requires an intact cell 
membrane. The robust cycling of membrane conductance also suggests that the membrane (and ion 
movement across the membrane) is a key component in the RBC clock.  
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5.3.2 Chemical Alteration  
As stated previously, kinase inhibition in various eukaryotic cells showed changes to circadian period 
which was believed to be post-translation regulation of clock protein activity and stability  (Isojima et 
al. 2009, O'Neill et al. 2011, Causton et al. 2015), At the time of writing, no reports have been made 
to describe manipulations to alter RBCs’ rhythms.  Since no clock proteins or DNA exits in RBCs, 
specific inhibition of phosphorylation of nucleated cells’ clock protein (such as CK1δ) should have 
minimal effects upon RBC rhythms. It was hypothesized though, that some aspect of timekeeping in 
RBCs must be dependent upon phosphorylation and thus Staurosporine (STS), a non-specific 
inhibitor, was investigated.  
RBC suspensions from the same four donors were treated with 10 µM of STS (or vehicle DMSO 
control), and then entrained and sampled every four hours as described previously (DEP data in 
Appendix D). When fit to the same damped cosinor model, a robust and significant lengthening 
(p≤0.0004 by Sidak’s multiple comparisons test) of circadian period was observed in both Geff and σcyt 
treated with STS (Figure 85).  
 
Figure 85: RBC rhythms are lengthened by kinase inhibition with 10 μM STS. STS lengthens RBC 
circadian period in Geff (A) and σcyt (B) data points show mean±SEM (n=4), solid line shows damped 
cosine fit. (C) Grouped quantification of period from (A) and (B) shows no significant effect of 
DMSO vehicle upon the rhythm in Geff or σcyt (p>0.9), but a significant lengthening due to STS 
(p≤0.0004) by Sidak’s multiple comparisons test. 
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STS treatment lengthened Geff from 22.4±1.27 hr to 33.09±1.09 hr (DMSO τ=23.44±2.27 hr) and σcyt 
period was lengthened from 20.88±0.84 hr to 32.73±1.0 hr (DMSO τ=19.73±1.56 hr).  
The amplitude of oscillation was significantly reduced for both parameters, similar to the effect of 
period-lengthening drugs upon clock gene expression rhythms in human nucleated cells (Isojima et 
al. 2009). Importantly, however, Geff and σcyt continued to oscillate in antiphase with each other; 
again suggesting they are mutually interdependent and regulated by the same cellular mechanism. 
Moreover, cellular morphology was normal during treatment with STS, and no significant changes to 
effective membrane capacitance were observed, implying that the RBCs were not dynamically 
compromised by the treatment.  Altering the clock speed thus excludes the possibility that the 
mechanism underlying RBC rhythms is some external environmental variable but an intracellular, 
local process. This is an important step towards delineating the RBC clock.   
The next experiment investigated this mechanism further by observing if ion transport affects the 
DEP response of entrained RBCs. Membrane-based models of circadian timekeeping pre-date clock-
gene discovery  (Njus et al. 1976, Pritchett and Reddy 2015). Pacemaker neurons in flies and mouse 
models have shown that changes in ion transport and membrane excitability are an important 
contribution to these models (Nitabach et al. 2002, Colwell 2011).  Following the observations that 
rhythms in PRX over-oxidation are not present in RBC lysates (Figure 84b) and the anti-phasic nature 
of the DEP parameters, it was hypothesised that trans-membrane ion flux (and perhaps specifically 
efflux) must contribute. The potassium ionophore, Valinomycin was investigated as K+ flux across the 
RBC membrane is crucial in many of the RBC membrane transport systems such as Gardos, pumps 
and symporters described in Chapter 3.  
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Figure 86: (A) Effective membrane conductance (Geff) and (B) cytoplasmic conductivity (σcyt) for 
isolated human RBCs treated with 30 nM Valinomycin (red) and none treated (black) measured by 
DEP following 2 days entrainment by temperature cycles. Data points show mean±SEM (Appendix 
D), whilst solid line is the respective cosinor fit.  (C) VAL treatment increases circadian period of 
RBCs in both parameters. 2-way ANOVA: p=0.0011 for Valinomycin effect, p=0.52 for DEP 
parameter, p=0.87 for parameter vs. Valinomycin interaction. 
 
RBC rhythms in Geff and σcyt were observed to be lengthened by about 6 hours compared with 
controls (Figure 86). VAL treatment lengthened Geff from 22.25±0.65 hr (R2=0.91) to 29.03±2.3 hr 
(R2=0.3) and σcyt period was lengthened from 21.49±0.43 hr (R2=0.96) to 27.75±1.8 hr (R2=0.32).  
Membrane conductance baseline was also observed to be increased by nearly three-fold due to VAL 
treatment. This is expected since Valinomycin increases membrane permeability to K+ ions (net 
efflux), and with the associated reduction in mean cytoplasmic conductivity can be said to follow 
expectations of the Goldman–Hodgkin–Katz voltage equation whereby when membrane potential 
increases intracellular concentration of K+ baseline levels decrease (Goldman 1943). Additionally, the 
robustness of the rhythms was drastically decreased with VAL treatment when comparing goodness 
of fit of the cosinor curves for each parameter (Geff R2 of 0.91 compared to 0.3 and σcyt R2 of 0.96 to 
0.32) suggesting intracellular K+ affects maintenance of the robust RBC clock rhythm.  
 Page | 135 
 
 
Figure 87: 30 nM VAL treated RBCs at 48 hr post-entrainment and post treatment. 
As shown previously, RBC morphology was unaffected at 30 nM VAL treatment (Figure 87) 
confirming again no dynamic changes to the RBC are responsible for this shift in DEP response. It is 
therefore plausible that circadian regulation of K+ movement across the RBC membrane must be a 
significant factor in the electrophysiological rhythms observed and moreover K+ may be 
mechanistically responsible for the maintenance of circadian rhythm in these cells. 
5.3.3 Whole Blood and Animal Modelling  
In addition to DEP’s ability to mechanistically dissect circadian control in RBCs it also has potential to 
be used as a phase marker in circadian studies. As previously described, the timings of cycles such as 
food intake and light exposure are temporally aligned, which coordinate rhythms in peripheral 
physiology. However, misalignment of extrinsic cycles can lead to disturbances and subsequent 
adverse health consequences (Partch et al. 2014). The term circadian desynchrony is used to 
describe circumstances in which circadian timing of sleep-wake and/or feeding-fasting cycles are 
misaligned to the timing of the external light-dark cycle such as in shift workers.  Currently melatonin 
is the primary marker used in studies of circadian desynchrony and is shown to be a robust measure 
even in presence of external variables (Mirick and Davis 2008). Unlike melatonin, which is typically 
detected by radioimmunoassay, DEP analysis is performed in minutes and with less sample 
preparation/contamination. Thus the potential for DEP to assay whole blood was investigated. 
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Optimisation: Since vole ultradian sampling must be conducted circa every 20 minutes, it was not 
feasible to adhere to the same protocol for isolation of RBCs as these required upwards of 30 
minutes centrifugation. The challenge associated with no centrifuge step was ensuring conductivity 
of the DEP medium remained low and cell concentration remained high enough to perform the DEP 
assay whilst being spiked with high conductive whole blood. It was found for whole blood that the 
standard conductivity of 40-45 mS/m used on isolated RBCs yielded DEP spectra with a high number 
of data points to the left of the first dispersion (Figure 88a) and model fits were not able to capture 
the “high tail” produced by these trials, though the cell concentration remained adequate for DEP 
response (Figure 88a&b).  
 
Figure 88: Example DEP spectrum for 40mS/m DEP medium spiked with 10µL whole blood 
exhibiting a high abundance of left dispersion (11) data points, but adequate cell concentration. 
It was thus decided to use 10mS/m DEP medium for whole blood sampling which produced more 
reliable DEP output when spike with 10µL of blood. This was repeated 29 times across 4 vole 
experiments to confirm the conductivity adjustment (13.9 ± 1mS/m) and cell concentration (7.9x106 
± 0.6 cells/ml) with no significant change due to donor or replicate (p>0.1) determined by two-way 
ANOVA for either parameter. Vole cell radius measurement was found to be normally distributed 
with a mean of 3.3 ±0.6 µm with no donor effect found (p>0.2) with 2-way ANOVA.   
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Vole sampling: Once it was established that whole blood samples could be successfully obtained and 
measured through DEP analysis, an animal model was used to corroborate DEP as a viable, 
noninvasive method of measuring circadian synchrony and desynchrony in vivo.  The vole was used 
to measure DEP in blood samples collected from the tail. The vole is naturally in a state of circadian 
desycnchrony, because it expresses short (ultradian) feeding-fasting cycles, whilst being under a 
circadian light-dark cycle (Figure 89) (van der Veen et al. 2006, van der Veen et al. 2011).  
 
Figure 89: The vole is in a natural state of circadian desycnchrony as it expresses short (ultradian) 
feeding-fasting cycles, whilst being under a circadian light-dark cycle. 
 
Figure 90: Example actogram of Vole 3 used to measure ultradian timing of each vole individually. 
On the 7th day clear rhythms can be seen in bursts of approximately 30 minutes.  
After monitoring for 1 week (Figure 90), tail knick samples were analysed every 30 minutes from ZT 
0h with DEP for 5 voles (Appendix D). The electrophysiological data was then compared to the 
ultradian feeding-fasting cycle correlate of each vole (Figure 90-Figure 91) and fit to the cosinor 
curve of phase defined by the actogram.  In each case, cytoplasmic conductivity and effective 
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membrane conductance matched well with cosinor curves of the vole cycle (Figure 91-Figure 92). 
Vole 2 was unable to be bled after the first 5 data points, however showed very good correlation up 
until termination of its experiment (Figure 93). This is the first electrophysiological correlate of the 
ultradian feeding-fasting cycle and the first physiological blood measure obtained from the same 
host across the time course.  
 
 
Figure 91: Cytoplasmic conductivity fit to each vole cosinor curve. Data points (black circles) are 
mean parameters determined by at least n=3 spectra fits at each time points. R2 values indicate 
the goodness of fit to the cosinor curve determined by the phase of the actogram and fitted 
amplitude and mesor to DEP data (red line). 
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Figure 92: Effective membrane conductivity fit to each vole cosinor curve. Data points (black 
circles) are mean parameters determined by at least n=3 spectra fits at each time points. R2 values 
indicate the goodness of fit to the cosinor curve determined by the phase of the actogram and 
fitted amplitude and mesor to DEP data (red line). 
 
 
Figure 93: The first 5 data points obtained for vole 2 of cytoplasmic conductivity and effective 
membrane capacitance prior to vole unable to provide more blood. 
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Optimising human whole blood protocol: Before any controlled human studies can be performed 
there are a few challenges to consider rendering DEP viable for human whole blood analysis.  First, 
consideration of how to obtain and then prepare whole blood in low conductive DEP medium and if 
the process was repeatable across various donors as found in the vole. Eight donors were initially 
screened for these purposes over a 12 hour interval every 4 hours (0800, 1200, 1600 and 2000 hr). 
Finger-prick assays were employed as readily available lancets (used for diabetes testing) could be 
adopted for this purpose. To prevent coagulation, heparin coated capillary tubes were used to draw 
the droplets of blood produced by finger prick.  It was found across all donors and time that the 1 cm 
(approximately 10 µL) of blood increased the conductivity of a 5 mL volume of DEP medium 
(originally at 10 mS/m) an average of 33±6 mS/m. Cell counts for each of these time points averaged 
across donors 9.4±0.2 x106 cells/mL. These proved normally distributed and demonstrated no 
statistical difference (p>0.05) for donor or replicate effect by 2-way ANOVA.  
Interestingly, despite having no controls on the donors with respect to night/day and feeding cycles, 
DEP parameters showed some hint of cycling and time dependency (Figure 94). Membrane 
conductance and cytoplasmic conductivity demonstrated donor independent time response (p≤ 
0.02) for time effect and p ≥ 0.2 for donor effect) whilst membrane conductance was once again 
found to be unchanged across time (p=0.66) or donor (p=0.77). Also, it was noted the same anti-
phasic behaviour was present in whole blood assays found in the isolated and entrained RBCs 
though, similar to vole results, the range of membrane conductance values decreased when 
compared to the isolated samples resuspended in higher conductive media. Ionic content within the 
RBCs reflected in cytoplasmic conductivity, was similar to values produced by isolated RBC 
measurement. The peak and trough (Figure 94d) of the average data also shows a similar circadian 
timing as isolated RBCs given the Geff peak at the 1600 (4pm) time point and corresponding σcyt 
trough.  
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Figure 94: Individual donor traces (n=5 at each time point for each donor). Cytoplasmic 
conductivity (a) demonstrated no significant change across donors (p=0.87) but hinted at time 
dependency (p=0.02) whilst membrane conductance (b) showed a more robust time effect 
(p=0.0081) but also more donor variation (p=0.2). Membrane capacitance remained unchanged 
across time and donor (p≥0.66) all with 2-way ANOVA.  
 Page | 142 
 
The next consideration was whether human whole blood DEP sampling would yield similar DEP 
response compared to isolated RBCs given the mixed population.  Two donor blood samples were 
prepared both as isolated RBCs (Section 5.2.1) and as 10 µL whole blood to 5 mL of DEP medium 
mixture (described in Section 5.2.3).  Five repeats of each sample for each donor were taken and the 
average DEP spectra for both samples were obtained (Figure 95).  Parameters showed no significant 
variation (p ≥ 0.27 for sample type effect) between the samples, moreover the collective data fit the 
model with R2=0.91 for both donors.  
 
Figure 95: DEP response for isolated RBCs compared to Whole Blood response. 
 
5.4 Implications and Future Work 
This work has shown that there is a circadian oscillation in RBCs across species in both membrane 
conductance (Geff) and cytoplasmic conductivity (σcyt), but not in a third parameter, membrane 
capacitance (Ceff), indicating no changes in membrane morphology or cell size. Incidentally this 
means that Ceff may serve as an internal negative control. Geff and σcyt oscillate in antiphase to one 
another: As Geff reaches its peak, during the anticipated cold phase, σcyt is at its lowest value. This 
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relationship suggests a transmembrane ionic efflux with some speculation of the origin given in 
Figure 96.  
The Gardos channels, are the most emblematic ion channels of the RBCs. These belong to the small 
conductance Ca2+-activated K+ channels family (hSK4 channels) and is encoded by KCNN4 (Hoffman 
et al. 2003). Their activity is modulated by calmodulin (CaM), a Ca2+-sensor protein. So far, it is not 
clear whether Ca-CaM activates Gardos channels directly or indirectly by affecting the channels 
phosphorylation levels via activating Ca2+-CaM dependent protein kinase (CaMKII) and/or Ca2+-CaM 
dependent protein phosphatase, calcineurin. Furthermore, Gardos channels are activated by PKA, 
and inhibited by PKC (Horga et al. 2000) and modulated by CK1𝛼 (Kucherenko et al. 2012). The 
proteome database also includes two members of a very intriguing family of ion channels, the 
chloride intracellular channel proteins (CLIC1 and CLIC3), which have not hitherto been specifically 
studied in RBCs. This relatively recently discovered ion channel family is highly conserved in 
chordates (Littler et al. 2010). CLICs have unique dimorphic properties, alternating between soluble 
(in reducing conditions) and membrane-bound (in oxidising conditions) forms. Their cycling property 
has been shown to be modulated by cellular redox state, in particular NADPH oxidase (NOX) and 
superoxide levels (Averaimo et al. 2010) produced possibly from NOX1 and NOX2 (Tulk et al. 2002). 
Reduced intracellular state prevents CLIC1 from translocating to the membrane and hence resides in 
the cytoplasm, whereas, increased cellular oxidation state will enhance CLIC1 oxidation, by forming 
disulphide bonds, modifying its configuration to facilitate its translocation to the membrane forming 
a functional Cl- channel (Littler et al. 2004, Goodchild et al. 2009). Furthermore, activation of NOX1/2 
increase the production of the superoxide anion- which modulates the activity of ion channels either 
directly through oxidation or indirectly by activating target protein kinase such as PKC or Erk- MAPK. 
The  hypothesis is that in  RBCs, either CLIC1 or CLIC3, or both, move into the plasma membrane 
under oxidising conditions, and that this is a key step linking the redox state circadian oscillation with 
the electrophysiological one, although the Staurosporine data indicates that protein kinases are also 
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involved. This hypothesis can be tested by immunocytochemistry and application of specific CLIC1 
and CLIC3 inhibitors. 
 
Figure 96: Schematic diagram for the proposed intracellular signalling pathways modulating 
Gardos and CLIC.  A: Gardos channels activity is inhibited by PKC, enhanced by PKA. They are also 
activated by raised Ca2+  and  calmodulin (CaM). The latter may indirectly affect the channel 
through the activation of Ca2+-CaM dependent protein Kinase II (CaMKII) or calcineurin. B: redox 
state mediates the cycling of CLIC between the cytoplasm and membrane. CLIC activity could be 
modulated by NOX, O2.-- Erk-MAPK. 
These findings are consistent with the current RBC clock model whereby timing is sustained by a 
mechanism that includes one (or more) ATP-dependent processes and contains functional input 
(temperature-sensing) and output of rhythms in metabolism and redox balance (O'Neill and Reddy 
2011; Cho, Yoon et al. 2014). Moreover this work has introduced circadian regulation of membrane 
electrophysiology and ion flux. It is not clear to what extent these circadian outputs also contribute 
to timekeeping mechanism, but certainly the RBC membrane seems to be required (Figure 97). 
 Page | 145 
 
 
Figure 97: Model summary of findings. The RBC clock can be entrained by temperature cycles, its 
period is sensitive to kinase inhibition and transmembrane ion flux, and it drives rhythms in 
metabolism, redox balance and cellular electrophysiology. 
 Understanding the transcription-independent RBC clock is a critical step towards disentangling its 
physiological and pathophysiological effects in vivo from those driven by cycling systemic cues. Since 
RBCs are the most abundant cell type in the human body, and have a vital function, it is also 
important to establish whether or not cell-autonomous circadian regulation of RBC metabolism has 
any physiological consequence. For example, (Gascoyne et al. 1997) used DEP to show 
electrophysiological changes in Plasmodium infected RBCs, and hence it is possible that 
electrophysiological RBC cycles may contribute to the diurnal variability in cycles of malarial infection 
and replication. Circadian rhythms in RBCs may also be an as yet unexplored factor underlying the 
strong diurnal rhythms in the onset of myocardial infarction (Partch et al. 2014). 
Finally this work demonstrates that DEP has significant potential as a circadian phase marker. Unlike 
melatonin, which is detected by radioimmunoassay, DEP assays are performed in minutes, and our 
observations suggest it is possible they can be performed using whole blood sampled from animals 
and humans. In animal studies, specifically to that of the vole and ultradian studies, one of the main 
issues with detecting circadian desynchrony in physiology is the absence of a non-invasive, rapid 
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method for detecting systemic temporal state. This work is a major step forward in producing a 
physiologically relevant marker sustained from the same host animal throughout an experiment 
without the need of animal sacrifice. Measurement of rhythms in animals routinely requires the 
sacrifice of multiple animals per time-point, meaning that anywhere between 10 to 50 animals are 
used in a ‘standard’ experiment. DEP has the potential to provide an accurate and reproducible 
readout of rhythm status using very small blood volumes, and significantly reduce the numbers of 
animals required for an experiment. Thus, the findings represented here show a way both towards a 
greater understanding of enigmatic, entirely post-translational circadian rhythms in human RBCs, as 
well as a methodological advance that has even wider potential. 
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Chapter 6: Discussion and Future Work 
6.1 Key Findings 
As highlighted, DEP has be used in many biomedical applications. It has not, however, found 
mainstream use. This is due to the complicated nature of most DEP experiments including elaborate 
fabrication techniques and data analysis. The 3DEP system has been developed as an easy to use, 
cost effective, DEP based assay for cell suspensions. It was thus predicted, 3DEP could be used in the 
field of molecular targeting for drug based studies. To prove its utility, experiments were conducted 
to determine its experimental operating limitations as well as data acquisition and analysis. 3DEP 
was then compared against routinely used assays to measure a drug’s IC50. It was then predicted, 
and experimentally proven that 3DEP may be able to support in the molecular targeting of the RBC 
molecular clock.  
6.1.1 3DEP Analysis and Automated Fitting 
Initially, the 40 point resuspension experiments were set out to ascertain whether multiple spectra 
could be obtained from a single 80µL sample, the principle idea being that most physiologically 
relevant samples, such as biopsies, would exist at low cell concentrations and thus low volume.  
From these experiments it was found that resuspension of the sample (using a pipette to “mix” the 
sample in the chip) was not as effective at reproducible DEP spectra as simply, shortening the typical 
40 s experimental run to 20 s and even down to 6 s. This result was not only significant for this 
purpose but would carry through the remaining work in this thesis as 10 s experimental timings were 
thus used throughout. This shortened experimental time made it possible to achieve a high 
throughput of data collection for RBC and vole measurements (some of which were conducted every 
30 minutes). 
An automatic fitting algorithm using non-linear least squares curve fitting was assessed for its 
reproducibility of DEP spectra fit for four cell types. Yeast, RBCs, k562 and HeLa cells were all 
evaluated using 100 spectra (five 20 point frequency sweeps combined for one 100 point spectrum). 
First, the data generated by the 3DEP analysis of light intensity changes was evaluated for normalcy 
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across the 10+ repeats to ensure appropriate use of the fitting algorithm was made. This was 
confirmed for all cell types across all 100 points (with the removal of obvious outliers due to 
bubbles, or pin connection failure). Overall, the automatic fitting algorithm proved successful in 
consistently modelling varying cell types, with known radius.  
An interesting observation was also made using these high resolution data and that is what appears 
to be a cell specific plateau dip in each of the population spectra. This dip occurs at 1336 kHz for 
yeast, 2329 kHz for RBCs and 3250 kHz for k562 and HeLa cells.   Perhaps this could be a function of 
cell radii or some other property unique to cell type. 
6.1.2 Multipopulation Measurements  
In the multipopulation experiments, four sub-populations were successfully detected using 10 
second DEP analysis. It was found that healthy cells contain a small sub-population (10%) with lower 
cytoplasmic conductivity and lower membrane capacitance. It also showed a slightly smaller radius 
measurement but was within the standard deviation of radii measurements (n=100) conducted on 
the whole sample under microscopy. This could indicate a sub-population damaged in the cell 
sample handling and releasing ions as a result. The cell samples incubated with 10 µM DOX also 
showed a DEP spectrum made up of two sub-populations. Both sub-populations of the treated 
sample showed a decrease in cytoplasmic conductivity, radius, and membrane conductance with 
slight changes in membrane capacitance. This correlates with the cell dying, losing the membrane 
integrity and ions leaking. After careful observation of the cells under the haemocytometer, a large 
presence (about 50%) of cell debris was noticed. The debris was around 1.5 µm in diameter with the 
best fit of the data to the model indicating a radius measurement of 1 µm.  
Cytotoxicity experiments showed that the 3DEP system was able to detect the ratio of healthy sub-
population in the samples of increasing concentrations which was used to calculate the IC50 of 
doxorubicin. The IC50 value of doxorubicin on Jurkat cells, calculated from the DEP experiments, fell 
within the ranges found in the literature and were close to the values obtained using MTT. In the 
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case of doxorubicin, the sub-populations that were being picked up were most likely early and late 
apoptotic. In early apoptosis the cells are still fully functioning, so in a test like MTT (were viability is 
measured by the ability of the cell to metabolize tetrazolium salt) the early apoptotic population 
would appear to be healthy. Longer incubation times would ensure that the apoptotic population 
has reached a late apoptotic stage and are no longer able to metabolise the salt. Overall, DEP proved 
to be a reliable and rapid measure compared to MTT. 
 
6.1.3 DEP Measurement of Circadian Rhythms 
Following the isolation and entrainment of RBCs, 3DEP analysis was used to obtain the  
electrophysiological properties of RBCs from four male adult donors. The preliminary results 
provided DEP fingerprints of these four donors, from which the extracted membrane conductance 
Geff and cytoplasmic conductivity σcyt fluctuated antiphasically with near-24-hour periods. The 
averages of Geff and σcyt were fit to cosinor curves peaking at 17.35 h and 5.45 h after the end of the 
temperature cycle, respectively. No significant variation was observed in Ceff, confirming the 
microscopic observation that cell radius and morphology did not change over the incubation. The 
near-antiphasic appearance of Geff and σcyt suggests a rhythmic regulation of transmembrane ion 
flux. These results demonstrated, for the first time, a circadian rhythm in the electrophysiological 
properties of both red blood cell membrane and cytoplasm.  
These  observed changes in electrophysiological parameters are hypothesised to reflect alterations 
in ion channel activity, which in turn is likely to be mediated by post-translational modifications, in 
particular phosphorylation. As a first step towards elucidating the mechanism underlying 
timekeeping in RBCs, investigation to what extent it shares key features with the clock mechanism in 
nucleated cells was conducted. As an initial test, it was predicted that RBC rhythms would be 
sensitive to the generic kinase inhibitor, Staurosporine. An increase in the circadian period of the 
electrophysiological oscillation by circa 10 h was detected. The amplitude of oscillation was 
significantly reduced for both parameters, similar to the effect of period-lengthening drugs upon 
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clock gene expression rhythms in human nucleated cells. Importantly, however, Geff and σcyt 
continued to oscillate in antiphase with each other – again suggesting they are mutually 
interdependent and regulated by the same cellular mechanism.  
Next, transmembrane ion flux was hypothesised to contribute in formation of these rhythms. It was 
therefore tested whether the potassium ionophore, Valinomycin had an effect on the 
electrophysiological rhythms reported by DEP. RBC rhythms in Geff and σcyt were observed to be 
lengthened by about 6 hours compared with controls. Membrane conductance baseline was also 
observed to be increased by nearly three-fold due to VAL treatment. This is expected since 
Valinomycin increases membrane permeability to K+ ions (net efflux). Additionally, the robustness of 
the rhythms was drastically decreased with VAL treatment when comparing goodness of fit of the 
cosinor curves for each parameter suggesting intracellular K+ affects maintenance of the robust RBC 
clock rhythm.  
In addition to DEP’s ability to mechanistically dissect circadian control in RBCs it also has potential to 
be used as a phase marker in circadian studies. Procedures were optimised for whole blood sampling 
from vole tail knicks. In each case, cytoplasmic conductivity and effective membrane conductance 
matched well with cosinor curves of the vole cycle. This is the first electrophysiological correlate of 
the ultradian feeding-fasting cycle and the first physiological blood measure obtained from the same 
host across the time course. Conditions for human sampling were considered and optimised across 8 
donors via finger prick assays and it was found that across 2 donors whole blood samples showed 
statistically similar spectra results to that of the isolated RBC. Together this work demonstrates that 
DEP has significant potential as a circadian phase marker. Unlike melatonin, which is detected by 
radioimmunoassay, DEP assays are performed in minutes, and our observations suggest it is possible 
they can be performed using whole blood sampled from animals and humans. 
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6.2 Future Work 
6.2.1 Modelling 
High Resolution Spectra: As stated previously, an interesting observation in the spectra plateau of 
each cell type was observed. A dip occurs at 1336 kHz for yeast, 2329 kHz for RBCs and 3250 kHz for 
k562 and HeLa cells.   Further investigation into this (higher resolution around those frequencies) 
should unveil whether or not this is a consistent result across cell types or an operational limitation 
of the system.  
Multipopulation: Automated fitting has been implemented for single population, but to realize the 
full potential of DEP as a tool in drug discovery, the multipopulation model must be automised. 
Currently, this is challenging as each population contains at least 3 degrees of freedom with the 
single shell model and by adding the complexity of fitting population percentage, this could 
drastically reduce the reliability of the fitting algorithm (if not making convergence impossible). 
Possibly, this fitting could be done in stages where the bulk population is best fit to a single 
population, and then subsequently adding populations until an optimal fit is achieved. Another 
added complexity is the possibility of smaller particles having different optical properties to healthy 
cells. Further investigation would need to be carried out and perhaps a compensation algorithm can 
be applied in the plotting of the model of multiple sub-populations. 
6.2.2 Circadian Applications 
Delineating the RBC clock mechanism: Following from this work a proposal set forth to the BBSRC, 
and subsequently awarded funding (BB/M021556/1), highlighted the following questions: 
1)   Which protein kinase (s) and/or protein phosphatase(s) underlie and sustain the circadian 
clock in isolated human RBCs? 
2)   Which ion channel(s) facilitate(s) the circadian rhythm observed by DEP? 
3)   Are electrophysiological rhythms required for RBC metabolic oscillations, and vice versa? 
To answer these questions the following aims have been determined: 
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1. Sequentially probe the effect of inhibitors of the different ion channels, kinases, and protein 
phosphatases known to be present in RBCs. Generic inhibitors will be used followed by, where 
available, others specific to isoforms, using both DEP and PRX redox status as readouts. 
2. Investigate further using patch clamping (for channel candidates) or other agents such as 
activators, as well as immunocytochemistry once a change (lengthening or shortening in 
electrophysiological and/or redox circadian period) is observed via DEP.    
3. Construct a unified model through manipulating key candidate components simultaneously. The 
hypothesis is that such a combination will abolish circadian rhythmicity altogether. A 
simultaneous abolition of rhythms in electrophysiological and redox parameters would indicate 
that they are inextricably linked. 
Ultradian Measure in the Vole: Following from this work, a proposed plan of investigation is as 
follows: 
Measure ultradian cycles in DEP at two circadian time points (light/dark) in the blood of voles under 
3 conditions of circadian (de)synchrony: 
 Natural expression of circadian desynchrony of ultradian feeding-fasting and circadian light-
dark cycles 
 Imposed circadian synchrony of feeding through temporal (not caloric) food restriction 
 Imposed circadian synchrony of sleeping through temporal sleep restriction 
Voles should be kept on a 12-hours light, 12-hours dark cycle with ad libitum food availability. Using 
passive-infrared activity monitors onsets and offset of ultradian behavioural activity bouts in real-
time can be established. In the middle of the light and the middle of the dark samples will be 
collected through pinprick tail bleeding every 30 minutes and measured for DEP.  
In order to validate and understand the way in which this assay works, and what biological processes 
the DEP signatures represent, simultaneously in-house in vitro approaches to study the molecular 
markers of biological rhythmicity to correlate with DEP can be used. These are standard and active in 
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vitro techniques, routinely used by the biological rhythm team at the University of Surrey. To this 
end, the same targets as discussed above will be assessed in the vole RBC. 
6.3 Conclusions  
This thesis has examined a DEP tool with potential for mainstream biomedical use. 3DEP’s utility as a 
reliable, reproducible measurement technique for electrophysiology has been demonstrated on a 
number of cells and benchmarked against standard measurement assays. Limitations of the 
technique have also been discussed. 
For the first time, the results highlight the presence of a circadian rhythm in the electrophysiological 
properties of both the red blood cell membrane and cytoplasm. Antiphasic fluctuations in the 
membrane conductance and intracellular cytoplasmic conductivity with near 24 hour periods, 
implicates transmembrane ion flux as a physiologically relevant clock output that can be 
pharmacologically manipulated. This work has also demonstrated that not only is dielectrophoresis a 
robust technique for exploring the RBC timekeeping mechanism but also has diagnostic potential as 
a circadian biomarker in whole blood. 
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Appendix A: DEP Spectra 
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Midpoint Frequencies - Membrane: 64.6kHz Cytoplasm: 56.2MHz
RMS error spectrum 0.19649
R spectrum 0.95075
Spectrum   medium=0.01S/m
 
 
Model
Spectrum
10
4
10
5
10
6
10
7
10
8
-0.5
0
0.5
1
1.5
Frequency [Hz]
Bands: 6 to 9 Timerange: 2 to 38 sec
cytoplasm: r = 5.2m,  = 0.6S/m,  = 50 membrane: d = 8nm,  = 4e-006S/m,  = 9
Midpoint Frequencies - Membrane: 64.6kHz Cytoplasm: 56.2MHz
RMS error spectrum 0.19125
R spectrum 0.95405
Spectrum   medium=0.01S/m
 
 
Model
Spectrum
10
4
10
5
10
6
10
7
-1
-0.5
0
0.5
1
1.5
Frequency [Hz]
Bands: 6 to 9 Timerange: 2 to 38 sec
cytoplasm: r = 5.2m,  = 0.6S/m,  = 50 membrane: d = 8nm,  = 4e-006S/m,  = 9
Midpoint Frequencies - Membrane: 64.6kHz Cytoplasm: 56.2MHz
RMS error spectrum 0.22462
R spectrum 0.94269
Spectrum   medium=0.01S/m
 
 
Model
Spectrum
10
4
10
5
10
6
10
7
10
8
-1
-0.5
0
0.5
1
1.5
Frequency [Hz]
Bands: 6 to 9 Timerange: 2 to 38 sec
cytoplasm: r = 5.2m,  = 0.6S/m,  = 50 membrane: d = 8nm,  = 4e-006S/m,  = 9
Midpoint Frequencies - Membrane: 64.6kHz Cytoplasm: 56.2MHz
RMS error spectrum 0.21286
R spectrum 0.94583
Spectrum   medium=0.01S/m
 
 
Model
Spectrum
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6 
 
 
   
7 
   
8 
   
10
4
10
5
10
6
10
7
10
8
-0.5
0
0.5
1
1.5
Frequency [Hz]
Bands: 6 to 9 Timerange: 2 to 38 sec
cytoplasm: r = 5.2m,  = 0.6S/m,  = 50 membrane: d = 8nm,  = 4e-006S/m,  = 9
Midpoint Frequencies - Membrane: 64.6kHz Cytoplasm: 56.2MHz
RMS error spectrum 0.15699
R spectrum 0.97065
Spectrum   medium=0.01S/m
 
 
Model
Spectrum
10
4
10
5
10
6
10
7
-1
-0.5
0
0.5
1
1.5
2
Frequency [Hz]
Bands: 6 to 9 Timerange: 2 to 38 sec
cytoplasm: r = 5.2m,  = 0.4S/m,  = 50 membrane: d = 8nm,  = 4e-006S/m,  = 9
Midpoint Frequencies - Membrane: 64.6kHz Cytoplasm: 37.2MHz
RMS error spectrum 0.18587
R spectrum 0.96073
Spectrum   medium=0.01S/m
 
 
Model
Spectrum
10
4
10
5
10
6
10
7
10
8
-1
-0.5
0
0.5
1
1.5
2
Frequency [Hz]
Bands: 6 to 9 Timerange: 2 to 38 sec
cytoplasm: r = 5.2m,  = 0.4S/m,  = 50 membrane: d = 8nm,  = 4e-006S/m,  = 9
Midpoint Frequencies - Membrane: 64.6kHz Cytoplasm: 37.2MHz
RMS error spectrum 0.19678
R spectrum 0.9543
Spectrum   medium=0.01S/m
 
 
Model
Spectrum
10
4
10
5
10
6
10
7
-0.5
0
0.5
1
1.5
Frequency [Hz]
Bands: 6 to 9 Timerange: 2 to 38 sec
cytoplasm: r = 5.2m,  = 0.4S/m,  = 50 membrane: d = 8nm,  = 4e-006S/m,  = 9
Midpoint Frequencies - Membrane: 64.6kHz Cytoplasm: 37.2MHz
RMS error spectrum 0.13186
R spectrum 0.97999
Spectrum   medium=0.01S/m
 
 
Model
Spectrum
10
4
10
5
10
6
10
7
10
8
-0.5
0
0.5
1
1.5
2
Frequency [Hz]
Bands: 6 to 9 Timerange: 2 to 38 sec
cytoplasm: r = 5.2m,  = 0.4S/m,  = 50 membrane: d = 8nm,  = 4e-006S/m,  = 9
Midpoint Frequencies - Membrane: 64.6kHz Cytoplasm: 37.2MHz
RMS error spectrum 0.29469
R spectrum 0.8854
Spectrum   medium=0.01S/m
 
 
Model
Spectrum
10
4
10
5
10
6
10
7
10
8
-0.5
0
0.5
1
1.5
2
Frequency [Hz]
Bands: 6 to 9 Timerange: 2 to 38 sec
cytoplasm: r = 5.2m,  = 0.4S/m,  = 50 membrane: d = 8nm,  = 4e-006S/m,  = 9
Midpoint Frequencies - Membrane: 64.6kHz Cytoplasm: 37.2MHz
RMS error spectrum 0.22814
R spectrum 0.93594
Spectrum   medium=0.01S/m
 
 
Model
Spectrum
10
4
10
5
10
6
10
7
10
8
-0.5
0
0.5
1
1.5
2
Frequency [Hz]
Bands: 6 to 9 Timerange: 2 to 38 sec
cytoplasm: r = 5.2m,  = 0.4S/m,  = 50 membrane: d = 8nm,  = 4e-006S/m,  = 9
Midpoint Frequencies - Membrane: 64.6kHz Cytoplasm: 37.2MHz
RMS error spectrum 0.16231
R spectrum 0.9669
Spectrum   medium=0.01S/m
 
 
Model
Spectrum
10
4
10
5
10
6
10
7
-0.5
0
0.5
1
1.5
2
Frequency [Hz]
Bands: 6 to 9 Timerange: 2 to 38 sec
cytoplasm: r = 5.2m,  = 0.4S/m,  = 50 membrane: d = 8nm,  = 4e-006S/m,  = 9
Midpoint Frequencies - Membrane: 64.6kHz Cytoplasm: 37.2MHz
RMS error spectrum 0.19552
R spectrum 0.95579
Spectrum   medium=0.01S/m
 
 
Model
Spectrum
10
4
10
5
10
6
10
7
10
8
-0.5
0
0.5
1
1.5
2
Frequency [Hz]
Bands: 6 to 9 Timerange: 2 to 38 sec
cytoplasm: r = 5.2m,  = 0.45S/m,  = 50 membrane: d = 8nm,  = 4e-006S/m,  = 9
Midpoint Frequencies - Membrane: 64.6kHz Cytoplasm: 42.7MHz
RMS error spectrum 0.17831
R spectrum 0.96119
Spectrum   medium=0.01S/m
 
 
Model
Spectrum
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N    
9 
   
10 
   
 
10
4
10
5
10
6
10
7
10
8
-0.5
0
0.5
1
1.5
2
Frequency [Hz]
Bands: 6 to 9 Timerange: 2 to 38 sec
cytoplasm: r = 5.2m,  = 0.45S/m,  = 50 membrane: d = 8nm,  = 4e-006S/m,  = 9
Midpoint Frequencies - Membrane: 64.6kHz Cytoplasm: 42.7MHz
RMS error spectrum 0.13782
R spectrum 0.97459
Spectrum   medium=0.01S/m
 
 
Model
Spectrum
10
4
10
5
10
6
10
7
-0.5
0
0.5
1
1.5
2
Frequency [Hz]
Bands: 6 to 9 Timerange: 2 to 38 sec
cytoplasm: r = 5.2m,  = 0.45S/m,  = 50 membrane: d = 8nm,  = 4e-006S/m,  = 9
Midpoint Frequencies - Membrane: 64.6kHz Cytoplasm: 42.7MHz
RMS error spectrum 0.20198
R spectrum 0.95733
Spectrum   medium=0.01S/m
 
 
Model
Spectrum
10
4
10
5
10
6
10
7
10
8
-0.5
0
0.5
1
1.5
2
Frequency [Hz]
Bands: 6 to 9 Timerange: 2 to 38 sec
cytoplasm: r = 5.2m,  = 0.45S/m,  = 50 membrane: d = 8nm,  = 4e-006S/m,  = 9
Midpoint Frequencies - Membrane: 64.6kHz Cytoplasm: 42.7MHz
RMS error spectrum 0.17282
R spectrum 0.96307
Spectrum   medium=0.01S/m
 
 
Model
Spectrum
10
4
10
5
10
6
10
7
10
8
-0.5
0
0.5
1
1.5
2
Frequency [Hz]
Bands: 6 to 9 Timerange: 2 to 38 sec
cytoplasm: r = 5.2m,  = 0.45S/m,  = 50 membrane: d = 8nm,  = 4e-006S/m,  = 9
Midpoint Frequencies - Membrane: 64.6kHz Cytoplasm: 42.7MHz
RMS error spectrum 0.15827
R spectrum 0.96818
Spectrum   medium=0.01S/m
 
 
Model
Spectrum
10
4
10
5
10
6
10
7
-0.5
0
0.5
1
1.5
2
Frequency [Hz]
Bands: 6 to 9 Timerange: 2 to 38 sec
cytoplasm: r = 5.2m,  = 0.45S/m,  = 50 membrane: d = 8nm,  = 4e-006S/m,  = 9
Midpoint Frequencies - Membrane: 64.6kHz Cytoplasm: 42.7MHz
RMS error spectrum 0.21057
R spectrum 0.95253
Spectrum   medium=0.01S/m
 
 
Model
Spectrum
10
4
10
5
10
6
10
7
10
8
-0.5
0
0.5
1
1.5
2
Frequency [Hz]
Bands: 6 to 9 Timerange: 2 to 38 sec
cytoplasm: r = 5.2m,  = 0.45S/m,  = 50 membrane: d = 8nm,  = 4e-006S/m,  = 9
Midpoint Frequencies - Membrane: 64.6kHz Cytoplasm: 42.7MHz
RMS error spectrum 0.20097
R spectrum 0.95289
Spectrum   medium=0.01S/m
 
 
Model
Spectrum
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40 point no resuspension 
30 second repeats 
N Frequency set A Frequency set B 
1 
  
2 
 
  
3 
  
10
4
10
5
10
6
10
7
-0.5
0
0.5
1
1.5
2
2.5
Frequency [Hz]
Bands: 6 to 9 Timerange: 2 to 28 sec
cytoplasm: r = 5.2m,  = 0.45S/m,  = 50 membrane: d = 8nm,  = 1e-05S/m,  = 8.5
Midpoint Frequencies - Membrane: 81.3kHz Cytoplasm: 42.7MHz
RMS error spectrum 0.45085
R spectrum 0.61926
Spectrum   medium=0.01S/m
 
 
Model
Spectrum
10
4
10
5
10
6
10
7
10
8
-1
-0.5
0
0.5
1
1.5
Frequency [Hz]
Bands: 6 to 9 Timerange: 2 to 28 sec
cytoplasm: r = 5.2m,  = 0.45S/m,  = 50 membrane: d = 8nm,  = 5e-06S/m,  = 9
Midpoint Frequencies - Membrane: 67.6kHz Cytoplasm: 42.7MHz
RMS error spectrum 0.12993
R spectrum 0.97689
Spectrum   medium=0.01S/m
 
 
Model
Spectrum
10
4
10
5
10
6
10
7
-0.5
0
0.5
1
1.5
2
Frequency [Hz]
Bands: 6 to 9 Timerange: 2 to 28 sec
cytoplasm: r = 5.2m,  = 0.45S/m,  = 50 membrane: d = 8nm,  = 1e-05S/m,  = 8.5
Midpoint Frequencies - Membrane: 81.3kHz Cytoplasm: 42.7MHz
RMS error spectrum 0.34092
R spectrum 0.8175
Spectrum   medium=0.01S/m
 
 
10
4
10
5
10
6
10
7
10
8
-0.5
0
0.5
1
1.5
2
Frequency [Hz]
Bands: 6 to 9 Timerange: 2 to 28 sec
cytoplasm: r = 5.2m,  = 0.5S/m,  = 50 membrane: d = 8nm,  = 8e-06S/m,  = 10
Midpoint Frequencies - Membrane: 67.6kHz Cytoplasm: 46.8MHz
RMS error spectrum 0.14483
R spectrum 0.96717
Spectrum   medium=0.01S/m
 
 
10
4
10
5
10
6
10
7
-0.5
0
0.5
1
1.5
2
Frequency [Hz]
Bands: 6 to 9 Timerange: 2 to 28 sec
cytoplasm: r = 5.2m,  = 0.5S/m,  = 50 membrane: d = 8nm,  = 8e-06S/m,  = 10
Midpoint Frequencies - Membrane: 67.6kHz Cytoplasm: 46.8MHz
RMS error spectrum 0.22545
R spectrum 0.92942
Spectrum   medium=0.01S/m
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4 
  
5 
  
6 
  
7 
  
10
4
10
5
10
6
10
7
10
8
-0.5
0
0.5
1
1.5
2
Frequency [Hz]
Bands: 6 to 9 Timerange: 2 to 28 sec
cytoplasm: r = 5.2m,  = 0.5S/m,  = 50 membrane: d = 8nm,  = 5e-06S/m,  = 10
Midpoint Frequencies - Membrane: 61.7kHz Cytoplasm: 46.8MHz
RMS error spectrum 0.15494
R spectrum 0.96881
Spectrum   medium=0.01S/m
 
 
10
4
10
5
10
6
10
7
10
8
-0.5
0
0.5
1
1.5
2
Frequency [Hz]
Bands: 6 to 9 Timerange: 2 to 28 sec
cytoplasm: r = 5.2m,  = 0.5S/m,  = 50 membrane: d = 8nm,  = 5e-06S/m,  = 10
Midpoint Frequencies - Membrane: 61.7kHz Cytoplasm: 46.8MHz
RMS error spectrum 0.15494
R spectrum 0.96881
Spectrum   medium=0.01S/m
 
 
10
4
10
5
10
6
10
7
10
8
-0.5
0
0.5
1
1.5
2
Frequency [Hz]
Bands: 6 to 9 Timerange: 2 to 28 sec
cytoplasm: r = 5.2m,  = 0.45S/m,  = 50 membrane: d = 8nm,  = 8e-06S/m,  = 11
Midpoint Frequencies - Membrane: 58.9kHz Cytoplasm: 40.7MHz
RMS error spectrum 0.14424
R spectrum 0.96764
Spectrum   medium=0.01S/m
 
 
10
5
10
6
10
7
-0.5
0
0.5
1
1.5
Frequency [Hz]
Bands: 6 to 9 Timerange: 2 to 28 sec
cytoplasm: r = 5.2m,  = 0.45S/m,  = 50 membrane: d = 8nm,  = 8e-06S/m,  = 11
Midpoint Frequencies - Membrane: 58.9kHz Cytoplasm: 40.7MHz
RMS error spectrum 0.27245
R spectrum 0.86331
Spectrum   medium=0.01S/m
 
 
10
4
10
5
10
6
10
7
10
8
-0.5
0
0.5
1
1.5
2
Frequency [Hz]
Bands: 6 to 9 Timerange: 2 to 28 sec
cytoplasm: r = 5.2m,  = 0.45S/m,  = 50 membrane: d = 8nm,  = 7e-06S/m,  = 9
Midpoint Frequencies - Membrane: 70.8kHz Cytoplasm: 42.7MHz
RMS error spectrum 0.13451
R spectrum 0.97521
Spectrum   medium=0.01S/m
 
 
10
4
10
5
10
6
10
7
-0.5
0
0.5
1
1.5
2
2.5
Frequency [Hz]
Bands: 6 to 9 Timerange: 2 to 28 sec
cytoplasm: r = 5.2m,  = 0.45S/m,  = 50 membrane: d = 8nm,  = 7e-06S/m,  = 9
Midpoint Frequencies - Membrane: 70.8kHz Cytoplasm: 42.7MHz
RMS error spectrum 0.34843
R spectrum 0.83973
Spectrum   medium=0.01S/m
 
 
10
4
10
5
10
6
10
7
10
8
-0.5
0
0.5
1
1.5
2
Frequency [Hz]
Bands: 6 to 9 Timerange: 2 to 28 sec
cytoplasm: r = 5.2m,  = 0.45S/m,  = 50 membrane: d = 8nm,  = 7e-06S/m,  = 9
Midpoint Frequencies - Membrane: 70.8kHz Cytoplasm: 42.7MHz
RMS error spectrum 0.12863
R spectrum 0.97667
Spectrum   medium=0.01S/m
 
 
10
4
10
5
10
6
10
7
-1.5
-1
-0.5
0
0.5
1
1.5
2
Frequency [Hz]
Bands: 6 to 9 Timerange: 2 to 28 sec
cytoplasm: r = 5.2m,  = 0.45S/m,  = 50 membrane: d = 8nm,  = 7e-06S/m,  = 9
Midpoint Frequencies - Membrane: 70.8kHz Cytoplasm: 42.7MHz
RMS error spectrum 0.37778
R spectrum 0.83061
Spectrum   medium=0.01S/m
 
 
Model
Spectrum
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8 
  
9 
  
10 
  
A
V 
E 
  
 
10
4
10
5
10
6
10
7
10
8
-0.5
0
0.5
1
1.5
2
Frequency [Hz]
Bands: 6 to 9 Timerange: 2 to 28 sec
cytoplasm: r = 5.2m,  = 0.45S/m,  = 50 membrane: d = 8nm,  = 5e-06S/m,  = 9
Midpoint Frequencies - Membrane: 67.6kHz Cytoplasm: 42.7MHz
RMS error spectrum 0.18037
R spectrum 0.95744
Spectrum   medium=0.01S/m
 
 
Model
Spectrum
10
4
10
5
10
6
10
7
-1
-0.5
0
0.5
1
1.5
2
Frequency [Hz]
Bands: 6 to 9 Timerange: 2 to 28 sec
cytoplasm: r = 5.2m,  = 0.45S/m,  = 50 membrane: d = 8nm,  = 7e-06S/m,  = 9
Midpoint Frequencies - Membrane: 70.8kHz Cytoplasm: 42.7MHz
RMS error spectrum 0.36217
R spectrum 0.83314
Spectrum   medium=0.01S/m
 
 
Model
Spectrum
10
4
10
5
10
6
10
7
10
8
-0.5
0
0.5
1
1.5
2
Frequency [Hz]
Bands: 6 to 9 Timerange: 2 to 28 sec
cytoplasm: r = 5.2m,  = 0.45S/m,  = 50 membrane: d = 8nm,  = 7e-06S/m,  = 9
Midpoint Frequencies - Membrane: 70.8kHz Cytoplasm: 42.7MHz
RMS error spectrum 0.13251
R spectrum 0.97404
Spectrum   medium=0.01S/m
 
 
10
4
10
5
10
6
10
7
-1
-0.5
0
0.5
1
1.5
2
Frequency [Hz]
Bands: 6 to 9 Timerange: 2 to 28 sec
cytoplasm: r = 5.2m,  = 0.45S/m,  = 50 membrane: d = 8nm,  = 7e-06S/m,  = 9
Midpoint Frequencies - Membrane: 70.8kHz Cytoplasm: 42.7MHz
RMS error spectrum 0.35306
R spectrum 0.83311
Spectrum   medium=0.01S/m
 
 
10
4
10
5
10
6
10
7
10
8
-0.5
0
0.5
1
1.5
Frequency [Hz]
Bands: 6 to 9 Timerange: 2 to 28 sec
cytoplasm: r = 5.2m,  = 0.45S/m,  = 50 membrane: d = 8nm,  = 7e-06S/m,  = 9
Midpoint Frequencies - Membrane: 70.8kHz Cytoplasm: 42.7MHz
RMS error spectrum 0.12225
R spectrum 0.98026
Spectrum   medium=0.01S/m
 
 
10
4
10
5
10
6
10
7
-0.5
0
0.5
1
1.5
2
Frequency [Hz]
Bands: 6 to 9 Timerange: 2 to 28 sec
cytoplasm: r = 5.2m,  = 0.45S/m,  = 50 membrane: d = 8nm,  = 7e-06S/m,  = 9
Midpoint Frequencies - Membrane: 70.8kHz Cytoplasm: 42.7MHz
RMS error spectrum 0.46912
R spectrum 0.69684
Spectrum   medium=0.01S/m
 
 
10
4
10
5
10
6
10
7
10
8
-0.4
-0.2
0
0.2
0.4
0.6
0.8
1
1.2
1.4
1.6
Frequency [Hz]
cytoplasm: r = 5.2m,  = 0.46S/m,  = 50 membrane: d = 8nm,  = 6e-06S/m,  = 10
R = 0.98492
spectrum 
 
 
Average experiment
Single experiment
Model
10
4
10
5
10
6
10
7
-1
-0.5
0
0.5
1
1.5
2
Frequency [Hz]
cytoplasm: r = 5m,  = 0.5S/m,  = 50 membrane: d = 8nm,  = 1e-05S/m,  = 8
R = 0.91472
spectrum 
 
 
Average experiment
Single experiment
Model
 Page | A-8  
 
 
 
 
20 second repeats 
N Run A Run B No Scale Scaled 
1 
  
 
 
2 
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3 
    
4 
 
   
5 
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6 second Repeats 
 
N Frequency set A Frequency set B 
1 
  
2 
 
  
3 
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4 
  
5 
  
6 
  
7 
  
10
4
10
5
10
6
10
7
-1
-0.5
0
0.5
1
1.5
2
Frequency [Hz]
Bands: 6 to 9 Timerange: 0.5 to 5.5 sec
cytoplasm: r = 5.5m,  = 0.45S/m,  = 50 membrane: d = 8nm,  = 5e-006S/m,  = 7.5
Midpoint Frequencies - Membrane: 77.6kHz Cytoplasm: 42.7MHz
RMS error spectrum 0.29057
R spectrum 0.90205
Spectrum   medium=0.01S/m
 
 
Model
Spectrum
10
4
10
5
10
6
10
7
-0.5
0
0.5
1
1.5
2
Frequency [Hz]
Bands: 6 to 9 Timerange: 0.5 to 5.5 sec
cytoplasm: r = 5.5m,  = 0.5S/m,  = 50 membrane: d = 8nm,  = 5e-006S/m,  = 7.5
Midpoint Frequencies - Membrane: 77.6kHz Cytoplasm: 46.8MHz
RMS error spectrum 0.11849
R spectrum 0.98073
Spectrum   medium=0.01S/m
 
 
10
4
10
5
10
6
10
7
-2
-1.5
-1
-0.5
0
0.5
1
1.5
2
Frequency [Hz]
Bands: 6 to 9 Timerange: 0.5 to 5.5 sec
cytoplasm: r = 5.5m,  = 0.5S/m,  = 50 membrane: d = 8nm,  = 5e-006S/m,  = 7.5
Midpoint Frequencies - Membrane: 77.6kHz Cytoplasm: 46.8MHz
RMS error spectrum 0.45268
R spectrum 0.92596
Spectrum   medium=0.01S/m
 
 
Model
Spectrum
10
4
10
5
10
6
10
7
10
8
-1
-0.5
0
0.5
1
1.5
2
Frequency [Hz]
Bands: 6 to 9 Timerange: 0.5 to 5.5 sec
cytoplasm: r = 5.5m,  = 0.5S/m,  = 50 membrane: d = 8nm,  = 5e-006S/m,  = 7.5
Midpoint Frequencies - Membrane: 77.6kHz Cytoplasm: 46.8MHz
RMS error spectrum 0.17901
R spectrum 0.96061
Spectrum   medium=0.01S/m
 
 
10
4
10
5
10
6
10
7
-1.5
-1
-0.5
0
0.5
1
1.5
2
Frequency [Hz]
Bands: 6 to 9 Timerange: 0.5 to 5.5 sec
cytoplasm: r = 5.5m,  = 0.5S/m,  = 50 membrane: d = 8nm,  = 5e-006S/m,  = 7.5
Midpoint Frequencies - Membrane: 77.6kHz Cytoplasm: 46.8MHz
RMS error spectrum 0.29728
R spectrum 0.91257
Spectrum   medium=0.01S/m
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8 
  
9 
  
10 
  
11 
  
10
4
10
5
10
6
10
7
10
8
-0.5
0
0.5
1
1.5
2
Frequency [Hz]
Bands: 6 to 9 Timerange: 0.5 to 5.5 sec
cytoplasm: r = 5.5m,  = 0.5S/m,  = 50 membrane: d = 8nm,  = 5e-006S/m,  = 7.5
Midpoint Frequencies - Membrane: 77.6kHz Cytoplasm: 46.8MHz
RMS error spectrum 0.19352
R spectrum 0.96344
Spectrum   medium=0.01S/m
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cytoplasm: r = 5.5m,  = 0.5S/m,  = 50 membrane: d = 8nm,  = 5e-006S/m,  = 7.5
Midpoint Frequencies - Membrane: 77.6kHz Cytoplasm: 46.8MHz
RMS error spectrum 0.33946
R spectrum 0.86427
Spectrum   medium=0.01S/m
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cytoplasm: r = 5.5m,  = 0.45S/m,  = 50 membrane: d = 8nm,  = 5e-006S/m,  = 7.5
Midpoint Frequencies - Membrane: 77.6kHz Cytoplasm: 42.7MHz
RMS error spectrum 0.18417
R spectrum 0.96192
Spectrum   medium=0.01S/m
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RMS error spectrum 0.29564
R spectrum 0.91631
Spectrum   medium=0.01S/m
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Midpoint Frequencies - Membrane: 77.6kHz Cytoplasm: 42.7MHz
RMS error spectrum 0.25453
R spectrum 0.91523
Spectrum   medium=0.01S/m
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cytoplasm: r = 5.5m,  = 0.45S/m,  = 50 membrane: d = 8nm,  = 5e-006S/m,  = 7.5
Midpoint Frequencies - Membrane: 77.6kHz Cytoplasm: 42.7MHz
RMS error spectrum 0.18184
R spectrum 0.96539
Spectrum   medium=0.01S/m
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RMS error spectrum 0.17772
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Spectrum   medium=0.01S/m
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Midpoint Frequencies - Membrane: 77.6kHz Cytoplasm: 42.7MHz
RMS error spectrum 0.24321
R spectrum 0.91573
Spectrum   medium=0.01S/m
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Bands: 6 to 9 Timerange: 0.5 to 5.5 sec
cytoplasm: r = 5.5m,  = 0.45S/m,  = 50 membrane: d = 8nm,  = 5e-006S/m,  = 7.5
Midpoint Frequencies - Membrane: 77.6kHz Cytoplasm: 42.7MHz
RMS error spectrum 0.24047
R spectrum 0.93705
Spectrum   medium=0.01S/m
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cytoplasm: r = 5.5m,  = 0.45S/m,  = 50 membrane: d = 8nm,  = 5e-006S/m,  = 7.5
Midpoint Frequencies - Membrane: 77.6kHz Cytoplasm: 42.7MHz
RMS error spectrum 0.14102
R spectrum 0.9778
Spectrum   medium=0.01S/m
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Appendix B: Statistics 
 
Radius Statistics (µm) 
Cell Lines 
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RBC Treated and Untreated: 
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RBC All Donors: 
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Vole RBCs 
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Appendix C: MATLAB CODE 
 
Twoshell.m 
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DEP_well_specplotter.m 
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Multipopulation.m 
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Cosinor.m 
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Appendix D: RBC Auto-Fitting Data 
Control Donor Data 
 
 
 
Variable Units Donor 1
Geff S/m2 Time Geff s.e. Geff Ceff s.e. Ceff Cyt Con s.e.cyt con
Ceff F/m2 0 7125 579.6012 0.005202 0.000263 0.1225 0.017795
Cyt Con S/m 4 5250 531.5029 0.004611 0.000365 0.165 0.027469
8 5770.833 242.384 0.005312 4.43E-05 0.13 0.009165
12 6458.333 908.1039 0.005534 0.000639 0.156667 0.02
16 8437.926 729.059 0.005609 0.000214 0.11839 0.008285
20 8125 665.8121 0.005146 0.000451 0.14 0.015123
24 4062.5 312.5 0.005257 0.000277 0.145 0.025
28 4127.091 884.8221 0.005504 0.000198 0.163333 0.025096
32 6875 #DIV/0! 0.005534 #DIV/0! 0.13 #DIV/0!
36 8625 488.2334 0.00487 0.000198 0.1275 0.016906
40 8906.537 546.3329 0.00494 0.000521 0.118894 0.012364
44 6425.209 410.8603 0.00557 0.000376 0.121741 0.002844
48 4167.726 550.1977 0.004975 0.00032 0.163345 0.013345
*DIV/0! When only 
one spectrum
Donor 2
Time Geff s.e. Geff Ceff s.e. Ceff Cyt Con s.e.cyt con
0 6875 927.37 0.005534 0.000613 0.2 0.007987
4 5840.05 952.6592 0.005549 0.00032 0.236215 0.043857
8 4079.115 891.8761 0.005728 0.000262 0.20524 0.040128
12 5505.541 322.3872 0.005758 0.000966 0.138 0.011055
16 9600.943 734.0746 0.00572 0.000487 0.105013 0.016085
20 6958.333 216.1483 0.004965 0.000287 0.100169 0.00592
24 6723.312 856.4183 0.005097 0.000425 0.170854 0.014438
28 6250 #DIV/0! 0.00498 #DIV/0! 0.15 #DIV/0!
32 7099.87 628.0317 0.005266 0.000232 0.1225 0.005281
36 8137.007 169.9037 0.005475 5.95E-05 0.094847 0.010154
40 10541.67 83.33333 0.005903 0.000369 0.122667 0.01392
44 5822.944 1447.944 0.005191 0.000343 0.173045 0.053045
48 5106.58 106.5798 0.004983 2.37E-06 0.135001 0.015001
Donor 3
Time Geff s.e. Geff Ceff s.e. Ceff Cyt Con s.e.cyt con
0 8821.232 777.4867 0.005643 0.000213 0.149175 0.024426
4 5680.211 624.3107 0.006446 0.000218 0.1375 0.00648
8 5734.809 1463.276 0.005291 0.000489 0.15918 0.033948
12 5797.029 549.7402 0.006214 0.000109 0.1375 0.017295
16 12520.52 530.5769 0.006479 0.001 0.109669 0.024125
20 9398.53 874.0446 0.005812 0.000241 0.126461 0.033927
24 5772.225 415.4932 0.005525 0.000668 0.187664 0.076594
28 5610.435 515.527 0.005344 0.000104 0.185442 0.043791
32 6352.85 469.6762 0.005481 0.000631 0.1425 0.022879
36 8187.5 312.5 0.006364 0.000277 0.11 0.001435
40 11419.14 1419.144 0.005225 0.000862 0.099327 0.000673
44 11156.12 1521.295 0.006007 0.000299 0.129915 0.007829
48 6150.392 1605.035 0.006267 0.0009 0.176328 0.004076
Donor 4
Time Geff s.e. Geff Ceff s.e. Ceff Cyt Con s.e.cyt con
0 9751.421 1621.566 0.006552 0.000952 0.106504 0.025458
4 9725 467.5587 0.007554 1.94E-05 0.125 0.063661
8 7183.283 814.3387 0.006832 0.000208 0.142922 0.021424
12 11939.8 1862.007 0.006671 0.000841 0.118798 0.033149
16 12539.66 1962.07 0.007292 0.00044 0.092614 0.00797
20 8833.333 1637.362 0.006103 0.000317 0.173333 0.051705
24 9669.461 811.7971 0.00647 0.001087 0.183835 0.051925
28 4002.083 698.5873 0.00681 0.001278 0.19 0.064232
32 6410.075 #DIV/0! 0.006885 #DIV/0! 0.2 #DIV/0!
36 10000 #DIV/0! 0.006641 #DIV/0! 0.09 #DIV/0!
40 12248.64 2784.262 0.00679 0.000608 0.110722 0.012612
44 7224.54 3639.25 0.006736 0.000824 0.179752 0.034334
48 8860.959 1764.041 0.005919 0.002168 0.250315 0.009685
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DMSO Control 
 
  
Donor 1
time σcyt εcyt Gspec Cspec
0 0.12375 60 7187.5 0.015218
4 0.127919 60 8738.047 0.022967
8 0.173523 60 7881.823 0.018386
12 0.141364 60 8993.57 0.022016
16 0.12025 60 10595.7 0.017642
20 0.138063 60 6299.914 0.019796
24 0.206439 60 6975.594 0.019241
28 0.195583 60 4381.803 0.015171
32 0.127672 60 7186.483 0.016114
36 0.137594 60 7991.222 0.016772
40 0.133943 60 9819.654 0.016353
44 0.162776 60 5132.874 0.01809
48 0.191061 60 5622.56 0.014824
Donor 2
time σcyt εcyt Gspec Cspec
0 0.105959 60 11137.52 0.025871
4 0.122514 60 9709.665 0.024741
8 0.131174 60 7967.257 0.025695
12 0.108918 60 9300.349 0.019121
16 0.109613 60 10611.12 0.024401
20 0.148539 60 7725.916 0.02009
24 0.159448 60 8255.128 0.015934
28 0.156045 60 6124.846 0.00668
32 0.107169 60 8785.777 0.019263
36 0.085995 60 9664.122 0.025025
40 0.110082 60 10391.29 0.024466
44 0.114161 60 8012.696 0.020307
48 0.10044 60 10009.66 0.022666
Donor 3
Time σcyt εcyt Gspec Cspec
0 0.118957 60 5936.312 0.013477
4 0.137213 60 5295.179 0.013058
8 0.126413 60 5834.353 0.013426
12 0.098802 60 5855.903 0.008616
16 0.121292 60 7180.088 0.013339
20 0.162717 60 5720.752 0.010705
24 0.156609 60 4895.634 0.008705
28 0.172538 60 3919.572 0.003619
32 0.121426 60 5213.512 0.010063
36 0.095308 60 5538.441 0.012098
40 0.109375 60 6277.545 0.012944
44 0.126755 60 4745.001 0.010796
48 0.116351 60 5445.191 0.010898
Donor 4
time σcyt εcyt Gspec Cspec
0 0.104692 60 9747.696 0.027025
4 0.09643 60 9069.614 0.03068
8 0.132233 60 7864.006 0.032521
12 0.096517 60 9593.39 0.031987
16 0.109157 60 13181.6 0.026984
20 0.091409 60 9563.185 0.022547
24 0.148452 60 8200.829 0.028184
28 0.174721 60 2478.678 0.010446
32 0.128557 60 7282.378 0.037105
36 0.115668 60 8353.153 0.029695
40 0.086778 60 12885.75 0.028416
44 0.128974 60 7142.821 0.025858
48 0.109726 60 8524.643 0.028394
AVE
Time cyt con perm geff ceff s.e. cyt cons.e. geff
0 0.113339 60 8502.256 0.020398 0.004736 1183.51 0.003519
4 0.121019 60 8203.126 0.022862 0.00874 990.0655 0.00366
8 0.140836 60 7386.86 0.022507 0.010969 517.9926 0.004182
12 0.1114 60 8435.803 0.020435 0.010345 868.6404 0.004808
16 0.115078 60 10392.13 0.020592 0.003295 1231.116 0.003118
20 0.135182 60 7327.442 0.018284 0.015441 856.0859 0.002601
24 0.167737 60 7081.796 0.018016 0.01311 786.3166 0.004041
28 0.174722 60 4226.225 0.008979 0.008108 751.4942 0.002492
32 0.121206 60 7117.037 0.020636 0.004941 732.5902 0.005812
36 0.108641 60 7886.734 0.020898 0.011468 861.3001 0.003967
40 0.110045 60 9843.561 0.020545 0.00963 1362.35 0.003567
44 0.133166 60 6258.348 0.018763 0.010395 786.1797 0.003118
48 0.129395 60 7400.515 0.019196 0.020813 1120.11 0.003922
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STS Treatment 
 
 
Donor 1
time σcyt εcyt Gspec Cspec
0 0.13825 60 6250 0.010791
4 0.126289 60 8360.813 0.025319
8 0.128351 60 8541.997 0.016505
12 0.117208 60 10151.22 0.022099
16 0.12425 60 8812.5 0.019922
20 0.121667 60 9625 0.019922
24 0.126333 60 7708.333 0.018815
28 0.163695 60 7085.626 0.019762
32 0.151643 60 7795.592 0.019264
36 0.148862 60 8341.567 0.018412
40 0.112883 60 8773.91 0.01936
44 0.109487 60 10897.38 0.024244
48 0.123294 60 8493.677 0.021778
Donor 2
time σcyt εcyt Gspec Cspec
0 0.078298 60 7161.948 0.015836
4 0.081356 60 7095.465 0.012598
8 0.080848 60 7062.972 0.011597
12 0.065684 60 7140.114 0.011688
16 0.097699 60 6926.695 0.011646
20 0.078171 60 7302.227 0.010185
24 0.123667 60 7339.168 0.01312
28 0.125444 60 7381.445 0.005984
32 0.082115 60 7816.584 0.012877
36 0.07039 60 7566.609 0.013627
40 0.089659 60 7736.584 0.012944
44 0.082896 60 7435.583 0.010286
48 0.072908 60 7332.144 0.01165
Donor 3
Time σcyt εcyt Gspec Cspec
0 0.179784 60 10525.92 0.007726
4 0.129281 60 10494 0.005784
8 0.110481 60 11389.94 0.006519
12 0.110696 60 10757.64 0.007392
16 0.108182 60 9714.517 0.008021
20 0.133756 60 7755.952 0.006618
24 0.182819 60 8011.656 0.006214
28 0.194984 60 7499.561 0.007424
32 0.223349 60 7491.25 0.007374
36 0.178913 60 8729.579 0.007137
40 0.138376 60 9538.232 0.006987
44 0.11475 60 9746.319 0.006041
48 0.125217 60 10694.56 0.007636
Donor 4
Time σcyt εcyt Gspec Cspec
0 0.11108 60 6412.713 0.011258
4 0.105858 60 6083.683 0.010069
8 0.093359 60 7373.572 0.010066
12 0.088877 60 6393.218 0.010403
16 0.093326 60 6687.418 0.011908
20 0.107044 60 6678.035 0.010023
24 0.114245 60 6298.83 0.011284
28 0.129186 60 6131.397 0.010107
32 0.095066 60 6570.212 0.012039
36 0.097517 60 6798.47 0.010546
40 0.072988 60 7146.755 0.007499
44 0.087134 60 6596.952 0.010382
48 0.095019 60 6561.497 0.008904
AVE
Time cyt con perm geff ceff s.e. cyt cons.e. geff s.e. ceff
0 0.126853 60 7587.644 0.011403 0.021482 999.3502 0.001672
4 0.110696 60 8008.49 0.013442 0.011078 950.4554 0.004201
8 0.10326 60 8592.122 0.011172 0.010336 985.4562 0.002072
12 0.095616 60 8610.55 0.012896 0.011673 1082.529 0.003197
16 0.105864 60 8035.282 0.012874 0.006876 734.2571 0.002511
20 0.110159 60 7840.304 0.011687 0.01198 634.603 0.002865
24 0.136766 60 7339.497 0.012358 0.015568 373.1426 0.002601
28 0.153327 60 7024.507 0.010819 0.016338 310.1697 0.003101
32 0.138043 60 7418.409 0.012888 0.032194 292.3402 0.002446
36 0.123921 60 7859.056 0.01243 0.02451 428.2713 0.002394
40 0.103477 60 8298.871 0.011697 0.014221 532.6987 0.002888
44 0.098567 60 8669.059 0.012738 0.007945 997.5385 0.003967
48 0.10411 60 8270.47 0.012492 0.012483 900.3281 0.003207
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VAL Treatment 
 
 
Donor 1
Cyt Conductivity:  Mem  Conductance:  Mem Capacitance:  CI CI CI
0 0.105740 21832.67 0.014671 0.015349 2122.685 0.001742
4 0.157340 12032.79622 0.006268383 0.017587 750.2953 0.000339
8 0.067891 17718.01533 0.011890131 0.001331 1043.953 0.000655
12 0.073365 20213.3809 0.010390169 0.002532 1608.25 0.001096
16 0.082081 18927.74318 0.019945709 0.003092 1176.115 0.002245
20 0.066510 20899.35679 0.016781222 0.00098 1067.374 0.001187
24 0.192568 5851.563022 0.006558758 0.031746 911.531 0.000226
28 0.136766 7285.384417 0.008566004 0.016501 1085.622 0.00029
32 0.179657 8410.144756 0.007113518 0.036928 1113.976 0.000311
36 0.107992 15724.53 0.006553 0.006817 811.7173 0.00036
40 0.118927 15621.0314 0.006290919 0.011354 974.2581 0.000398
44 0.072660 19549.07 0.021721 0.002901 1998.714 0.002902
48 0.126766 14909.44808 0.006157584 0.008893 654.3797 0.00035
Donor 3
Cyt Conductivity:  Mem  Conductance:  Mem Capacitance:  CI CI CI
0 0.076658221 22668.73644 0.013463441 0.005067 2079.122 0.002354
4 0.098039226 22264.30577 0.01710554 0.010816 1910.51 0.003783
8 0.090829001 18229.29898 0.006967556 0.007493 1491.242 0.001017
12 0.082001284 20327.82233 0.007679195 0.00301 917.1443 0.001395
16 0.088550981 19216.2277 0.01466652 0.006937 1472.577 0.003034
20 0.07833379 20261.22607 0.00919592 0.002564 1116.159 0.001649
24 0.112212679 12359.22272 0.013885501 0.021953 2232.519 0.002109
28 0.076682287 23337.34215 0.019341613 0.004196 1807.918 0.003399
32 0.079055742 21793.53614 0.011816156 0.0022 815.4062 0.002096
36 0.092125127 18935.91291 0.009153732 0.00767 1378.262 0.001732
40 0.077398303 21130.89511 0.008960461 0.002753 1019.111 0.001579
44 0.077580734 19951.95324 0.010172485 0.00278 1094.516 0.001255
48 0.0758247 23159.67836 0.007467603 0.002343 998.1673 0.001193
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Donor 4
Cyt Conductivity:  Mem  Conductance:  Mem Capacitance:  CI CI CI
0 0.078301474 23924.78618 0.0147107 0.002435 1425.561 0.002801
4 0.101483434 21027.99219 0.015855253 0.014606 2110.321 0.004061
8 0.076725091 20474.40536 0.006681035 0.001735 819.2132 0.000776
12 0.068728698 25568.03023 0.022780747 0.002424 1835.503 0.006027
16 0.068913381 23137.48211 0.019634221 0.00276 1918.595 0.004496
20 0.083761155 20444.7287 0.0117486 0.006715 1839.887 0.003289
24 0.074239675 22745.27434 0.011829776 0.001459 1041.632 0.002167
28 0.123110598 15017.52625 0.012664351 0.022329 1637.982 0.002425
32 0.078480323 21212.59571 0.012262669 0.002338 829.9053 0.002189
36 0.075784178 21656.29521 0.012870461 0.001559 807.0784 0.00275
40 0.089363015 16914.75229 0.009327496 0.005288 1256.816 0.001641
44 0.080727935 19368.73962 0.008571487 0.002093 868.6463 0.001241
48 0.075113842 22474.97323 0.011242019 0.002612 1206.216 0.001686
Donor 5
Time Cyt Conductivity:  Mem  Conductance:  Mem Capacitance:  CI CI CI
0 0.132621761 12635.89468 0.012709522 0.0278 1911.24 0.001136
4 0.076127649 18186.89049 0.020441192 0.002469 1766.657 0.001846
8 0.07629226 21065.25706 0.011774092 0.001281 920.1882 0.000716
12 0.09242443 17271.41342 0.011801242 0.006549 1398.424 0.001301
16 0.081813027 16981.29016 0.012287868 0.003161 1062.47 0.000712
20 0.071905453 23746.21456 0.019317529 0.001895 1425.373 0.001712
24 0.098442986 17188.81185 0.013511755 0.013183 2101.99 0.001238
28 0.097998851 10421.77195 0.018854015 0.006593 1240.126 0.001645
32 0.102855451 12424.41528 0.015467669 0.010498 1629.053 0.001226
36 0.093773985 20220.83736 0.009164961 0.005193 973.7546 0.00098
40 0.085872621 22282.462 0.013797904 0.002967 997.7234 0.001498
44 0.0766652 16786.12934 0.016867756 0.002298 1336.894 0.001718
48 0.123875806 15779.12324 0.005860758 0.008935 690.5169 0.000408
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Whole Blood vs Isolated 
 
isolated whole blood
Auto-Fit Singel-Shell Modelparameters: Auto-Fit Singel-Shell Modelparameters: 
Pearson Correlation Coeffcient R: 0.907919099705233 Pearson Correlation Coeffcient R: 0.882707630951079
Midpoint Membrane:  354.1662  kHz Midpoint Membrane:  223.4785  kHz
Midpoint Cytoplasm:  14092.19  kHz Midpoint Cytoplasm:  14092.19  kHz
Cell parameters: Cell parameters: 
Cytoplasm Conductivity:   0.0924786815671788S/m +-0.00498940438702513 Cytoplasm Conductivity:   0.0906459298665923S/m +-0.00425607533405261
Cytoplasm Permitivity:   60 (Fixed) Cytoplasm Permitivity:   60 (Fixed)
Specific Membrane Conductance:  17937.52  S/m^2 +-956.086210626578 Specific Membrane Conductance:  17526.03  S/m^2 +-901.163376687085
Spcific Membrane Capacitance:  0.011966  F/m^2 +-0.000936105970874455 Spcific Membrane Capacitance:  0.01948  F/m^2 +-0.00118016759552668
Cell Radius:  4.2  um (Fixed) Cell Radius:  4.2  um (Fixed)
Medium Coductivity:  0.043  S/m (Fixed) Medium Coductivity:  0.043  S/m (Fixed)
Medium Permitivity:   78 (Fixed) Medium Permitivity:   78 (Fixed)
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Vole DEP Data 
 
 
 
 
Vole 1
σcyt Gspec Cspec
0 0.095 281.25 0.004593
30 0.084 120 0.004074
60 0.155194 472.338 0.00422
90 0.104475 1229.223 0.004529
120 0.083376 844.7527 0.004657
150 0.087369 671.4506 0.004725
180 0.123628 953.9921 0.004297
210 0.090871 309.8747 0.004643
Vole 2
σcyt Gspec Cspec
0 0.093333 416.6667 0.004648
30 0.104465 994.3031 0.004966
60 0.121569 1065.624 0.004832
90 0.11 172.5 0.005025
120 0.083899 473.0801 0.004771
Vole 3
σcyt Gspec Cspec
0 0.105 90.625 0.004704
30 0.092 362.5 0.00425
60 0.156 275 0.005157
90 0.156 180 0.004471
120 0.13 196.875 0.004316
150 0.11375 453.125 0.004289
180 0.12 30.1 0.004715
210 0.145 28.125 0.004372
Vole 4 σcyt Gspec Cspec
0 0.09039 348.5235 0.004785
30 0.1325 46.875 0.004704
60 0.14 33.33333 0.004058
90 0.123333 458.3333 0.005276
120 0.110733 518.0933 0.004276
150 0.13 454.1667 0.004538
180 0.143333 250 0.005165
210 0.1025 231.25 0.005146
Vole 5 σcyt Gspec Cspec
0 0.112871 1816.715 0.009283
30 0.092367 2080.514 0.011704
60 0.08756 1798.487 0.009456
90 0.118794 1145.653 0.009691
120 0.098489 1896.141 0.008735
150 0.082114 1423.923 0.009554
180 0.154235 1378.775 0.008719
210 0.081346 1763.133 0.009676
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Kai F Hoettges, Erin A. Henslee, Ruth M. Torcal Serrano, Rita I Jabr, Abdul Waheed, 
Patrizia Camelleti, Christopher H. Fry, Fatima H. Labeed, Michael P. Hughes. Ten –
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Nature Methods (preparation). 
Conference Proceedings 
Erin A. Henslee, Malcolm von Schantz, John O’Niell, and Fatima H. Labeed. 
Electrophysiological Rhythms in Red Blood Cells, Annual Meeting of the 
AES Electrophoresis Society, Salt Lake City, UT, 2015 
 
Erin A. Henslee and Fatima H. Labeed., Robust Dielectrophoretic Cell Aggregation in 
Biocompatible Hydrogels, Annual Meeting of the AES Electrophoresis Society, Salt  
Lake City, UT, 2015 
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